{
  "nbformat": 4,
  "nbformat_minor": 0,
  "metadata": {
    "colab": {
      "provenance": [],
      "authorship_tag": "ABX9TyOXzP7ENPIAwIqSIX+nE1J5",
      "include_colab_link": true
    },
    "kernelspec": {
      "name": "python3",
      "display_name": "Python 3"
    },
    "language_info": {
      "name": "python"
    }
  },
  "cells": [
    {
      "cell_type": "markdown",
      "metadata": {
        "id": "view-in-github",
        "colab_type": "text"
      },
      "source": [
        "<a href=\"https://colab.research.google.com/github/kelvin-kiplagat/DTE-Team-5/blob/main/DTE_Team_5_Phase_II.ipynb\" target=\"_parent\"><img src=\"https://colab.research.google.com/assets/colab-badge.svg\" alt=\"Open In Colab\"/></a>"
      ]
    },
    {
      "cell_type": "markdown",
      "source": [
        "**Libraries**"
      ],
      "metadata": {
        "id": "SwN-9f0WAfst"
      }
    },
    {
      "cell_type": "code",
      "execution_count": 1,
      "metadata": {
        "id": "aHNMEjreAUqi",
        "colab": {
          "base_uri": "https://localhost:8080/"
        },
        "outputId": "009d03e5-5d41-4797-df45-1a88cdcc4365"
      },
      "outputs": [
        {
          "output_type": "stream",
          "name": "stderr",
          "text": [
            "[nltk_data] Downloading package punkt to /root/nltk_data...\n",
            "[nltk_data]   Unzipping tokenizers/punkt.zip.\n"
          ]
        }
      ],
      "source": [
        "import numpy as np\n",
        "import pandas as pd\n",
        "import matplotlib.pyplot as plt\n",
        "import seaborn as sns\n",
        "import os\n",
        "from functools import reduce\n",
        "\n",
        "# ML\n",
        "from sklearn.feature_extraction.text import TfidfVectorizer, CountVectorizer\n",
        "from sklearn.decomposition import LatentDirichletAllocation\n",
        "import nltk\n",
        "from sklearn.model_selection import train_test_split\n",
        "\n",
        "nltk.download('punkt')\n",
        "plt.style.use(\"seaborn-v0_8-bright\")"
      ]
    },
    {
      "cell_type": "markdown",
      "source": [
        "**Mount Drive**"
      ],
      "metadata": {
        "id": "Y0ko0jAXIRBo"
      }
    },
    {
      "cell_type": "code",
      "source": [
        "from google.colab import drive\n",
        "drive.mount(\"drive\")"
      ],
      "metadata": {
        "colab": {
          "base_uri": "https://localhost:8080/"
        },
        "id": "Lcy8X0QpIQX6",
        "outputId": "bb8b0581-62cc-4027-e56f-9a4aa1fe55d1"
      },
      "execution_count": 2,
      "outputs": [
        {
          "output_type": "stream",
          "name": "stdout",
          "text": [
            "Mounted at drive\n"
          ]
        }
      ]
    },
    {
      "cell_type": "markdown",
      "source": [
        "**Datasets**\n",
        "- Full paths to the datasets"
      ],
      "metadata": {
        "id": "b4KknJjtA1iC"
      }
    },
    {
      "cell_type": "code",
      "source": [
        "access_path = './drive/MyDrive/Datathon/Phase II/Data'"
      ],
      "metadata": {
        "id": "m2WL8ax_AfGP"
      },
      "execution_count": 3,
      "outputs": []
    },
    {
      "cell_type": "markdown",
      "source": [],
      "metadata": {
        "id": "YptWQYCZCYSj"
      }
    },
    {
      "cell_type": "code",
      "source": [
        "# Read in the dataframes\n",
        "cancer_df, covid_df, heart_df, hiv_df, malaria_df, pneumonia_df = [pd.read_csv(access_path + f\"/{fname}\") for fname in os.listdir(access_path)]\n",
        "\n",
        "datasets = [cancer_df, covid_df, heart_df, hiv_df, malaria_df, pneumonia_df]\n",
        "study_areas = [\"cancer\", \"covid\", \"heart\", \"HIV\", \"malaria\", \"pneumonia\"]\n",
        "cols_to_drop = ['nct_number', 'study_title', 'study_url', 'acronym', 'brief_summary', 'other_ids', 'study_documents'] #'secondary_outcome_measures', 'primary_outcome_measures'\n",
        "\n",
        "\n",
        "# process the column names, drop unnecessary columns, and merge the dataframes into one big dataframe\n",
        "clinical_df = pd.DataFrame()\n",
        "for i in range(len(datasets)):\n",
        "    df = datasets[i]\n",
        "    disease_of_interest = study_areas[i]\n",
        "    df.columns = [col.lower().replace(\" \",\"_\") for col in df.columns]\n",
        "    df_ = df.drop(columns = cols_to_drop)\n",
        "    df_['study_area'] = disease_of_interest\n",
        "    clinical_df = pd.concat([clinical_df, df_], axis = 0, ignore_index = True)\n",
        "\n",
        "# Drop rows that do not have a start date\n",
        "print(f\"Number of trials with no start date: {clinical_df.start_date.isna().sum()}\")\n",
        "clinical_df = clinical_df.loc[clinical_df.start_date.notna(), :]\n",
        "# Preprocess date columns\n",
        "date_columns = [\"start_date\", \"primary_completion_date\", \"completion_date\", \"first_posted\", \"results_first_posted\", \"last_update_posted\"]\n",
        "clinical_df[date_columns] = reduce(lambda x, y : pd.concat([x, y], axis = 1), [pd.to_datetime(clinical_df[col], format = \"%Y-%m-%d\", errors = \"coerce\") for col in date_columns])\n",
        "clinical_df['start_year'] = clinical_df.start_date.apply(lambda x : x.year)\n",
        "clinical_df = clinical_df.loc[clinical_df.start_year < 2024, :] # Filter out any clinical trial that has not started\n",
        "clinical_df['days_to_completion'] = (clinical_df.completion_date - clinical_df.start_date).apply(lambda x : x.days) # Compute days to completion\n",
        "\n",
        "# Extract the Masking Type and Intervention Model\n",
        "def extract_model(text):\n",
        "    if type(text) != float: # Unpopular way of eliminating NaNs\n",
        "        if \"Intervention\" in text:\n",
        "            texts = text.split(\"|\")\n",
        "            intervention_model = texts[1].split(\": \")[1]\n",
        "            return (intervention_model)\n",
        "        return np.nan\n",
        "    return np.nan\n",
        "\n",
        "def extract_masking(text):\n",
        "    if type(text) != float: # Unpopular way of eliminating NaNs\n",
        "        if \"Intervention\" in text:\n",
        "            texts = text.split(\"|\")\n",
        "            masking = texts[2].split(\" \")[1]\n",
        "            return (masking)\n",
        "        return np.nan\n",
        "    return np.nan\n",
        "\n",
        "# Add those columns\n",
        "clinical_df[\"intervention_model\"] = clinical_df.study_design.apply(extract_model)\n",
        "clinical_df[\"masking\"] = clinical_df.study_design.apply(extract_masking)\n",
        "clinical_df[\"has_collaborators\"] =  clinical_df.collaborators.apply(lambda x: 0 if pd.isnull(x)  else 1) # 0 if no collaborators else 1\n",
        "clinical_df[\"interventions_count\"] = clinical_df.interventions.apply(lambda x: 0 if pd.isnull(x)  else len(x.split(\"|\")))\n",
        "clinical_df[\"all_outcome_measures\"] = (clinical_df[\"primary_outcome_measures\"].replace(np.nan, \"\") + \" \" + # Merge all the outcome measures into 1\n",
        "                                       clinical_df[\"secondary_outcome_measures\"].replace(np.nan, \"\") + \" \" +\n",
        "                                       clinical_df[\"other_outcome_measures\"].replace(np.nan, \"\"))\n",
        "clinical_df = clinical_df.drop(columns = ['secondary_outcome_measures', 'primary_outcome_measures', 'other_outcome_measures'])\n",
        "\n",
        "print(\"Total Number of Observations: \",clinical_df.shape[0])\n",
        "print(clinical_df.info())\n",
        "clinical_df.sample(5)"
      ],
      "metadata": {
        "colab": {
          "base_uri": "https://localhost:8080/",
          "height": 1000
        },
        "id": "ugQHaAzcCTIv",
        "outputId": "97afa66e-ddba-4f88-b925-2de9140d8540"
      },
      "execution_count": 4,
      "outputs": [
        {
          "output_type": "stream",
          "name": "stdout",
          "text": [
            "Number of trials with no start date: 2356\n",
            "Total Number of Observations:  159008\n",
            "<class 'pandas.core.frame.DataFrame'>\n",
            "Int64Index: 159008 entries, 0 to 161862\n",
            "Data columns (total 28 columns):\n",
            " #   Column                   Non-Null Count   Dtype         \n",
            "---  ------                   --------------   -----         \n",
            " 0   study_status             159008 non-null  object        \n",
            " 1   study_results            159008 non-null  object        \n",
            " 2   conditions               159006 non-null  object        \n",
            " 3   interventions            141952 non-null  object        \n",
            " 4   sponsor                  159008 non-null  object        \n",
            " 5   collaborators            60055 non-null   object        \n",
            " 6   sex                      158872 non-null  object        \n",
            " 7   age                      159008 non-null  object        \n",
            " 8   phases                   79909 non-null   object        \n",
            " 9   enrollment               156568 non-null  float64       \n",
            " 10  funder_type              159008 non-null  object        \n",
            " 11  study_type               159008 non-null  object        \n",
            " 12  study_design             158971 non-null  object        \n",
            " 13  start_date               159008 non-null  datetime64[ns]\n",
            " 14  primary_completion_date  152868 non-null  datetime64[ns]\n",
            " 15  completion_date          153386 non-null  datetime64[ns]\n",
            " 16  first_posted             159008 non-null  datetime64[ns]\n",
            " 17  results_first_posted     19812 non-null   datetime64[ns]\n",
            " 18  last_update_posted       159008 non-null  datetime64[ns]\n",
            " 19  locations                145480 non-null  object        \n",
            " 20  study_area               159008 non-null  object        \n",
            " 21  start_year               159008 non-null  int64         \n",
            " 22  days_to_completion       153386 non-null  float64       \n",
            " 23  intervention_model       118366 non-null  object        \n",
            " 24  masking                  118366 non-null  object        \n",
            " 25  has_collaborators        159008 non-null  int64         \n",
            " 26  interventions_count      159008 non-null  int64         \n",
            " 27  all_outcome_measures     159008 non-null  object        \n",
            "dtypes: datetime64[ns](6), float64(2), int64(3), object(17)\n",
            "memory usage: 35.2+ MB\n",
            "None\n"
          ]
        },
        {
          "output_type": "execute_result",
          "data": {
            "text/plain": [
              "       study_status study_results  \\\n",
              "51006    RECRUITING            NO   \n",
              "34895    RECRUITING            NO   \n",
              "158445      UNKNOWN            NO   \n",
              "128796      UNKNOWN            NO   \n",
              "85911       UNKNOWN            NO   \n",
              "\n",
              "                                               conditions  \\\n",
              "51006   Breast Cancer Patients Undergoing Mastectomy W...   \n",
              "34895                                  Solid Tumor, Adult   \n",
              "158445                                    Senile Cataract   \n",
              "128796                           Congestive Heart Failure   \n",
              "85911                     HIV-associated Hodgkin Lymphoma   \n",
              "\n",
              "                                            interventions  \\\n",
              "51006   DRUG: Morphine|OTHER: Ultrasound-guided erecto...   \n",
              "34895                                 BIOLOGICAL: GEN1053   \n",
              "158445                               OTHER: Questionnaire   \n",
              "128796                        RADIATION: Echocardiography   \n",
              "85911   DRUG: Doxorubicin|DRUG: Bleomycin|DRUG: Vinbla...   \n",
              "\n",
              "                                 sponsor                    collaborators  \\\n",
              "51006   The Netherlands Cancer Institute                              NaN   \n",
              "34895                             Genmab                      BioNTech SE   \n",
              "158445      Medical University Innsbruck                              NaN   \n",
              "128796                 Assiut University                              NaN   \n",
              "85911       Harlachinger Krebshilfe e.V.  Deutsche AIDS Gesellschaft e.V.   \n",
              "\n",
              "           sex                 age         phases  enrollment  ...  \\\n",
              "51006   FEMALE  ADULT, OLDER_ADULT            NaN       100.0  ...   \n",
              "34895      ALL  ADULT, OLDER_ADULT  PHASE1|PHASE2       103.0  ...   \n",
              "158445     ALL  ADULT, OLDER_ADULT            NaN       116.0  ...   \n",
              "128796     ALL  ADULT, OLDER_ADULT            NaN       289.0  ...   \n",
              "85911      ALL  ADULT, OLDER_ADULT         PHASE2       130.0  ...   \n",
              "\n",
              "       last_update_posted                                          locations  \\\n",
              "51006          2022-10-21  NKI-AvL, Amsterdam, Noord-Holland, 1066CX, Net...   \n",
              "34895          2023-08-08  Yale University, New Haven, Connecticut, 06510...   \n",
              "158445         2020-09-23  Medical University Innsbruck, Innsbruck, Tyrol...   \n",
              "128796         2020-06-22                                                NaN   \n",
              "85911          2011-11-09  Vivantes Auguste Victoria Klinikum, Berlin, 12...   \n",
              "\n",
              "       study_area start_year days_to_completion intervention_model masking  \\\n",
              "51006      cancer       2021              578.0           PARALLEL  TRIPLE   \n",
              "34895      cancer       2022             1731.0       SINGLE_GROUP    NONE   \n",
              "158445  pneumonia       2020              174.0                NaN     NaN   \n",
              "128796      heart       2020              518.0                NaN     NaN   \n",
              "85911      cancer       2004             3044.0       SINGLE_GROUP    NONE   \n",
              "\n",
              "       has_collaborators interventions_count  \\\n",
              "51006                  0                   2   \n",
              "34895                  1                   1   \n",
              "158445                 0                   1   \n",
              "128796                 0                   1   \n",
              "85911                  1                   9   \n",
              "\n",
              "                                     all_outcome_measures  \n",
              "51006   Mean difference of highest numerical rating sc...  \n",
              "34895   Escalation: Dose Limiting Toxicities (DLTs), T...  \n",
              "158445  Improvement Vision-related quality of life, Ex...  \n",
              "128796  risk factors of CHF in hemodialysis patients, ...  \n",
              "85911   Number of patients with World Health Organizat...  \n",
              "\n",
              "[5 rows x 28 columns]"
            ],
            "text/html": [
              "\n",
              "  <div id=\"df-ce64d6b1-a47a-4c3b-86ca-6fd8452c1845\" class=\"colab-df-container\">\n",
              "    <div>\n",
              "<style scoped>\n",
              "    .dataframe tbody tr th:only-of-type {\n",
              "        vertical-align: middle;\n",
              "    }\n",
              "\n",
              "    .dataframe tbody tr th {\n",
              "        vertical-align: top;\n",
              "    }\n",
              "\n",
              "    .dataframe thead th {\n",
              "        text-align: right;\n",
              "    }\n",
              "</style>\n",
              "<table border=\"1\" class=\"dataframe\">\n",
              "  <thead>\n",
              "    <tr style=\"text-align: right;\">\n",
              "      <th></th>\n",
              "      <th>study_status</th>\n",
              "      <th>study_results</th>\n",
              "      <th>conditions</th>\n",
              "      <th>interventions</th>\n",
              "      <th>sponsor</th>\n",
              "      <th>collaborators</th>\n",
              "      <th>sex</th>\n",
              "      <th>age</th>\n",
              "      <th>phases</th>\n",
              "      <th>enrollment</th>\n",
              "      <th>...</th>\n",
              "      <th>last_update_posted</th>\n",
              "      <th>locations</th>\n",
              "      <th>study_area</th>\n",
              "      <th>start_year</th>\n",
              "      <th>days_to_completion</th>\n",
              "      <th>intervention_model</th>\n",
              "      <th>masking</th>\n",
              "      <th>has_collaborators</th>\n",
              "      <th>interventions_count</th>\n",
              "      <th>all_outcome_measures</th>\n",
              "    </tr>\n",
              "  </thead>\n",
              "  <tbody>\n",
              "    <tr>\n",
              "      <th>51006</th>\n",
              "      <td>RECRUITING</td>\n",
              "      <td>NO</td>\n",
              "      <td>Breast Cancer Patients Undergoing Mastectomy W...</td>\n",
              "      <td>DRUG: Morphine|OTHER: Ultrasound-guided erecto...</td>\n",
              "      <td>The Netherlands Cancer Institute</td>\n",
              "      <td>NaN</td>\n",
              "      <td>FEMALE</td>\n",
              "      <td>ADULT, OLDER_ADULT</td>\n",
              "      <td>NaN</td>\n",
              "      <td>100.0</td>\n",
              "      <td>...</td>\n",
              "      <td>2022-10-21</td>\n",
              "      <td>NKI-AvL, Amsterdam, Noord-Holland, 1066CX, Net...</td>\n",
              "      <td>cancer</td>\n",
              "      <td>2021</td>\n",
              "      <td>578.0</td>\n",
              "      <td>PARALLEL</td>\n",
              "      <td>TRIPLE</td>\n",
              "      <td>0</td>\n",
              "      <td>2</td>\n",
              "      <td>Mean difference of highest numerical rating sc...</td>\n",
              "    </tr>\n",
              "    <tr>\n",
              "      <th>34895</th>\n",
              "      <td>RECRUITING</td>\n",
              "      <td>NO</td>\n",
              "      <td>Solid Tumor, Adult</td>\n",
              "      <td>BIOLOGICAL: GEN1053</td>\n",
              "      <td>Genmab</td>\n",
              "      <td>BioNTech SE</td>\n",
              "      <td>ALL</td>\n",
              "      <td>ADULT, OLDER_ADULT</td>\n",
              "      <td>PHASE1|PHASE2</td>\n",
              "      <td>103.0</td>\n",
              "      <td>...</td>\n",
              "      <td>2023-08-08</td>\n",
              "      <td>Yale University, New Haven, Connecticut, 06510...</td>\n",
              "      <td>cancer</td>\n",
              "      <td>2022</td>\n",
              "      <td>1731.0</td>\n",
              "      <td>SINGLE_GROUP</td>\n",
              "      <td>NONE</td>\n",
              "      <td>1</td>\n",
              "      <td>1</td>\n",
              "      <td>Escalation: Dose Limiting Toxicities (DLTs), T...</td>\n",
              "    </tr>\n",
              "    <tr>\n",
              "      <th>158445</th>\n",
              "      <td>UNKNOWN</td>\n",
              "      <td>NO</td>\n",
              "      <td>Senile Cataract</td>\n",
              "      <td>OTHER: Questionnaire</td>\n",
              "      <td>Medical University Innsbruck</td>\n",
              "      <td>NaN</td>\n",
              "      <td>ALL</td>\n",
              "      <td>ADULT, OLDER_ADULT</td>\n",
              "      <td>NaN</td>\n",
              "      <td>116.0</td>\n",
              "      <td>...</td>\n",
              "      <td>2020-09-23</td>\n",
              "      <td>Medical University Innsbruck, Innsbruck, Tyrol...</td>\n",
              "      <td>pneumonia</td>\n",
              "      <td>2020</td>\n",
              "      <td>174.0</td>\n",
              "      <td>NaN</td>\n",
              "      <td>NaN</td>\n",
              "      <td>0</td>\n",
              "      <td>1</td>\n",
              "      <td>Improvement Vision-related quality of life, Ex...</td>\n",
              "    </tr>\n",
              "    <tr>\n",
              "      <th>128796</th>\n",
              "      <td>UNKNOWN</td>\n",
              "      <td>NO</td>\n",
              "      <td>Congestive Heart Failure</td>\n",
              "      <td>RADIATION: Echocardiography</td>\n",
              "      <td>Assiut University</td>\n",
              "      <td>NaN</td>\n",
              "      <td>ALL</td>\n",
              "      <td>ADULT, OLDER_ADULT</td>\n",
              "      <td>NaN</td>\n",
              "      <td>289.0</td>\n",
              "      <td>...</td>\n",
              "      <td>2020-06-22</td>\n",
              "      <td>NaN</td>\n",
              "      <td>heart</td>\n",
              "      <td>2020</td>\n",
              "      <td>518.0</td>\n",
              "      <td>NaN</td>\n",
              "      <td>NaN</td>\n",
              "      <td>0</td>\n",
              "      <td>1</td>\n",
              "      <td>risk factors of CHF in hemodialysis patients, ...</td>\n",
              "    </tr>\n",
              "    <tr>\n",
              "      <th>85911</th>\n",
              "      <td>UNKNOWN</td>\n",
              "      <td>NO</td>\n",
              "      <td>HIV-associated Hodgkin Lymphoma</td>\n",
              "      <td>DRUG: Doxorubicin|DRUG: Bleomycin|DRUG: Vinbla...</td>\n",
              "      <td>Harlachinger Krebshilfe e.V.</td>\n",
              "      <td>Deutsche AIDS Gesellschaft e.V.</td>\n",
              "      <td>ALL</td>\n",
              "      <td>ADULT, OLDER_ADULT</td>\n",
              "      <td>PHASE2</td>\n",
              "      <td>130.0</td>\n",
              "      <td>...</td>\n",
              "      <td>2011-11-09</td>\n",
              "      <td>Vivantes Auguste Victoria Klinikum, Berlin, 12...</td>\n",
              "      <td>cancer</td>\n",
              "      <td>2004</td>\n",
              "      <td>3044.0</td>\n",
              "      <td>SINGLE_GROUP</td>\n",
              "      <td>NONE</td>\n",
              "      <td>1</td>\n",
              "      <td>9</td>\n",
              "      <td>Number of patients with World Health Organizat...</td>\n",
              "    </tr>\n",
              "  </tbody>\n",
              "</table>\n",
              "<p>5 rows Ã— 28 columns</p>\n",
              "</div>\n",
              "    <div class=\"colab-df-buttons\">\n",
              "\n",
              "  <div class=\"colab-df-container\">\n",
              "    <button class=\"colab-df-convert\" onclick=\"convertToInteractive('df-ce64d6b1-a47a-4c3b-86ca-6fd8452c1845')\"\n",
              "            title=\"Convert this dataframe to an interactive table.\"\n",
              "            style=\"display:none;\">\n",
              "\n",
              "  <svg xmlns=\"http://www.w3.org/2000/svg\" height=\"24px\" viewBox=\"0 -960 960 960\">\n",
              "    <path d=\"M120-120v-720h720v720H120Zm60-500h600v-160H180v160Zm220 220h160v-160H400v160Zm0 220h160v-160H400v160ZM180-400h160v-160H180v160Zm440 0h160v-160H620v160ZM180-180h160v-160H180v160Zm440 0h160v-160H620v160Z\"/>\n",
              "  </svg>\n",
              "    </button>\n",
              "\n",
              "  <style>\n",
              "    .colab-df-container {\n",
              "      display:flex;\n",
              "      gap: 12px;\n",
              "    }\n",
              "\n",
              "    .colab-df-convert {\n",
              "      background-color: #E8F0FE;\n",
              "      border: none;\n",
              "      border-radius: 50%;\n",
              "      cursor: pointer;\n",
              "      display: none;\n",
              "      fill: #1967D2;\n",
              "      height: 32px;\n",
              "      padding: 0 0 0 0;\n",
              "      width: 32px;\n",
              "    }\n",
              "\n",
              "    .colab-df-convert:hover {\n",
              "      background-color: #E2EBFA;\n",
              "      box-shadow: 0px 1px 2px rgba(60, 64, 67, 0.3), 0px 1px 3px 1px rgba(60, 64, 67, 0.15);\n",
              "      fill: #174EA6;\n",
              "    }\n",
              "\n",
              "    .colab-df-buttons div {\n",
              "      margin-bottom: 4px;\n",
              "    }\n",
              "\n",
              "    [theme=dark] .colab-df-convert {\n",
              "      background-color: #3B4455;\n",
              "      fill: #D2E3FC;\n",
              "    }\n",
              "\n",
              "    [theme=dark] .colab-df-convert:hover {\n",
              "      background-color: #434B5C;\n",
              "      box-shadow: 0px 1px 3px 1px rgba(0, 0, 0, 0.15);\n",
              "      filter: drop-shadow(0px 1px 2px rgba(0, 0, 0, 0.3));\n",
              "      fill: #FFFFFF;\n",
              "    }\n",
              "  </style>\n",
              "\n",
              "    <script>\n",
              "      const buttonEl =\n",
              "        document.querySelector('#df-ce64d6b1-a47a-4c3b-86ca-6fd8452c1845 button.colab-df-convert');\n",
              "      buttonEl.style.display =\n",
              "        google.colab.kernel.accessAllowed ? 'block' : 'none';\n",
              "\n",
              "      async function convertToInteractive(key) {\n",
              "        const element = document.querySelector('#df-ce64d6b1-a47a-4c3b-86ca-6fd8452c1845');\n",
              "        const dataTable =\n",
              "          await google.colab.kernel.invokeFunction('convertToInteractive',\n",
              "                                                    [key], {});\n",
              "        if (!dataTable) return;\n",
              "\n",
              "        const docLinkHtml = 'Like what you see? Visit the ' +\n",
              "          '<a target=\"_blank\" href=https://colab.research.google.com/notebooks/data_table.ipynb>data table notebook</a>'\n",
              "          + ' to learn more about interactive tables.';\n",
              "        element.innerHTML = '';\n",
              "        dataTable['output_type'] = 'display_data';\n",
              "        await google.colab.output.renderOutput(dataTable, element);\n",
              "        const docLink = document.createElement('div');\n",
              "        docLink.innerHTML = docLinkHtml;\n",
              "        element.appendChild(docLink);\n",
              "      }\n",
              "    </script>\n",
              "  </div>\n",
              "\n",
              "\n",
              "<div id=\"df-d38e2ecb-7102-4cc9-bcf7-56924d50bcfe\">\n",
              "  <button class=\"colab-df-quickchart\" onclick=\"quickchart('df-d38e2ecb-7102-4cc9-bcf7-56924d50bcfe')\"\n",
              "            title=\"Suggest charts.\"\n",
              "            style=\"display:none;\">\n",
              "\n",
              "<svg xmlns=\"http://www.w3.org/2000/svg\" height=\"24px\"viewBox=\"0 0 24 24\"\n",
              "     width=\"24px\">\n",
              "    <g>\n",
              "        <path d=\"M19 3H5c-1.1 0-2 .9-2 2v14c0 1.1.9 2 2 2h14c1.1 0 2-.9 2-2V5c0-1.1-.9-2-2-2zM9 17H7v-7h2v7zm4 0h-2V7h2v10zm4 0h-2v-4h2v4z\"/>\n",
              "    </g>\n",
              "</svg>\n",
              "  </button>\n",
              "\n",
              "<style>\n",
              "  .colab-df-quickchart {\n",
              "      --bg-color: #E8F0FE;\n",
              "      --fill-color: #1967D2;\n",
              "      --hover-bg-color: #E2EBFA;\n",
              "      --hover-fill-color: #174EA6;\n",
              "      --disabled-fill-color: #AAA;\n",
              "      --disabled-bg-color: #DDD;\n",
              "  }\n",
              "\n",
              "  [theme=dark] .colab-df-quickchart {\n",
              "      --bg-color: #3B4455;\n",
              "      --fill-color: #D2E3FC;\n",
              "      --hover-bg-color: #434B5C;\n",
              "      --hover-fill-color: #FFFFFF;\n",
              "      --disabled-bg-color: #3B4455;\n",
              "      --disabled-fill-color: #666;\n",
              "  }\n",
              "\n",
              "  .colab-df-quickchart {\n",
              "    background-color: var(--bg-color);\n",
              "    border: none;\n",
              "    border-radius: 50%;\n",
              "    cursor: pointer;\n",
              "    display: none;\n",
              "    fill: var(--fill-color);\n",
              "    height: 32px;\n",
              "    padding: 0;\n",
              "    width: 32px;\n",
              "  }\n",
              "\n",
              "  .colab-df-quickchart:hover {\n",
              "    background-color: var(--hover-bg-color);\n",
              "    box-shadow: 0 1px 2px rgba(60, 64, 67, 0.3), 0 1px 3px 1px rgba(60, 64, 67, 0.15);\n",
              "    fill: var(--button-hover-fill-color);\n",
              "  }\n",
              "\n",
              "  .colab-df-quickchart-complete:disabled,\n",
              "  .colab-df-quickchart-complete:disabled:hover {\n",
              "    background-color: var(--disabled-bg-color);\n",
              "    fill: var(--disabled-fill-color);\n",
              "    box-shadow: none;\n",
              "  }\n",
              "\n",
              "  .colab-df-spinner {\n",
              "    border: 2px solid var(--fill-color);\n",
              "    border-color: transparent;\n",
              "    border-bottom-color: var(--fill-color);\n",
              "    animation:\n",
              "      spin 1s steps(1) infinite;\n",
              "  }\n",
              "\n",
              "  @keyframes spin {\n",
              "    0% {\n",
              "      border-color: transparent;\n",
              "      border-bottom-color: var(--fill-color);\n",
              "      border-left-color: var(--fill-color);\n",
              "    }\n",
              "    20% {\n",
              "      border-color: transparent;\n",
              "      border-left-color: var(--fill-color);\n",
              "      border-top-color: var(--fill-color);\n",
              "    }\n",
              "    30% {\n",
              "      border-color: transparent;\n",
              "      border-left-color: var(--fill-color);\n",
              "      border-top-color: var(--fill-color);\n",
              "      border-right-color: var(--fill-color);\n",
              "    }\n",
              "    40% {\n",
              "      border-color: transparent;\n",
              "      border-right-color: var(--fill-color);\n",
              "      border-top-color: var(--fill-color);\n",
              "    }\n",
              "    60% {\n",
              "      border-color: transparent;\n",
              "      border-right-color: var(--fill-color);\n",
              "    }\n",
              "    80% {\n",
              "      border-color: transparent;\n",
              "      border-right-color: var(--fill-color);\n",
              "      border-bottom-color: var(--fill-color);\n",
              "    }\n",
              "    90% {\n",
              "      border-color: transparent;\n",
              "      border-bottom-color: var(--fill-color);\n",
              "    }\n",
              "  }\n",
              "</style>\n",
              "\n",
              "  <script>\n",
              "    async function quickchart(key) {\n",
              "      const quickchartButtonEl =\n",
              "        document.querySelector('#' + key + ' button');\n",
              "      quickchartButtonEl.disabled = true;  // To prevent multiple clicks.\n",
              "      quickchartButtonEl.classList.add('colab-df-spinner');\n",
              "      try {\n",
              "        const charts = await google.colab.kernel.invokeFunction(\n",
              "            'suggestCharts', [key], {});\n",
              "      } catch (error) {\n",
              "        console.error('Error during call to suggestCharts:', error);\n",
              "      }\n",
              "      quickchartButtonEl.classList.remove('colab-df-spinner');\n",
              "      quickchartButtonEl.classList.add('colab-df-quickchart-complete');\n",
              "    }\n",
              "    (() => {\n",
              "      let quickchartButtonEl =\n",
              "        document.querySelector('#df-d38e2ecb-7102-4cc9-bcf7-56924d50bcfe button');\n",
              "      quickchartButtonEl.style.display =\n",
              "        google.colab.kernel.accessAllowed ? 'block' : 'none';\n",
              "    })();\n",
              "  </script>\n",
              "</div>\n",
              "    </div>\n",
              "  </div>\n"
            ]
          },
          "metadata": {},
          "execution_count": 4
        }
      ]
    },
    {
      "cell_type": "markdown",
      "source": [
        "## **Clinical Trials with No Enrollment Data**"
      ],
      "metadata": {
        "id": "WJ16VlbF7Bqa"
      }
    },
    {
      "cell_type": "code",
      "source": [
        "no_enroll = clinical_df[clinical_df.enrollment == 0]\n",
        "# Bar Plot per Study Status\n",
        "no_enroll.study_status.value_counts().plot(kind = \"bar\", cmap = \"viridis\")\n",
        "plt.title(\"Number of Trials with No Enrollment per Study Status\")\n",
        "plt.ylabel(\"Count\")\n",
        "plt.grid(axis = \"y\")\n",
        "plt.show()\n",
        "\n",
        "# Interested in the \"COMPLETED\" with no enrollment\n",
        "print(\"\\n================================================\\nComplete Clinical Trials Data with No Enrollment\\n================================================\")\n",
        "no_enroll.loc[no_enroll.study_status == \"COMPLETED\", [\"sponsor\", \"study_results\", \"study_area\", \"start_date\", \"completion_date\", \"funder_type\"]]"
      ],
      "metadata": {
        "colab": {
          "base_uri": "https://localhost:8080/",
          "height": 912
        },
        "id": "Zq_uW4rohU4P",
        "outputId": "474b0d25-2554-4ea9-d5ff-e2891baa03e8"
      },
      "execution_count": 5,
      "outputs": [
        {
          "output_type": "display_data",
          "data": {
            "text/plain": [
              "<Figure size 640x480 with 1 Axes>"
            ],
            "image/png": "iVBORw0KGgoAAAANSUhEUgAAAkQAAAH/CAYAAAC2BcJxAAAAOXRFWHRTb2Z0d2FyZQBNYXRwbG90bGliIHZlcnNpb24zLjcuMSwgaHR0cHM6Ly9tYXRwbG90bGliLm9yZy/bCgiHAAAACXBIWXMAAA9hAAAPYQGoP6dpAABVV0lEQVR4nO3dd1QU5/4G8GcXqeJSlCKiiAUUS+xKrgooQhQTa2KJij0qatRo1KhYrteaWJJYY8FrrBhNNBYsiBUbioot0WBJkGKBRZQ+vz/87VxXioCwszDP5xzPcWfe3fkOuzvz7LzvzCgEQRBAREREJGNKqQsgIiIikhoDEREREckeAxERERHJHgMRERERyR4DEREREckeAxERERHJHgMRERERyR4DEREREckeAxERERHJHgMRFUpYWBgUCgV27doldSkFEhcXh549e6JixYpQKBRYtmxZsS8jKCgICoUC9+/fL/RzBw4ciOrVqxd7TQVVmNo1bS9dulTyhZVR9+/fh0KhQFBQkDht1qxZUCgU0hVFJap69eoYOHCg1GVQATAQ6SHNjsfExAT//PNPjvmenp6oX7++BJWVPuPHj0dISAimTp2KzZs346OPPsrRZuDAgVAoFO/8J5eN2sqVK7V22MVFs+O3s7PDy5cvc8yvXr06OnfuXGzLy+99NTExKbblyMW8efPw66+/Sl1Gody/fx+DBg1CzZo1YWJiAnt7e7Rt2xYzZ87UaldSn/mSkJCQgC+//BJ16tSBqakpbG1t0aJFC0yePBkvXrwQ223duvW9fgC+fPkSs2bNQlhY2PsXXUqUk7oAyltaWhoWLFiAH374QepSSq3Q0FB06dIFEydOzLPNF198AW9vb/FxdHQ0AgMDMXz4cLRp00acXrNmzVyf379/f/Tu3RvGxsbFV7iO5Fb7ypUrUalSpRILgPHx8Vi1ahW++uqrEnn9NxkbG2PdunU5phsYGJT4ssuaefPmoWfPnujatavUpRTI3bt30bx5c5iammLw4MGoXr06Hj9+jMuXL2PhwoWYPXu22LakP/PF5dmzZ2jWrBnUajUGDx6MOnXq4OnTp7h27RpWrVqFkSNHwtzcHMDrQBQVFYVx48YVaVkvX74U/0aenp7FtAb6jYFIjzVq1Ag//fQTpk6dCgcHB6nL0amUlBSUL1/+vV8nPj4elpaW+bZxd3eHu7u7+PjSpUsIDAyEu7s7+vXr984aDQwMSu0OVoraGzVqhMWLF2PUqFEwNTUt0WWVK1cu3/fwfQmCgNTU1BJfD8pdftuJpUuX4sWLF4iMjISTk5PWvPj4eF2UV+zWr1+Phw8f4syZM/jwww+15qnVahgZGUlUWdnALjM99s033yArKwsLFizIt11u4xI0FAoFZs2aJT7WdFv88ccf6NevHywsLGBjY4MZM2ZAEAQ8evQIXbp0gUqlgr29Pb777rtcl5mVlYVvvvkG9vb2KF++PD755BM8evQoR7vz58/jo48+goWFBczMzODh4YEzZ85otdHUdPPmTfTt2xdWVlZo3bp1vuv8119/4dNPP4W1tTXMzMzQqlUr7N+/X5yv6XYUBAErVqwQu0qKSvN6J06cwKhRo2BrawtHR0eteW+Ow/ntt9/g5+cHBwcHGBsbo2bNmvj3v/+NrKysdy5r+/btaNq0KSpUqACVSoUGDRpg+fLl+T6nSZMm6N69u9a0Bg0aQKFQ4Nq1a+K0HTt2QKFQ4NatW7nWXr16ddy4cQMnTpwQ/2Zv/zpMS0vDhAkTYGNjg/Lly6Nbt25ISEh453ppBAYGIi4uDqtWrXpn25SUFHz11VeoWrUqjI2N4erqim+//RaCIBR4ee+i+RucOXPmneul6dYLCQlBs2bNYGpqijVr1gB492eyMBQKBUaPHo3g4GC4ubnB1NQU7u7uuH79OgBgzZo1qFWrFkxMTODp6ZnrGLDCfPfu3r2LgQMHwtLSEhYWFhg0aJBWt6ZCoUBKSgo2bdpUoC5kzVjDHTt2SLaduHfvHhwdHXOEIQCwtbUV/5/fZz6v8V25fecFQcDcuXPh6OgIMzMzeHl54caNG1rP++uvv6BQKLB06dIcr3n27FkoFAps27Yt33UyMDBAq1atcsxTqVRiV7Cnpyf279+PBw8eiOukGauYnp6OwMBANG3aFBYWFihfvjzatGmD48ePi691//592NjYAABmz54tvoZmX+Lp6ZnrUaPcxkQWZXsmFR4h0mPOzs4YMGAAfvrpJ0yZMqVYjxL16tULdevWxYIFC7B//37MnTsX1tbWWLNmDdq1a4eFCxdiy5YtmDhxIpo3b462bdtqPf8///kPFAoFJk+ejPj4eCxbtgze3t6IjIwUfy2HhoaiY8eOaNq0KWbOnAmlUomNGzeiXbt2OHXqFFq0aKH1mp9++ilq166NefPm5bvDi4uLw4cffoiXL19i7NixqFixIjZt2oRPPvkEu3btQrdu3dC2bVts3rwZ/fv3R4cOHTBgwIBi+buNGjUKNjY2CAwMREpKSp7tgoKCYG5ujgkTJsDc3ByhoaEIDAyEWq3G4sWL83zekSNH0KdPH7Rv3x4LFy4EANy6dQtnzpzBl19+mefz2rRpo7UhffbsGW7cuAGlUolTp06hYcOGAIBTp07BxsYGdevWzfV1li1bhjFjxsDc3BzTpk0DANjZ2Wm1GTNmDKysrDBz5kzcv38fy5Ytw+jRo7Fjx44863u71nbt2mHRokUYOXJknkdXBEHAJ598guPHj2PIkCFo1KgRQkJCMGnSJPzzzz+57lRy8+TJkxzTjIyMoFKpirRed+7cQZ8+ffDFF19g2LBhcHV1LdBnsrBOnTqFvXv3IiAgAAAwf/58dO7cGV9//TVWrlyJUaNG4fnz51i0aBEGDx6M0NBQ8bmF/e599tlncHZ2xvz583H58mWsW7cOtra24mdw8+bNGDp0KFq0aIHhw4cDyLsL+U1SbiecnJxw9OhRhIaGol27dnm2K8hnviACAwMxd+5cdOrUCZ06dcLly5fh4+OD9PR0sU2NGjXwr3/9C1u2bMH48eO1nr9lyxZUqFABXbp0yXedsrKysHnzZvj7++fZbtq0aUhKSsLff/8tfk80XWlqtRrr1q1Dnz59MGzYMCQnJ2P9+vXw9fXFhQsX0KhRI9jY2IhdcN26dRN/bGm2IwVV1O2ZZATSOxs3bhQACBcvXhTu3bsnlCtXThg7dqw438PDQ6hXr574ODo6WgAgbNy4McdrARBmzpwpPp45c6YAQBg+fLg4LTMzU3B0dBQUCoWwYMECcfrz588FU1NTwd/fX5x2/PhxAYBQpUoVQa1Wi9N37twpABCWL18uCIIgZGdnC7Vr1xZ8fX2F7Oxssd3Lly8FZ2dnoUOHDjlq6tOnT4H+PuPGjRMACKdOnRKnJScnC87OzkL16tWFrKwsrfUPCAgo0OtqXLx4McffU/OetG7dWsjMzNRqr5kXHR2ttZ5v++KLLwQzMzMhNTVVnObv7y84OTmJj7/88ktBpVLlWMa7BAcHCwCEmzdvCoIgCHv37hWMjY2FTz75ROjVq5fYrmHDhkK3bt3yrb1evXqCh4dHjmVo2np7e2u9p+PHjxcMDAyExMTEfGvUvM8JCQnCiRMnBADCkiVLxPlOTk6Cn5+f+PjXX38VAAhz587Vep2ePXsKCoVCuHv3br7L8/f3FwDk+s/X17dI6+Xk5CQAEA4dOqS1rIJ+JnP7rmr+Lm8CIBgbG2u9L2vWrBEACPb29lrfvalTp2q9h0X57g0ePFhr+d26dRMqVqyoNa18+fJa24L86MN2IioqSjA1NRUACI0aNRK+/PJL4ddffxVSUlJytM3rM5/beyMIOb838fHxgpGRkeDn56e1Ht98840AQOvvpnkfb926JU5LT08XKlWq9M6/b2xsrGBjYyMAEOrUqSOMGDFC2Lp1a67fPT8/P61ti0ZmZqaQlpamNe358+eCnZ2d1ucgISEhx/5Dw8PDI9e/V3Ftz6TCLjM9V6NGDfTv3x9r167F48ePi+11hw4dKv7fwMAAzZo1gyAIGDJkiDjd0tISrq6u+Ouvv3I8f8CAAahQoYL4uGfPnqhcuTIOHDgAAIiMjMSff/6Jvn374unTp3jy5AmePHmClJQUtG/fHidPnkR2drbWa44YMaJAtR84cAAtWrTQOlxubm6O4cOH4/79+7h582bB/ghFMGzYsAKNuXnzqEdycjKePHmCNm3a4OXLl7h9+3aez7O0tERKSgqOHDlSqLo0g79PnjwJ4PXRhebNm6NDhw44deoUACAxMRFRUVFaA8WLYvjw4VrdCG3atEFWVhYePHhQ4Ndo27YtvLy8sGjRIrx69SrXNgcOHICBgQHGjh2rNf2rr76CIAg4ePDgO5djYmKCI0eO5PiXWzd0QdfL2dkZvr6+OWot7s9k+/bttbofWrZsCQDo0aOH1ndPM13zPS2O716bNm3w9OlTqNXqQtf9Jim3E/Xq1UNkZCT69euH+/fvY/ny5ejatSvs7Ozw008/vdd6ve3o0aNIT0/HmDFjtD5DuQ1o/uyzz2BiYoItW7aI00JCQvDkyZN3jnezs7PD1atXMWLECDx//hyrV69G3759YWtri3//+98F6ko2MDAQxxplZ2fj2bNnyMzMRLNmzXD58uUCrnHBFHV7JhUGolJg+vTpyMzMfOdYosKoVq2a1mMLCwuYmJigUqVKOaY/f/48x/Nr166t9VihUKBWrVpin/qff/4JAPD394eNjY3Wv3Xr1iEtLQ1JSUlar+Hs7Fyg2h88eABXV9cc0zXdQIXZMRdWQWu8ceMGunXrBgsLC6hUKtjY2Igbu7fX+02jRo2Ci4sLOnbsCEdHRwwePBiHDh165/Ls7OxQu3ZtMfycOnUKbdq0Qdu2bRETE4O//voLZ86cQXZ29nsHorc/O1ZWVgCQ6+ckP7NmzUJsbCxWr16d6/wHDx7AwcFBa4cKFO59NjAwgLe3d45/jRo1ytG2oOuV22egJD6TuX1HAaBq1aq5TtfUWZTvXnG9p2+TcjsBAC4uLti8eTOePHmCa9euYd68eShXrhyGDx+Oo0ePvte6vUnz/r69vjY2NuLfUsPS0hIff/wxtm7dKk7bsmULqlSpkm/XnkblypWxatUqPH78GHfu3MH3338vduOvX7++QPVu2rQJDRs2hImJCSpWrAgbGxvs378/321TURR1eyYVjiEqBWrUqIF+/fph7dq1mDJlSo75eQ0Wzm8Ab25HOfI68lGQXx1v0/yqW7x4ca47H+B/fdoapeFMnYLUmJiYCA8PD6hUKsyZM0e8Bsrly5cxefLkHL9432Rra4vIyEiEhITg4MGDOHjwIDZu3IgBAwZg06ZN+S63devWOHbsGF69eoWIiAgEBgaifv36sLS0xKlTp3Dr1i2Ym5ujcePGhV7vNxXX56Rt27bw9PTEokWLCvyrvyQVdL109TnNq5531VmU715xfvcLQ1fbCQMDAzRo0AANGjSAu7s7vLy8sGXLFq3LbeSmKNvWghgwYACCg4Nx9uxZNGjQAHv37sWoUaOgVBb8GIVCoYCLiwtcXFzg5+eH2rVrY8uWLVpH/3Pz888/Y+DAgejatSsmTZoEW1tbGBgYYP78+bh3716Bl53bZ+Ptv8v7bM+kwEBUSkyfPh0///yzODDtTZpfIImJiVrTS/JIieaXnYYgCLh796446E4z4FKlUr1zo1NYTk5OuHPnTo7pmq6o3M4q0aWwsDA8ffoUu3fv1hqMHh0dXaDnGxkZ4eOPP8bHH3+M7OxsjBo1CmvWrMGMGTNQq1atPJ/Xpk0bbNy4Edu3b0dWVhY+/PBDKJVKtG7dWgxEH3744Tu7/HR51eRZs2bB09NTPFPrTZpBscnJyVpHifTlfX6TPn0mS+q7V5TPhZTbibw0a9YMALSGIOS1bm9uW9+8fMfb21bN+/vnn3+iRo0a4vSEhIRcj7J99NFHsLGxwZYtW9CyZUu8fPkS/fv3L9oK4fWPZisrqwKt065du1CjRg3s3r1bq83bF6vM7/22srLKdShFbvucom7PpMAus1KiZs2a6NevH9asWYPY2FiteSqVCpUqVRLHj2isXLmyxOr573//i+TkZPHxrl278PjxY3Ts2BEA0LRpU9SsWRPffvut1tVTNQpzmvbbOnXqhAsXLiA8PFyclpKSgrVr16J69epwc3Mr8msXB03gePMXVHp6eoHej6dPn2o9ViqV4s4jLS0t3+dqusIWLlyIhg0bil0pbdq0wbFjx3Dp0qUCdZeVL18+R7guKR4eHvD09MTChQuRmpqqNa9Tp07IysrCjz/+qDV96dKlUCgU4mdNH+jTZ7KkvntF+VxIuZ04deoUMjIyckzXjF96s4szr3XTBLY3t62ayw+8ydvbG4aGhvjhhx+0vvd5XSm6XLly6NOnD3bu3ImgoCA0aNCgQGdwnT9/PtezWy9cuICnT5/mWKfcusBy2z6dP39e67MLAGZmZgBy/tAGXv9dbt++rfX+XL16NcelEt5neyYFHiEqRaZNm4bNmzfjzp07qFevnta8oUOHYsGCBRg6dCiaNWuGkydP4o8//iixWqytrdG6dWsMGjQIcXFxWLZsGWrVqoVhw4YBeP3BX7duHTp27Ih69eph0KBBqFKlCv755x8cP34cKpUK+/btK9Kyp0yZgm3btqFjx44YO3YsrK2tsWnTJkRHR+OXX34p1GHnkvDhhx/CysoK/v7+GDt2LBQKBTZv3lyg7oehQ4fi2bNnaNeuHRwdHfHgwQP88MMPaNSoUZ6nymvUqlUL9vb2uHPnDsaMGSNOb9u2LSZPngwABQpETZs2xapVqzB37lzUqlULtra2BRrbUFQzZ86El5dXjukff/wxvLy8MG3aNNy/fx8ffPABDh8+jN9++w3jxo0r0GnfmZmZ+Pnnn3Od161bt2K5+CegX5/JkvruNW3aFEePHsWSJUvg4OAAZ2dncUB3XqTcTixcuBARERHo3r27uBO+fPky/vvf/8La2lprwHNen3kfHx9Uq1YNQ4YMwaRJk2BgYIANGzbAxsYGDx8+FJ9vY2ODiRMnipdG6NSpE65cuYKDBw/mGJepMWDAAHz//fc4fvx4rkf+c7N582Zs2bIF3bp1Q9OmTWFkZIRbt25hw4YNMDExwTfffKO1Tjt27MCECRPQvHlzmJub4+OPP0bnzp2xe/dudOvWDX5+foiOjsbq1avh5uamFUpNTU3h5uaGHTt2wMXFBdbW1qhfvz7q16+PwYMHY8mSJfD19cWQIUMQHx+P1atXo169eloD8d9neyYJCc5so3d487T7t2lOJX7ztHtBeH2a6pAhQwQLCwuhQoUKwmeffSbEx8fnedp9QkJCjtctX758juW9fYq/5nTabdu2CVOnThVsbW0FU1NTwc/PT3jw4EGO51+5ckXo3r27ULFiRcHY2FhwcnISPvvsM+HYsWPvrCk/9+7dE3r27ClYWloKJiYmQosWLYTff/89RzsU82n3ub0nuZ26fubMGaFVq1aCqamp4ODgIHz99ddCSEiIAEA4fvy42O7t01R37dol+Pj4CLa2toKRkZFQrVo14YsvvhAeP35coNo//fRTAYCwY8cOcVp6erpgZmYmGBkZCa9evXpn7bGxsYKfn59QoUIFAYB4em1efwPNZ+LN9cpNfu+zh4eHAEDrtHtBeH3q+vjx4wUHBwfB0NBQqF27trB48WKtU5vzkt9p92+uc2HW6+1LA7ypIJ/Jwpx2//bnVvPcxYsX51pncHCw1vT3+e7l9rm4ffu20LZtW/FU9vxOEdeH7cSZM2eEgIAAoX79+oKFhYVgaGgoVKtWTRg4cKBw7949rbZ5feYFQRAiIiKEli1bit/HJUuW5Pr3ycrKEmbPni1UrlxZMDU1FTw9PYWoqCjByckpz79VvXr1BKVSKfz9998FWqdr164JkyZNEpo0aSJYW1sL5cqVEypXrix8+umnwuXLl7XavnjxQujbt69gaWkpABC3M9nZ2cK8efMEJycnwdjYWGjcuLHw+++/59gWCYIgnD17VmjatKlgZGSUY1/y888/CzVq1BCMjIyERo0aCSEhIcW+PdM1hSCU8Kg5IiKSlbCwMHh5eSE4OBg9e/aUuhy91bhxY1hbW+PYsWNSl0LgGCIiIiKdu3TpEiIjI4vtKvr0/jiGiIiISEeioqIQERGB7777DpUrV0avXr2kLon+H48QERER6ciuXbswaNAgZGRkYNu2beINWUl6HENEREREsscjRERERCR7DEREREQkexxUXQDZ2dmIiYlBhQoVdHpbAyIiIio6QRCQnJwMBweHd14glYGoAGJiYnLcYZqIiIhKh0ePHsHR0THfNgxEBaC5seSjR4+gUqkkroaIiIgKQq1Wo2rVqlo3iM4LA1EBaLrJVCoVAxEREVEpU5DhLhxUTURERLInaSCaNWsWFAqF1r86deqI81NTUxEQEICKFSvC3NwcPXr0QFxcnNZrPHz4EH5+fjAzM4OtrS0mTZqEzMxMrTZhYWFo0qQJjI2NUatWLQQFBeli9YiIiKiUkPwIUb169fD48WPx3+nTp8V548ePx759+xAcHIwTJ04gJiYG3bt3F+dnZWXBz88P6enpOHv2LDZt2oSgoCAEBgaKbaKjo+Hn5wcvLy9ERkZi3LhxGDp0KEJCQnS6nkRERKS/JL1S9axZs/Drr78iMjIyx7ykpCTY2Nhg69at4t2Sb9++jbp16yI8PBytWrXCwYMH0blzZ8TExMDOzg4AsHr1akyePBkJCQkwMjLC5MmTsX//fkRFRYmv3bt3byQmJuLQoUMFqlOtVsPCwgJJSUkcQ0RERFRKFGb/Lfmg6j///BMODg4wMTGBu7s75s+fj2rVqiEiIgIZGRnw9vYW29apUwfVqlUTA1F4eDgaNGgghiEA8PX1xciRI3Hjxg00btwY4eHhWq+haTNu3Lg8a0pLS0NaWpr4WK1WAwAyMjKQkZFRTGtOREREJakw+2xJA1HLli0RFBQEV1dXPH78GLNnz0abNm0QFRWF2NhYGBkZwdLSUus5dnZ2iI2NBQDExsZqhSHNfM28/Nqo1Wq8evUKpqamOeqaP38+Zs+enWP64cOHYWZmVuT1JSIiIt15+fJlgdtKGog6duwo/r9hw4Zo2bIlnJycsHPnzlyDiq5MnToVEyZMEB9rrmPg4+PDLjMiIqJSQtPDUxCSd5m9ydLSEi4uLrh79y46dOiA9PR0JCYmah0liouLg729PQDA3t4eFy5c0HoNzVlob7Z5+8y0uLg4qFSqPEOXsbExjI2Nc0w3NDSEoaFhkdePiIiIdKcw+2zJzzJ704sXL3Dv3j1UrlwZTZs2haGhIY4dOybOv3PnDh4+fAh3d3cAgLu7O65fv474+HixzZEjR6BSqeDm5ia2efM1NG00r0FEREQkaSCaOHEiTpw4gfv37+Ps2bPo1q0bDAwM0KdPH1hYWGDIkCGYMGECjh8/joiICAwaNAju7u5o1aoVAMDHxwdubm7o378/rl69ipCQEEyfPh0BAQHiEZ4RI0bgr7/+wtdff43bt29j5cqV2LlzJ8aPHy/lqhMREZEekbTL7O+//0afPn3w9OlT2NjYoHXr1jh37hxsbGwAAEuXLoVSqUSPHj2QlpYGX19frFy5Uny+gYEBfv/9d4wcORLu7u4oX748/P39MWfOHLGNs7Mz9u/fj/Hjx2P58uVwdHTEunXr4Ovrq/P1JSIiIv0k6XWISgteh4iIiKj0Kcz+W6/GEBERERFJgYGIiIiIZI+BiIiIiGRPr65DRLnroPxU6hIkcSQ7WOoSiIhIJniEiIiIiGSPgYiIiIhkj4GIiIiIZI+BiIiIiGSPgYiIiIhkj4GIiIiIZI+BiIiIiGSPgYiIiIhkj4GIiIiIZI+BiIiIiGSPgYiIiIhkj4GIiIiIZI+BiIiIiGSPgYiIiIhkj4GIiIiIZI+BiIiIiGSPgYiIiIhkj4GIiIiIZI+BiIiIiGSPgYiIiIhkj4GIiIiIZI+BiIiIiGSPgYiIiIhkj4GIiIiIZI+BiIiIiGSPgYiIiIhkj4GIiIiIZI+BiIiIiGSPgYiIiIhkj4GIiIiIZI+BiIiIiGSPgYiIiIhkj4GIiIiIZI+BiIiIiGSPgYiIiIhkj4GIiIiIZI+BiIiIiGSPgYiIiIhkj4GIiIiIZI+BiIiIiGSPgYiIiIhkj4GIiIiIZI+BiIiIiGSPgYiIiIhkj4GIiIiIZI+BiIiIiGSPgYiIiIhkj4GIiIiIZI+BiIiIiGSPgYiIiIhkj4GIiIiIZI+BiIiIiGSPgYiIiIhkj4GIiIiIZI+BiIiIiGSPgYiIiIhkj4GIiIiIZE9vAtGCBQugUCgwbtw4cVpqaioCAgJQsWJFmJubo0ePHoiLi9N63sOHD+Hn5wczMzPY2tpi0qRJyMzM1GoTFhaGJk2awNjYGLVq1UJQUJAO1oiIiIhKC70IRBcvXsSaNWvQsGFDrenjx4/Hvn37EBwcjBMnTiAmJgbdu3cX52dlZcHPzw/p6ek4e/YsNm3ahKCgIAQGBoptoqOj4efnBy8vL0RGRmLcuHEYOnQoQkJCdLZ+REREpN8kD0QvXrzA559/jp9++glWVlbi9KSkJKxfvx5LlixBu3bt0LRpU2zcuBFnz57FuXPnAACHDx/GzZs38fPPP6NRo0bo2LEj/v3vf2PFihVIT08HAKxevRrOzs747rvvULduXYwePRo9e/bE0qVLJVlfIiIi0j+SB6KAgAD4+fnB29tba3pERAQyMjK0ptepUwfVqlVDeHg4ACA8PBwNGjSAnZ2d2MbX1xdqtRo3btwQ27z92r6+vuJrEBEREZWTcuHbt2/H5cuXcfHixRzzYmNjYWRkBEtLS63pdnZ2iI2NFdu8GYY08zXz8mujVqvx6tUrmJqa5lh2Wloa0tLSxMdqtRoAkJGRgYyMjEKu5fszNDXU+TL1gRR/ayIiKjsKsx+RLBA9evQIX375JY4cOQITExOpysjV/PnzMXv27BzTDx8+DDMzM53X88XWXjpfpj44cOCA1CUQEVEp9vLlywK3lSwQRUREID4+Hk2aNBGnZWVl4eTJk/jxxx8REhKC9PR0JCYmah0liouLg729PQDA3t4eFy5c0HpdzVlob7Z5+8y0uLg4qFSqXI8OAcDUqVMxYcIE8bFarUbVqlXh4+MDlUpV9JUuoi6W/jpfpj74LXGT1CUQEVEppunhKQjJAlH79u1x/fp1rWmDBg1CnTp1MHnyZFStWhWGhoY4duwYevToAQC4c+cOHj58CHd3dwCAu7s7/vOf/yA+Ph62trYAgCNHjkClUsHNzU1s8/aRhiNHjoivkRtjY2MYGxvnmG5oaAhDQ913X2W8kmfXkRR/ayIiKjsKsx+RLBBVqFAB9evX15pWvnx5VKxYUZw+ZMgQTJgwAdbW1lCpVBgzZgzc3d3RqlUrAICPjw/c3NzQv39/LFq0CLGxsZg+fToCAgLEQDNixAj8+OOP+PrrrzF48GCEhoZi586d2L9/v25XmIiIiPSWpIOq32Xp0qVQKpXo0aMH0tLS4Ovri5UrV4rzDQwM8Pvvv2PkyJFwd3dH+fLl4e/vjzlz5ohtnJ2dsX//fowfPx7Lly+Ho6Mj1q1bB19fXylWiYiIiPSQQhAEQeoi9J1arYaFhQWSkpIkGUPUQfmpzpepD45kB0tdAhERlWKF2X9Lfh0iIiIiIqkxEBEREZHsMRARERGR7DEQERERkewxEBEREZHsMRARERGR7DEQERERkewxEBEREZHsMRARERGR7DEQERERkewxEBEREZHsMRARERGR7DEQERERkewxEBEREZHsMRARERGR7DEQERERkewxEBEREZHsMRARERGR7DEQERERkewxEBEREZHsMRARERGR7DEQERERkewxEBEREZHsMRARERGR7DEQERERkewxEBEREZHsMRARERGR7DEQERERkewxEBEREZHsMRARERGR7DEQERERkewxEBEREZHsMRARERGR7DEQERERkewxEBEREZHsMRARERGR7DEQERERkewxEBEREZHsMRARERGR7DEQERERkewxEBEREZHsMRARERGR7DEQERERkewxEBEREZHsMRARERGR7DEQERERkewxEBEREZHsMRARERGR7DEQERERkewxEBEREZHsMRARERGR7DEQERERkewxEBEREZHsMRARERGR7DEQERERkewxEBEREZHsMRARERGR7DEQERERkewxEBEREZHsMRARERGR7DEQERERkewxEBEREZHsSRqIVq1ahYYNG0KlUkGlUsHd3R0HDx4U56empiIgIAAVK1aEubk5evTogbi4OK3XePjwIfz8/GBmZgZbW1tMmjQJmZmZWm3CwsLQpEkTGBsbo1atWggKCtLF6hEREVEpIWkgcnR0xIIFCxAREYFLly6hXbt26NKlC27cuAEAGD9+PPbt24fg4GCcOHECMTEx6N69u/j8rKws+Pn5IT09HWfPnsWmTZsQFBSEwMBAsU10dDT8/Pzg5eWFyMhIjBs3DkOHDkVISIjO15eIiIj0k0IQBEHqIt5kbW2NxYsXo2fPnrCxscHWrVvRs2dPAMDt27dRt25dhIeHo1WrVjh48CA6d+6MmJgY2NnZAQBWr16NyZMnIyEhAUZGRpg8eTL279+PqKgocRm9e/dGYmIiDh06VKCa1Go1LCwskJSUBJVKVfwr/Q4dlJ/qfJn64Eh2sNQlEBFRKVaY/Xc5HdX0TllZWQgODkZKSgrc3d0RERGBjIwMeHt7i23q1KmDatWqiYEoPDwcDRo0EMMQAPj6+mLkyJG4ceMGGjdujPDwcK3X0LQZN25cnrWkpaUhLS1NfKxWqwEAGRkZyMjIKKY1LjhDU0OdL1MfSPG3JiKisqMw+xHJA9H169fh7u6O1NRUmJubY8+ePXBzc0NkZCSMjIxgaWmp1d7Ozg6xsbEAgNjYWK0wpJmvmZdfG7VajVevXsHU1DRHTfPnz8fs2bNzTD98+DDMzMyKvK5F9cXWXjpfpj44cOCA1CUQEVEp9vLlywK3lTwQubq6IjIyEklJSdi1axf8/f1x4sQJSWuaOnUqJkyYID5Wq9WoWrUqfHx8JOky62Lpr/Nl6oPfEjdJXQIREZVimh6egpA8EBkZGaFWrVoAgKZNm+LixYtYvnw5evXqhfT0dCQmJmodJYqLi4O9vT0AwN7eHhcuXNB6Pc1ZaG+2efvMtLi4OKhUqlyPDgGAsbExjI2Nc0w3NDSEoaHuu68yXsmz60iKvzUREZUdhdmP6N11iLKzs5GWloamTZvC0NAQx44dE+fduXMHDx8+hLu7OwDA3d0d169fR3x8vNjmyJEjUKlUcHNzE9u8+RqaNprXICIiIpL0CNHUqVPRsWNHVKtWDcnJydi6dSvCwsIQEhICCwsLDBkyBBMmTIC1tTVUKhXGjBkDd3d3tGrVCgDg4+MDNzc39O/fH4sWLUJsbCymT5+OgIAA8QjPiBEj8OOPP+Lrr7/G4MGDERoaip07d2L//v1SrjoRERHpEUkDUXx8PAYMGIDHjx/DwsICDRs2REhICDp06AAAWLp0KZRKJXr06IG0tDT4+vpi5cqV4vMNDAzw+++/Y+TIkXB3d0f58uXh7++POXPmiG2cnZ2xf/9+jB8/HsuXL4ejoyPWrVsHX19fna8vERER6Se9uw6RPuJ1iKTB6xAREdH7KMz+W+/GEBERERHpGgMRERERyR4DEREREckeAxERERHJHgMRERERyR4DEREREckeAxERERHJXpECUY0aNfD06dMc0xMTE1GjRo33LoqIiIhIl4oUiO7fv4+srKwc09PS0vDPP/+8d1FEREREulSoW3fs3btX/L/mfmMaWVlZOHbsGKpXr15sxRERERHpQqECUdeuXQEACoUC/v7+WvMMDQ1RvXp1fPfdd8VWHBEREZEuFCoQZWdnA3h9w9SLFy+iUqVKJVIUERERkS4V6W730dHRxV0HERERkWSKFIgA4NixYzh27Bji4+PFI0caGzZseO/CiIiIiHSlSIFo9uzZmDNnDpo1a4bKlStDoVAUd11EREREOlOkQLR69WoEBQWhf//+xV0PERERkc4V6TpE6enp+PDDD4u7FiIiIiJJFCkQDR06FFu3bi3uWoiIiIgkUaQus9TUVKxduxZHjx5Fw4YNYWhoqDV/yZIlxVIcERERkS4UKRBdu3YNjRo1AgBERUVpzeMAayIiIiptihSIjh8/Xtx1EBEREUmmSGOIiIiIiMqSIh0h8vLyyrdrLDQ0tMgFEREREelakQKRZvyQRkZGBiIjIxEVFZXjpq9ERERE+q5IgWjp0qW5Tp81axZevHjxXgURERER6VqxjiHq168f72NGREREpU6xBqLw8HCYmJgU50sSERERlbgidZl1795d67EgCHj8+DEuXbqEGTNmFEthRERERLpSpEBkYWGh9VipVMLV1RVz5syBj49PsRRGREREpCtFCkQbN24s7jqIiIiIJFOkQKQRERGBW7duAQDq1auHxo0bF0tRRERERLpUpEAUHx+P3r17IywsDJaWlgCAxMREeHl5Yfv27bCxsSnOGomIiIhKVJHOMhszZgySk5Nx48YNPHv2DM+ePUNUVBTUajXGjh1b3DUSERERlagiHSE6dOgQjh49irp164rT3NzcsGLFCg6qJiIiolKnSEeIsrOzYWhomGO6oaEhsrOz37soIiIiIl0qUiBq164dvvzyS8TExIjT/vnnH4wfPx7t27cvtuKIiIiIdKFIgejHH3+EWq1G9erVUbNmTdSsWRPOzs5Qq9X44YcfirtGIiIiohJVpDFEVatWxeXLl3H06FHcvn0bAFC3bl14e3sXa3FEREREulCoI0ShoaFwc3ODWq2GQqFAhw4dMGbMGIwZMwbNmzdHvXr1cOrUqZKqlYiIiKhEFCoQLVu2DMOGDYNKpcoxz8LCAl988QWWLFlSbMURERER6UKhAtHVq1fx0Ucf5Tnfx8cHERER710UERERkS4VKhDFxcXlerq9Rrly5ZCQkPDeRRERERHpUqECUZUqVRAVFZXn/GvXrqFy5crvXRQRERGRLhUqEHXq1AkzZsxAampqjnmvXr3CzJkz0blz52IrjoiIiEgXCnXa/fTp07F79264uLhg9OjRcHV1BQDcvn0bK1asQFZWFqZNm1YihRIRERGVlEIFIjs7O5w9exYjR47E1KlTIQgCAEChUMDX1xcrVqyAnZ1diRRKREREVFIKfWFGJycnHDhwAM+fP8fdu3chCAJq164NKyurkqiPiIiIqMQV6UrVAGBlZYXmzZsXZy1EREREkijSvcyIiIiIyhIGIiIiIpI9BiIiIiKSPQYiIiIikj0GIiIiIpI9BiIiIiKSPQYiIiIikj0GIiIiIpI9BiIiIiKSPQYiIiIikj0GIiIiIpI9BiIiIiKSPQYiIiIikj1JA9H8+fPRvHlzVKhQAba2tujatSvu3Lmj1SY1NRUBAQGoWLEizM3N0aNHD8TFxWm1efjwIfz8/GBmZgZbW1tMmjQJmZmZWm3CwsLQpEkTGBsbo1atWggKCirp1SMiIqJSQtJAdOLECQQEBODcuXM4cuQIMjIy4OPjg5SUFLHN+PHjsW/fPgQHB+PEiROIiYlB9+7dxflZWVnw8/NDeno6zp49i02bNiEoKAiBgYFim+joaPj5+cHLywuRkZEYN24chg4dipCQEJ2uLxEREeknhSAIgtRFaCQkJMDW1hYnTpxA27ZtkZSUBBsbG2zduhU9e/YEANy+fRt169ZFeHg4WrVqhYMHD6Jz586IiYmBnZ0dAGD16tWYPHkyEhISYGRkhMmTJ2P//v2IiooSl9W7d28kJibi0KFD76xLrVbDwsICSUlJUKlUJbPy+eig/FTny9QHR7KDpS6BiIhKscLsv8vpqKYCSUpKAgBYW1sDACIiIpCRkQFvb2+xTZ06dVCtWjUxEIWHh6NBgwZiGAIAX19fjBw5Ejdu3EDjxo0RHh6u9RqaNuPGjcu1jrS0NKSlpYmP1Wo1ACAjIwMZGRnFsq6FYWhqqPNl6gMp/tZERFR2FGY/ojeBKDs7G+PGjcO//vUv1K9fHwAQGxsLIyMjWFpaarW1s7NDbGys2ObNMKSZr5mXXxu1Wo1Xr17B1NRUa978+fMxe/bsHDUePnwYZmZmRV/JIvpiay+dL1MfHDhwQOoSiIioFHv58mWB2+pNIAoICEBUVBROnz4tdSmYOnUqJkyYID5Wq9WoWrUqfHx8JOky62Lpr/Nl6oPfEjdJXQIREZVimh6egtCLQDR69Gj8/vvvOHnyJBwdHcXp9vb2SE9PR2JiotZRori4ONjb24ttLly4oPV6mrPQ3mzz9plpcXFxUKlUOY4OAYCxsTGMjY1zTDc0NIShoe67rzJeybPrSIq/NRERlR2F2Y9IepaZIAgYPXo09uzZg9DQUDg7O2vNb9q0KQwNDXHs2DFx2p07d/Dw4UO4u7sDANzd3XH9+nXEx8eLbY4cOQKVSgU3NzexzZuvoWmjeQ0iIiKSN0mPEAUEBGDr1q347bffUKFCBXHMj4WFBUxNTWFhYYEhQ4ZgwoQJsLa2hkqlwpgxY+Du7o5WrVoBAHx8fODm5ob+/ftj0aJFiI2NxfTp0xEQECAe5RkxYgR+/PFHfP311xg8eDBCQ0Oxc+dO7N+/X7J1JyIiIv0h6Wn3CoUi1+kbN27EwIEDAby+MONXX32Fbdu2IS0tDb6+vli5cqXYHQYADx48wMiRIxEWFoby5cvD398fCxYsQLly/8t7YWFhGD9+PG7evAlHR0fMmDFDXMa78LR7afC0eyIieh+F2X/r1XWI9BUDkTQYiIiI6H0UZv/Ne5kRERGR7DEQERERkewxEBEREZHsMRARERGR7DEQERERkewxEBEREZHsMRARERGR7DEQERERkewxEBEREZHsMRARERGR7DEQERERkewxEBEREZHsMRARERGR7DEQERERkewxEBEREZHsMRARERGR7DEQERERkewxEBEREZHsMRARERGR7DEQERERkewxEBEREZHsMRARERGR7DEQERERkewxEBEREZHsMRARERGR7DEQERERkewxEBEREZHsMRARERGR7DEQERERkewxEBEREZHsMRARERGR7DEQERERkewxEBEREZHsMRARERGR7DEQERERkewxEBEREZHsMRARERGR7DEQERERkewxEBEREZHsMRARERGR7DEQERERkewxEBEREZHsMRARERGR7DEQERERkewxEBEREZHsMRARERGR7DEQERERkewxEBEREZHsMRARERGR7DEQERERkewxEBEREZHsMRARERGR7DEQERERkewxEBEREZHsMRARERGR7DEQERERkewxEBEREZHsMRARERGR7DEQERERkewxEBEREZHsMRARERGR7EkaiE6ePImPP/4YDg4OUCgU+PXXX7XmC4KAwMBAVK5cGaampvD29saff/6p1ebZs2f4/PPPoVKpYGlpiSFDhuDFixdaba5du4Y2bdrAxMQEVatWxaJFi0p61YiIiKgUkTQQpaSk4IMPPsCKFStynb9o0SJ8//33WL16Nc6fP4/y5cvD19cXqampYpvPP/8cN27cwJEjR/D777/j5MmTGD58uDhfrVbDx8cHTk5OiIiIwOLFizFr1iysXbu2xNePiIiISgeFIAiC1EUAgEKhwJ49e9C1a1cAr48OOTg44KuvvsLEiRMBAElJSbCzs0NQUBB69+6NW7duwc3NDRcvXkSzZs0AAIcOHUKnTp3w999/w8HBAatWrcK0adMQGxsLIyMjAMCUKVPw66+/4vbt2wWqTa1Ww8LCAklJSVCpVMW/8u/QQfmpzpepD45kB0tdAhERlWKF2X+X01FNhRYdHY3Y2Fh4e3uL0ywsLNCyZUuEh4ejd+/eCA8Ph6WlpRiGAMDb2xtKpRLnz59Ht27dEB4ejrZt24phCAB8fX2xcOFCPH/+HFZWVjmWnZaWhrS0NPGxWq0GAGRkZCAjI6MkVjdfhqaGOl+mPpDib01ERGVHYfYjehuIYmNjAQB2dnZa0+3s7MR5sbGxsLW11Zpfrlw5WFtba7VxdnbO8RqaebkFovnz52P27Nk5ph8+fBhmZmZFXKOi+2JrL50vUx8cOHBA6hKIiKgUe/nyZYHb6m0gktLUqVMxYcIE8bFarUbVqlXh4+MjSZdZF0t/nS9TH/yWuEnqEoiIqBTT9PAUhN4GInt7ewBAXFwcKleuLE6Pi4tDo0aNxDbx8fFaz8vMzMSzZ8/E59vb2yMuLk6rjeaxps3bjI2NYWxsnGO6oaEhDA11332V8UqeXUdS/K2JiKjsKMx+RG+vQ+Ts7Ax7e3scO3ZMnKZWq3H+/Hm4u7sDANzd3ZGYmIiIiAixTWhoKLKzs9GyZUuxzcmTJ7X6EY8cOQJXV9dcu8uIiIhIfiQNRC9evEBkZCQiIyMBvB5IHRkZiYcPH0KhUGDcuHGYO3cu9u7di+vXr2PAgAFwcHAQz0SrW7cuPvroIwwbNgwXLlzAmTNnMHr0aPTu3RsODg4AgL59+8LIyAhDhgzBjRs3sGPHDixfvlyrS4yIiIjkTdIus0uXLsHLy0t8rAkp/v7+CAoKwtdff42UlBQMHz4ciYmJaN26NQ4dOgQTExPxOVu2bMHo0aPRvn17KJVK9OjRA99//70438LCAocPH0ZAQACaNm2KSpUqITAwUOtaRURERCRvenMdIn3G6xBJg9chIiKi91GY/bfejiEiIiIi0hUGIiIiIpI9BiIiIiKSPQYiIiIikj0GIiIiIpI9BiIiIiKSPQYiIiIikj0GIiIiIpI9BiIiIiKSPQYiIiIikj0GIiIiIpI9BiIiIiKSPQYiIiIikj0GIiIiIpI9BiIiIiKSPQYiIiIikj0GIiIiIpI9BiIiIiKSPQYiIiIikj0GIiIiIpI9BiIiIiKSPQYiIiIikj0GIiIiIpI9BiIiIiKSPQYiIiIikj0GIiIiIpI9BiIiIiKSPQYiIiIikj0GIiIiIpI9BiIiIiKSPQYiIiIikj0GIiIiIpI9BiIiIiKSPQYiIiIikj0GIiIiIpI9BiIiIiKSPQYiIiIikj0GIiIiIpI9BiIiIiKSPQYiIiIikj0GIiIiIpI9BiIiIiKSPQYiIiIikj0GIiIiIpI9BiIiIiKSPQYiIiIikj0GIiIiIpI9BiIiIiKSPQYiIiIikj0GIiIiIpI9BiIiIiKSPQYiIiIikj0GIiIiIpI9BiIiIiKSPQYiIiIikj0GIiIiIpI9BiIiIiKSPQYiIiIikj0GIiIiIpI9BiIiIiKSPQYiIiIikj1ZBaIVK1agevXqMDExQcuWLXHhwgWpSyIiIiI9IJtAtGPHDkyYMAEzZ87E5cuX8cEHH8DX1xfx8fFSl0ZEREQSk00gWrJkCYYNG4ZBgwbBzc0Nq1evhpmZGTZs2CB1aURERCQxWQSi9PR0REREwNvbW5ymVCrh7e2N8PBwCSsjIiIifVBO6gJ04cmTJ8jKyoKdnZ3WdDs7O9y+fTtH+7S0NKSlpYmPk5KSAADPnj1DRkZGyRabGxPdL1IfPH36VOoSJNG76gipS5DE9kerpS5BEny/5YXvt24lJycDAARBeGdbWQSiwpo/fz5mz56dY7qzs7ME1chXpUq7pC6BdIjvt7zw/ZYXqd/v5ORkWFhY5NtGFoGoUqVKMDAwQFxcnNb0uLg42Nvb52g/depUTJgwQXycnZ2NZ8+eoWLFilAoFCVer75Qq9WoWrUqHj16BJVKJXU5VML4fssL3295kev7LQgCkpOT4eDg8M62sghERkZGaNq0KY4dO4auXbsCeB1yjh07htGjR+dob2xsDGNjY61plpaWOqhUP6lUKll9geSO77e88P2WFzm+3+86MqQhi0AEABMmTIC/vz+aNWuGFi1aYNmyZUhJScGgQYOkLo2IiIgkJptA1KtXLyQkJCAwMBCxsbFo1KgRDh06lGOgNREREcmPbAIRAIwePTrXLjLKnbGxMWbOnJmj+5DKJr7f8sL3W174fr+bQijIuWhEREREZZgsLsxIRERElB8GIiIiIpI9BiIiIiKSPQYiIiIikj1ZnWVGRCRXoaGh2L17N+7fvw+FQgFnZ2f07NkTbdu2lbo0Ir3As8yIZOzPP//Eb7/9prWT7Nq1K2rUqCF1aVSMRowYgbVr18LKygouLi4QBAF//vknEhMTMWrUKPzwww9Sl0gkOQYiAgAolcp33qdNoVAgMzNTRxVRSZs/fz4CAwORnZ0NW1tbCIKAhIQEGBgYYN68eZg4caLUJVIx2LNnD3r37o01a9bA399f/J5nZ2cjKCgII0eORHBwMD755BOJKyWSFgMRAQB+++23POeFh4fj+++/R3Z2NlJTU3VYFZWU48ePw9vbGzNmzMCXX34JKysrAMCzZ8+wbNkyzJs3D6GhoexOKQM++eQT1KtXD/Pnz891/uTJk3H79u18twFU+syZM6dA7QIDA0u4ktKDgYjydOfOHUyZMgX79u3D559/jjlz5sDJyUnqsqgY9OrVC5aWllizZk2u84cPH47k5GRs27ZNx5VRcXN0dMTu3bvRokWLXOefP38ePXr0wN9//63jyqgkNW7cOM95CoUCd+7cQWpqKrKysnRYlX7joGrKISYmBjNnzsSmTZvg6+uLyMhI1K9fX+qyqBhduHABmzdvznN+//79MWDAAB1WRCXlyZMncHR0zHO+o6Mjnj59qsOKSBeuXLmS6/TIyEhMmTIFUVFRGDZsmI6r0m887Z5ESUlJmDx5MmrVqoUbN27g2LFj2LdvH8NQGRQXF4fq1avnOd/Z2RmxsbG6K4hKTHp6OgwNDfOcX65cOaSnp+uwIpJCdHQ0+vXrh+bNm8PCwgI3btzA6tWrpS5Lr/AIEQEAFi1ahIULF8Le3h7btm1Dly5dpC6JSlBqaiqMjIzynG9oaMidZBkyY8YMmJmZ5Trv5cuXOq6GdOnJkyeYPXs21q5di9atW+Ps2bNo3ry51GXpJY4hIgCvzzIzNTWFt7c3DAwM8my3e/duHVZFJUWpVGLu3LkwNzfPdX5ycjICAwM5vqAM8PT0fOcZpMDrgfZUdqSkpODbb7/FkiVLUKtWLcyfPx8+Pj5Sl6XXGIgIADBw4MACbTQ3btyog2qopFWvXr1A73d0dLQOqiGi4mZvb4/k5GSMGTMGffr0yfP73rBhQx1Xpr8YiIiIiMoYpfJ/Q4QVCgXe3NVrHisUCh4FfgPHEBGA10d+2rdvj2rVqkldChEVIzc3N5w+fRrW1tYAgFGjRmHOnDmoVKkSACA+Ph7Vq1fnWKIyhkd3C49HiAgAYGpqivT0dDg5OcHLy0v8V6VKFalLoxLQqVMnbNu2DRYWFgCABQsWYMSIEbC0tAQAPH36FG3atMHNmzclrJKKg1KpRGxsLGxtbQEAKpUKkZGR4u1Z4uLiULlyZWRnZ0tZJpHkeNo9AQASExNx9OhRDBgwAHfv3sWwYcNQrVo1uLq6YsSIEdixYwfi4uKkLpOKSUhICNLS0sTH8+bNw7Nnz8THmZmZuHPnjhSlUQnL7TdwQcaTUeni5OSEQYMG4b///S8ePXokdTmlArvMCABgbGwsHhWaNWsWUlNTER4ejuPHjyMsLAybNm1CRkYG72VWRry9U+SBYqKyZdCgQQgLC8P27duRnp4OZ2dneHl5oV27dvDy8oK9vb3UJeodBiLKlVKpFG/4qhmAx/FFRKWP5jv89jQq22bNmgUASEtLw5kzZ3DixAmEhYVh8+bNyMjIgIuLC9q1a4cVK1ZIW6ge4RgiAvD6arbnzp1DWFgYQkNDcf78eTg5OaFt27Zo27YtPDw8ULVqVanLpGJiYGCA2NhY2NjYAAAqVKiAa9euwdnZGcDrcSUODg48A6UMUCqVqF+/PsqVe/3799q1a6hTp454Yc7MzEzcuHGD77VMPH/+HN999x1++OEHvHjxgu/7G3iEiAAAFhYWsLW1xccff4yAgABs376dh1TLMEEQMHDgQBgbGwN4feXqESNGoHz58gCgNb6ISreZM2dqPc7tKvQ9evTQVTmkY+np6QgPD0dYWBjCwsJw/vx5VKlSBT179oSHh4fU5ekVHiEiAECrVq1w5coVuLq6wtPTEx4eHvD09ETFihWlLo1KAC/EKR8PHz6Eo6Oj1nVpqOybM2eOGIA0R/s9PDzg4eEBBwcHqcvTSwxEJHrx4gVOnz4tDqS+cuUKXFxcxIDk4eEhnrpLRKWDgYEBHj9+zO+uzCiVSlSrVg1TpkzBp59+yh+3BcBARHlKTk7GqVOncOTIEWzcuBEvXrzgWWZlBHeS8vH2dYhIHkJCQvL9casZP0j/w0BEOWRnZ+PixYsICwvD8ePHcebMGaSkpMDJyYlXPy0juJOUD6VSibi4OO4AZUzz4/bEiRM4fvw4rl69ilq1asHLyws//vij1OXpDQYiAgBcuHBBHHR3+vRpvHjxAo6OjvD09BSvT1S9enWpy6RiwkAkH0qlEsOHD4eZmVm+7ZYsWaKjikgqWVlZuHDhAvbu3YuVK1fyLLO38CwzAvB6ULW9vT28vLywZMkSeHl5oWbNmlKXRSVo3bp1MDc3z7fN2LFjdVQNlaTr16+Lp9nnhtclKpuys7Nx6dIlsetMc7Tf0dER3bp1g5eXl9Ql6hUeISIAwJ07d+Dq6prrPEEQcOjQIaxfvx67du3ScWVUEpRKJRwdHWFgYJBnG4VCgb/++kuHVVFJ4NFAeerYsSPOnj2L5ORkODg4wMvLSzzir7mPHWnjESICgFzDUHR0NDZs2ICgoCAkJCTA29tbgsqopFy6dIk7SRng0R95srS0xOLFi+Hl5YXatWtLXU6pwEBEWtLS0rBr1y6sX78ep0+fRlZWFr799lsMGTIEKpVK6vKomHAnKR/v6gRITEzEzz//jNGjR+uoItKFbdu2SV1CqcMrdREAICIiAqNGjYK9vT2WLVuGrl274tGjR1AqlfD19WUYKmPYUy4fGzduhIWFRY7px44dQ9++fVG5cuUcV7OmsiEzMxOLFy9GkyZNYG5uDnNzczRp0gTffvstMjIypC5P7zAQEQCgZcuWMDY2xrlz53Dx4kWMHTsWdnZ2UpdFJWTmzJnvHFBNZYO/v794i5ZHjx5hzpw5cHZ2ho+PDxQKBfbs2YPY2FiJq6Ti9urVK3h6emLKlCmwsbHB0KFDMXToUNjY2GDy5Mlo3749UlNTpS5TrzAQEQCgffv2WL9+PebMmYNDhw7xCEIZZ2pqqtVtdubMGa37lyUnJ2PUqFFSlEbFLCMjA8HBwfD19YWrqysiIyOxePFiKJVKTJs2DR999BEMDQ2lLpOK2YIFC/Do0SNcuXIFISEhWLZsGZYtW4aQkBBcvnwZDx48wIIFC6QuU6/wLDMSPXr0CBs3bsTGjRvx6tUr9OrVCytXrsS1a9dQt25dqcujYvT2lapVKhUiIyPFs094t/uyw9bWFnXq1EG/fv3w6aefwsrKCgBgaGiIq1evws3NTeIKqSS4urpi3rx5ed64Nzg4GNOmTcMff/yh48r0F48Qkahq1aoIDAxEdHQ0Nm/ejISEBJQrVw5dunTBN998g4iICKlLpGLy9u8g/i4quzIzM6FQKKBQKPK9zAKVLQ8ePECLFi3ynN+qVSs8fPhQhxXpPwYiylWHDh2wdetWxMTEYMyYMTh48GC+Xy4i0k8xMTEYPnw4tm3bBnt7e/To0QN79uzhmYZlnEqlQnx8fJ7zY2NjUaFCBR1WpP8YiChfVlZWGDNmDK5cuYL58+dLXQ4RFZKJiQk+//xzhIaG4vr166hbty7Gjh2LzMxM/Oc//8GRI0fYNVoGeXl5Yd68eXnOX7BgAa9U/RaOISJRZmYmbt++DSMjI7i4uIjTf/vtN8ycORO3bt3SGnhLpZdSqcTcuXPFM80mT56MSZMmoVKlSgBeD6oODAzkjrKMys7ORkhICNavX499+/ahQoUKePLkidRlUTG6efMmWrZsiXr16mHChAmoU6cOBEHArVu3sHTpUty8eRPnzp1DvXr1pC5VbzAQEQAgKioKnTt3xqNHjwAAXbp0wapVq/DZZ58hKioKw4YNw+jRo+Ho6ChxpVQcqlevXqAuk+joaB1UQ1JKSEjA5s2bMWHCBKlLoWJ27tw5DBkyBLdu3RK/74IgoE6dOli/fj3c3d0lrlC/MBARAMDPzw9paWkYN24ctm3bhm3btsHV1RVDhgxBQEAATE1NpS6RiIiKIDIyUjybzMXFBY0aNZK2ID3FQEQAXp+ae/jwYTRq1AhJSUmwsrLCpk2b0L9/f6lLIwn8/fffmDNnDtauXSt1KfSenJ2d33k0UKFQ4N69ezqqiEg/MRARgJx3xK5QoQIuX77MmwLK1NWrV9GkSROOISoDli9fnue8+/fvY82aNUhLS+N7XcbMmTOnQO0CAwNLuJLSgzd3JQCvfyEmJyfDxMQEgiBAoVDg1atXUKvVWu14TzOi0uXLL7/MMe3Zs2f497//jVWrVqFly5ZYuHChBJVRSdqzZ0+e8xQKBe7cuYPU1FQGojcwEBGA1wPt3jyzTBAENG7cWOuxQqHgr0iiUuzVq1dYsmQJvv32Wzg5OWH37t3o1KmT1GVRCbhy5Uqu0yMjIzFlyhTxZBn6HwYiAgAcP35c6hKIqIRkZWXhp59+wuzZs2FiYoLvv/8e/fr148UZZSQ6OhozZszAjh070L17d9y4cYNDIt7CQEQAAA8PD6lLIB3q3r17vvMTExN1UwiVuJ07d2L69OlITEzEtGnTMHLkSBgZGUldFunIkydPMHv2bKxduxatW7fG2bNn0bx5c6nL0kscVE1akpKScOTIEdy/fx8KhQLOzs7w9vbm2KEyZtCgQQVqt3HjxhKuhEqaUqmEqakp+vTpk+/3eMmSJTqsikpaSkoKvv32WyxZsgS1atXC/Pnz4ePjI3VZeo2BiEQ///wzRo8enWMgtYWFBVavXo1evXpJVBkRFZWnp2eBTrsPDQ3VUUWkC/b29khOTsaYMWPQp0+fPD8DDRs21HFl+ouBiAAAly9fRsuWLfH5559j/Pjx4mXeb968iWXLlmH79u24ePEiPvjgA6lLpWJy//59HDlyBOnp6fD09OQl/InKEKXyf7cqVSgUeHNXr3nME2W0MRARgNddKC9evEBwcHCu83v27AmVSoUNGzbouDIqCcePH0fnzp3x6tUrAEC5cuWwYcMG9OvXT+LKiKg4PHjwoEDtnJycSriS0oOBiAC8vpz7ypUr4e3tnev8o0ePYtSoUeLl36l0a926NSpVqoRVq1bBxMQE06dPx549exATEyN1aVTMCnqPMo4hKltiYmLg4OCQb5vt27ejd+/eOqpI/zEQEQDA3NwcN2/eRLVq1XKd//DhQ9StWxcpKSk6roxKgqWlJc6ePQs3NzcAwMuXL6FSqRAXF4eKFStKXB0VJy8vr3e24Riisqd+/fo4ffo0LC0tc52/fft2DBgwAOnp6botTI/xtHsC8HqHaGJikud8Y2NjpKam6rAiKklqtRqVKlUSH5uZmcHU1BRJSUkMRGUMrzEmTzY2NujYsSOOHTsGMzMzrXk7d+5E//79MW/ePImq008MRCQKCQmBhYVFrvN4XZqy5+33Ozs7G8eOHUNUVJQ47ZNPPpGiNCJ6T/v27YOnpye6du2K/fv3w9DQEAAQHByM/v37Y+7cuZg0aZLEVeoXdpkRAO0zEvLCMxLKDr7f8sGbfMpXQkIC2rZti/r162Pnzp345Zdf0LdvX8yaNQvffPON1OXpHQYiIqIyTKlUwsHBAba2tshrc69QKHD58mUdV0a68OjRI7Ru3Rq1a9fGqVOnMGPGDEyfPl3qsvQSAxERURnm5+eH0NBQ+Pr6YvDgwejcuXOBjhBS6Xbt2jXx/7dv38aAAQPQpUsXTJs2TasdL8z4PwxEBADYu3dvgdpxTEnZcPLkyQK1a9u2bQlXQroQExODTZs2ISgoCGq1GgMGDMDgwYPh6uoqdWlUQpRKpdYFGDW7+rf/z27x/2EgIgA5x5S8fWVTzTR+ecoGzcYSQL7dKHy/y56TJ09i48aN+OWXX9CgQQMcPXoUpqamUpdFxYwXZiw8nmVGAF6fYfSmChUq4OrVq6hRo4ZEFVFJsrKyQoUKFTBw4ED0799f6xR8KtuaN2+O+/fv4+bNm7hy5QoyMjIYiMogBp3CYyAikqHHjx9jz5492LBhAxYtWoROnTphyJAh+Oijj955I1AqncLDw7Fhwwbs3LkTLi4uGDRoEPr27QuVSiV1aVQCHj58WKB2eV2MV47YZUa54hEi+Xj48CGCgoKwadMmpKWlwd/fH7Nnz0a5cvy9VBYsWrQIQUFBePLkCT7//HMMGjSIA2ll4M1u8TdpxhQBr7vFMzMzdV2a3mIgolwxEMlPdHQ0hgwZghMnTiAhIQHW1tZSl0TFQKlUolq1aujcuTOMjIzybMd7mZUtV69ezXW6IAjYvn07vv/+e5ibmyM+Pl7Hlekv/gSkXCkUCnadyEBaWhp++eUXbNiwAeHh4fDz88P+/fsZhsqQtm3bQqFQ4MaNG3m24Xe97Pnggw9yTDt69CimTJmCP/74A19//TW++uorCSrTXzxCRABeD7J9c6OYmJgIlUqV4+yzZ8+e6bo0KgEXLlzAxo0bsX37dlSvXh2DBg1Cv379GISIyqDLly9j8uTJOHXqFIYOHYrAwEDY2tpKXZbe4REiAgAsW7ZM6hJIh1q1aoVq1aph7NixaNq0KQDg9OnTOdrxulPycOnSJTRr1kzqMqiY3bt3D9988w1++eUXfPbZZ7h58yaHQeSDR4gIwOtrk3z44YccSCsTvJeZ/Lx48QIGBgZap9hHRkZixowZOHDgAN/rMmbUqFFYv349vLy8sGDBAjRq1EjqkvQeAxEBAAwMDPD48WMeRiUqYx49eoTPPvsMFy5cgIGBAUaPHo25c+dixIgR2LFjB7p164bx48ejZcuWUpdKxUipVMLExAR16tTJtx3vYfc/PBxAAPK+WjERlW6TJk1Camoqli9fjt27d2P58uU4deoUWrZsiXv37sHR0VHqEqkEBAYGcrB8IfEIEQF4/WsiLi4ONjY2UpdCOhQcHIxt27bhjz/+AAC4uLigb9++6Nmzp8SVUXFxcHDA7t270apVK8THx8Pe3h5LlizBuHHjpC6NSK8wEBGA14GoY8eOMDY2zrfd7t27dVQRlaTs7Gz06dMHwcHBcHFxEQ+r37p1C3fv3sWnn36Kbdu28RdmGWBgYICYmBjY2dkBAMzNzREREcEbu5Zxb585rGFhYQEXFxdMnDgRHTp0kKAy/cUuMxJVqFCB9zSSieXLl+Po0aPYu3cvOnfurDVv7969GDRoEJYvX86jCGXEm4PolUplvhdopLIhrzOHExMTERERgc6dO2PXrl34+OOPdVuYHuMRIgLweiMZGxvLQdUy0bBhQ4wbNw6DBw/Odf769euxfPlyXLt2TceVUXFTKpWwsLAQjxbwGmMEvL4y+a5du3D27FmpS9EbDEQEgGeZyY2pqSnu3LmT540dHzx4gDp16uDVq1c6royK26ZNmwrUzt/fv4QrIX3yxx9/oFWrVgzCb2CXGQHgWWZyY2pqisTExDwDkVqthomJiY6ropLAoEO5SUtLY9fpW959dTaShePHj/O2DTLi7u6OVatW5Tl/xYoVcHd312FFVFIuXLiQ70UX09LSsHPnTh1WRPpg/fr1vFjjW9hlRgCA77//vkDtxo4dW8KVkC6cPXsWnp6e6Nq1KyZOnIg6depAEATcunUL3333HX777TccP34c//rXv6Quld7T293hKpUKkZGR4i0c4uLi4ODgwCtVlzETJkzIdXpSUhIuX76MP/74AydPnhRv3UMMRPT/nJ2d39lGoVDgr7/+0kE1pAt79uzB8OHDc4whsLKywpo1a9CjRw+JKqPi9PYJExUqVMDVq1e1AlHlypWRnZ0tZZlUzLy8vHKdrlKp4OrqipEjRxZouy8nDEQEAIiOjuaXQ4ZevnyJkJAQ/PnnnwBeX5jRx8cHZmZmEldGxaUggYhHiIg4qJr+X82aNeHk5AQvLy+0a9cOXl5eqFKlitRlUQkJDQ3F6NGjce7cOXTr1k1rXlJSEurVq4fVq1ejTZs2ElVIRKRbDEQE4PUOMiwsDGFhYdi2bRvS09NRo0YNMRx5eXmJV7ql0m/ZsmUYNmwYVCpVjnkWFhb44osvsGTJEgaiMuLmzZuIjY0F8PqM0tu3b+PFixcAgCdPnkhZGpHeYJcZ5ZCamoqzZ8+KAenChQvIyMhAnTp1cOPGDanLo2Lg5OSEQ4cOoW7durnOv337Nnx8fPDw4UMdV0bFTalUQqFQ5HppDc10hULBLjOSPQYiylN6ejrOnDmDgwcPYs2aNXjx4gU3mmWEiYkJoqKiUKtWrVzn3717Fw0aNOCFGcuABw8eFKidk5NTCVdCpN/YZUai9PR0nDt3DsePH0dYWBjOnz+PqlWrom3btvjxxx/h4eEhdYlUTKpUqZJvILp27RoqV66s46qoJGzatAkTJ07kQHmid+ARIgIAtGvXDufPn4ezszM8PDzQpk0beHh4cKdYRo0ZMwZhYWG4ePFijitSv3r1Ci1atICXl1eBr09F+ou35SEqGAYiAgAYGhqicuXK6Nq1Kzw9PeHh4YGKFStKXRaVkLi4ODRp0gQGBgYYPXo0XF1dAbweO7RixQpkZWXh8uXLHEhfBvDGzUQFw0BEAICUlBScOnUKYWFhOH78OCIjI+Hi4gIPDw8xINnY2EhdJhWjBw8eYOTIkQgJCREH3CoUCvj6+mLFihW8LlUZoVQqERcXx+8v0TswEFGukpOTcfr0aXE80dWrV1G7dm1ERUVJXRoVs+fPn+Pu3bsQBAG1a9eGlZWV1CVRMVIqlbCwsIBCoci3He96TnLHQdWUq/Lly8Pa2hrW1tawsrJCuXLlcOvWLanLohJgZWWF5s2bS10GlaDZs2fDwsJC6jKI9BqPEBEAIDs7G5cuXRK7zM6cOYOUlBRUqVJFvDCjl5cXT80lKmU4hoioYHiEiAAAlpaWSElJgb29Pby8vLB06VJ4enqiZs2aUpdGRO/hXV1lRPQaAxEBABYvXgwvLy+4uLhIXQoRFSN2AhAVDLvMiIiISPaUUhdAREREJDUGIiIiIpI9BiIiIiKSPQYiIiIikj0GIiIiIpI9BiIiIiKSPQYiIiIikj0GIiIiIpK9/wOqnvjBx++T/QAAAABJRU5ErkJggg==\n"
          },
          "metadata": {}
        },
        {
          "output_type": "stream",
          "name": "stdout",
          "text": [
            "\n",
            "================================================\n",
            "Complete Clinical Trials Data with No Enrollment\n",
            "================================================\n"
          ]
        },
        {
          "output_type": "execute_result",
          "data": {
            "text/plain": [
              "                                                  sponsor study_results  \\\n",
              "110182                                    ViiV Healthcare            NO   \n",
              "128145  National Heart, Lung, and Blood Institute (NHLBI)            NO   \n",
              "141951                                    ViiV Healthcare            NO   \n",
              "144401  National Institute of Allergy and Infectious D...            NO   \n",
              "147761  National Institute of Environmental Health Sci...            NO   \n",
              "151090  National Institute of Allergy and Infectious D...            NO   \n",
              "152129  National Institute of Allergy and Infectious D...            NO   \n",
              "152153  National Institute of Allergy and Infectious D...            NO   \n",
              "156975  National Institutes of Health Clinical Center ...            NO   \n",
              "\n",
              "       study_area start_date completion_date funder_type  \n",
              "110182      heart 2009-03-01      2010-12-01    INDUSTRY  \n",
              "128145      heart 2007-01-11      2007-12-10         NIH  \n",
              "141951        HIV 2009-03-01      2010-12-01    INDUSTRY  \n",
              "144401        HIV 2006-02-16      2007-11-15         NIH  \n",
              "147761        HIV 2004-06-25      2007-12-28         NIH  \n",
              "151090    malaria 2004-06-09      2008-02-06         NIH  \n",
              "152129    malaria 2005-03-07      2008-06-17         NIH  \n",
              "152153    malaria 2005-03-08      2008-07-02         NIH  \n",
              "156975  pneumonia 2006-08-11      2007-05-22         NIH  "
            ],
            "text/html": [
              "\n",
              "  <div id=\"df-ea5c64df-160c-46c6-9523-ce2294057e70\" class=\"colab-df-container\">\n",
              "    <div>\n",
              "<style scoped>\n",
              "    .dataframe tbody tr th:only-of-type {\n",
              "        vertical-align: middle;\n",
              "    }\n",
              "\n",
              "    .dataframe tbody tr th {\n",
              "        vertical-align: top;\n",
              "    }\n",
              "\n",
              "    .dataframe thead th {\n",
              "        text-align: right;\n",
              "    }\n",
              "</style>\n",
              "<table border=\"1\" class=\"dataframe\">\n",
              "  <thead>\n",
              "    <tr style=\"text-align: right;\">\n",
              "      <th></th>\n",
              "      <th>sponsor</th>\n",
              "      <th>study_results</th>\n",
              "      <th>study_area</th>\n",
              "      <th>start_date</th>\n",
              "      <th>completion_date</th>\n",
              "      <th>funder_type</th>\n",
              "    </tr>\n",
              "  </thead>\n",
              "  <tbody>\n",
              "    <tr>\n",
              "      <th>110182</th>\n",
              "      <td>ViiV Healthcare</td>\n",
              "      <td>NO</td>\n",
              "      <td>heart</td>\n",
              "      <td>2009-03-01</td>\n",
              "      <td>2010-12-01</td>\n",
              "      <td>INDUSTRY</td>\n",
              "    </tr>\n",
              "    <tr>\n",
              "      <th>128145</th>\n",
              "      <td>National Heart, Lung, and Blood Institute (NHLBI)</td>\n",
              "      <td>NO</td>\n",
              "      <td>heart</td>\n",
              "      <td>2007-01-11</td>\n",
              "      <td>2007-12-10</td>\n",
              "      <td>NIH</td>\n",
              "    </tr>\n",
              "    <tr>\n",
              "      <th>141951</th>\n",
              "      <td>ViiV Healthcare</td>\n",
              "      <td>NO</td>\n",
              "      <td>HIV</td>\n",
              "      <td>2009-03-01</td>\n",
              "      <td>2010-12-01</td>\n",
              "      <td>INDUSTRY</td>\n",
              "    </tr>\n",
              "    <tr>\n",
              "      <th>144401</th>\n",
              "      <td>National Institute of Allergy and Infectious D...</td>\n",
              "      <td>NO</td>\n",
              "      <td>HIV</td>\n",
              "      <td>2006-02-16</td>\n",
              "      <td>2007-11-15</td>\n",
              "      <td>NIH</td>\n",
              "    </tr>\n",
              "    <tr>\n",
              "      <th>147761</th>\n",
              "      <td>National Institute of Environmental Health Sci...</td>\n",
              "      <td>NO</td>\n",
              "      <td>HIV</td>\n",
              "      <td>2004-06-25</td>\n",
              "      <td>2007-12-28</td>\n",
              "      <td>NIH</td>\n",
              "    </tr>\n",
              "    <tr>\n",
              "      <th>151090</th>\n",
              "      <td>National Institute of Allergy and Infectious D...</td>\n",
              "      <td>NO</td>\n",
              "      <td>malaria</td>\n",
              "      <td>2004-06-09</td>\n",
              "      <td>2008-02-06</td>\n",
              "      <td>NIH</td>\n",
              "    </tr>\n",
              "    <tr>\n",
              "      <th>152129</th>\n",
              "      <td>National Institute of Allergy and Infectious D...</td>\n",
              "      <td>NO</td>\n",
              "      <td>malaria</td>\n",
              "      <td>2005-03-07</td>\n",
              "      <td>2008-06-17</td>\n",
              "      <td>NIH</td>\n",
              "    </tr>\n",
              "    <tr>\n",
              "      <th>152153</th>\n",
              "      <td>National Institute of Allergy and Infectious D...</td>\n",
              "      <td>NO</td>\n",
              "      <td>malaria</td>\n",
              "      <td>2005-03-08</td>\n",
              "      <td>2008-07-02</td>\n",
              "      <td>NIH</td>\n",
              "    </tr>\n",
              "    <tr>\n",
              "      <th>156975</th>\n",
              "      <td>National Institutes of Health Clinical Center ...</td>\n",
              "      <td>NO</td>\n",
              "      <td>pneumonia</td>\n",
              "      <td>2006-08-11</td>\n",
              "      <td>2007-05-22</td>\n",
              "      <td>NIH</td>\n",
              "    </tr>\n",
              "  </tbody>\n",
              "</table>\n",
              "</div>\n",
              "    <div class=\"colab-df-buttons\">\n",
              "\n",
              "  <div class=\"colab-df-container\">\n",
              "    <button class=\"colab-df-convert\" onclick=\"convertToInteractive('df-ea5c64df-160c-46c6-9523-ce2294057e70')\"\n",
              "            title=\"Convert this dataframe to an interactive table.\"\n",
              "            style=\"display:none;\">\n",
              "\n",
              "  <svg xmlns=\"http://www.w3.org/2000/svg\" height=\"24px\" viewBox=\"0 -960 960 960\">\n",
              "    <path d=\"M120-120v-720h720v720H120Zm60-500h600v-160H180v160Zm220 220h160v-160H400v160Zm0 220h160v-160H400v160ZM180-400h160v-160H180v160Zm440 0h160v-160H620v160ZM180-180h160v-160H180v160Zm440 0h160v-160H620v160Z\"/>\n",
              "  </svg>\n",
              "    </button>\n",
              "\n",
              "  <style>\n",
              "    .colab-df-container {\n",
              "      display:flex;\n",
              "      gap: 12px;\n",
              "    }\n",
              "\n",
              "    .colab-df-convert {\n",
              "      background-color: #E8F0FE;\n",
              "      border: none;\n",
              "      border-radius: 50%;\n",
              "      cursor: pointer;\n",
              "      display: none;\n",
              "      fill: #1967D2;\n",
              "      height: 32px;\n",
              "      padding: 0 0 0 0;\n",
              "      width: 32px;\n",
              "    }\n",
              "\n",
              "    .colab-df-convert:hover {\n",
              "      background-color: #E2EBFA;\n",
              "      box-shadow: 0px 1px 2px rgba(60, 64, 67, 0.3), 0px 1px 3px 1px rgba(60, 64, 67, 0.15);\n",
              "      fill: #174EA6;\n",
              "    }\n",
              "\n",
              "    .colab-df-buttons div {\n",
              "      margin-bottom: 4px;\n",
              "    }\n",
              "\n",
              "    [theme=dark] .colab-df-convert {\n",
              "      background-color: #3B4455;\n",
              "      fill: #D2E3FC;\n",
              "    }\n",
              "\n",
              "    [theme=dark] .colab-df-convert:hover {\n",
              "      background-color: #434B5C;\n",
              "      box-shadow: 0px 1px 3px 1px rgba(0, 0, 0, 0.15);\n",
              "      filter: drop-shadow(0px 1px 2px rgba(0, 0, 0, 0.3));\n",
              "      fill: #FFFFFF;\n",
              "    }\n",
              "  </style>\n",
              "\n",
              "    <script>\n",
              "      const buttonEl =\n",
              "        document.querySelector('#df-ea5c64df-160c-46c6-9523-ce2294057e70 button.colab-df-convert');\n",
              "      buttonEl.style.display =\n",
              "        google.colab.kernel.accessAllowed ? 'block' : 'none';\n",
              "\n",
              "      async function convertToInteractive(key) {\n",
              "        const element = document.querySelector('#df-ea5c64df-160c-46c6-9523-ce2294057e70');\n",
              "        const dataTable =\n",
              "          await google.colab.kernel.invokeFunction('convertToInteractive',\n",
              "                                                    [key], {});\n",
              "        if (!dataTable) return;\n",
              "\n",
              "        const docLinkHtml = 'Like what you see? Visit the ' +\n",
              "          '<a target=\"_blank\" href=https://colab.research.google.com/notebooks/data_table.ipynb>data table notebook</a>'\n",
              "          + ' to learn more about interactive tables.';\n",
              "        element.innerHTML = '';\n",
              "        dataTable['output_type'] = 'display_data';\n",
              "        await google.colab.output.renderOutput(dataTable, element);\n",
              "        const docLink = document.createElement('div');\n",
              "        docLink.innerHTML = docLinkHtml;\n",
              "        element.appendChild(docLink);\n",
              "      }\n",
              "    </script>\n",
              "  </div>\n",
              "\n",
              "\n",
              "<div id=\"df-55dda706-60ff-485e-bc47-1ac878bcdff5\">\n",
              "  <button class=\"colab-df-quickchart\" onclick=\"quickchart('df-55dda706-60ff-485e-bc47-1ac878bcdff5')\"\n",
              "            title=\"Suggest charts.\"\n",
              "            style=\"display:none;\">\n",
              "\n",
              "<svg xmlns=\"http://www.w3.org/2000/svg\" height=\"24px\"viewBox=\"0 0 24 24\"\n",
              "     width=\"24px\">\n",
              "    <g>\n",
              "        <path d=\"M19 3H5c-1.1 0-2 .9-2 2v14c0 1.1.9 2 2 2h14c1.1 0 2-.9 2-2V5c0-1.1-.9-2-2-2zM9 17H7v-7h2v7zm4 0h-2V7h2v10zm4 0h-2v-4h2v4z\"/>\n",
              "    </g>\n",
              "</svg>\n",
              "  </button>\n",
              "\n",
              "<style>\n",
              "  .colab-df-quickchart {\n",
              "      --bg-color: #E8F0FE;\n",
              "      --fill-color: #1967D2;\n",
              "      --hover-bg-color: #E2EBFA;\n",
              "      --hover-fill-color: #174EA6;\n",
              "      --disabled-fill-color: #AAA;\n",
              "      --disabled-bg-color: #DDD;\n",
              "  }\n",
              "\n",
              "  [theme=dark] .colab-df-quickchart {\n",
              "      --bg-color: #3B4455;\n",
              "      --fill-color: #D2E3FC;\n",
              "      --hover-bg-color: #434B5C;\n",
              "      --hover-fill-color: #FFFFFF;\n",
              "      --disabled-bg-color: #3B4455;\n",
              "      --disabled-fill-color: #666;\n",
              "  }\n",
              "\n",
              "  .colab-df-quickchart {\n",
              "    background-color: var(--bg-color);\n",
              "    border: none;\n",
              "    border-radius: 50%;\n",
              "    cursor: pointer;\n",
              "    display: none;\n",
              "    fill: var(--fill-color);\n",
              "    height: 32px;\n",
              "    padding: 0;\n",
              "    width: 32px;\n",
              "  }\n",
              "\n",
              "  .colab-df-quickchart:hover {\n",
              "    background-color: var(--hover-bg-color);\n",
              "    box-shadow: 0 1px 2px rgba(60, 64, 67, 0.3), 0 1px 3px 1px rgba(60, 64, 67, 0.15);\n",
              "    fill: var(--button-hover-fill-color);\n",
              "  }\n",
              "\n",
              "  .colab-df-quickchart-complete:disabled,\n",
              "  .colab-df-quickchart-complete:disabled:hover {\n",
              "    background-color: var(--disabled-bg-color);\n",
              "    fill: var(--disabled-fill-color);\n",
              "    box-shadow: none;\n",
              "  }\n",
              "\n",
              "  .colab-df-spinner {\n",
              "    border: 2px solid var(--fill-color);\n",
              "    border-color: transparent;\n",
              "    border-bottom-color: var(--fill-color);\n",
              "    animation:\n",
              "      spin 1s steps(1) infinite;\n",
              "  }\n",
              "\n",
              "  @keyframes spin {\n",
              "    0% {\n",
              "      border-color: transparent;\n",
              "      border-bottom-color: var(--fill-color);\n",
              "      border-left-color: var(--fill-color);\n",
              "    }\n",
              "    20% {\n",
              "      border-color: transparent;\n",
              "      border-left-color: var(--fill-color);\n",
              "      border-top-color: var(--fill-color);\n",
              "    }\n",
              "    30% {\n",
              "      border-color: transparent;\n",
              "      border-left-color: var(--fill-color);\n",
              "      border-top-color: var(--fill-color);\n",
              "      border-right-color: var(--fill-color);\n",
              "    }\n",
              "    40% {\n",
              "      border-color: transparent;\n",
              "      border-right-color: var(--fill-color);\n",
              "      border-top-color: var(--fill-color);\n",
              "    }\n",
              "    60% {\n",
              "      border-color: transparent;\n",
              "      border-right-color: var(--fill-color);\n",
              "    }\n",
              "    80% {\n",
              "      border-color: transparent;\n",
              "      border-right-color: var(--fill-color);\n",
              "      border-bottom-color: var(--fill-color);\n",
              "    }\n",
              "    90% {\n",
              "      border-color: transparent;\n",
              "      border-bottom-color: var(--fill-color);\n",
              "    }\n",
              "  }\n",
              "</style>\n",
              "\n",
              "  <script>\n",
              "    async function quickchart(key) {\n",
              "      const quickchartButtonEl =\n",
              "        document.querySelector('#' + key + ' button');\n",
              "      quickchartButtonEl.disabled = true;  // To prevent multiple clicks.\n",
              "      quickchartButtonEl.classList.add('colab-df-spinner');\n",
              "      try {\n",
              "        const charts = await google.colab.kernel.invokeFunction(\n",
              "            'suggestCharts', [key], {});\n",
              "      } catch (error) {\n",
              "        console.error('Error during call to suggestCharts:', error);\n",
              "      }\n",
              "      quickchartButtonEl.classList.remove('colab-df-spinner');\n",
              "      quickchartButtonEl.classList.add('colab-df-quickchart-complete');\n",
              "    }\n",
              "    (() => {\n",
              "      let quickchartButtonEl =\n",
              "        document.querySelector('#df-55dda706-60ff-485e-bc47-1ac878bcdff5 button');\n",
              "      quickchartButtonEl.style.display =\n",
              "        google.colab.kernel.accessAllowed ? 'block' : 'none';\n",
              "    })();\n",
              "  </script>\n",
              "</div>\n",
              "    </div>\n",
              "  </div>\n"
            ]
          },
          "metadata": {},
          "execution_count": 5
        }
      ]
    },
    {
      "cell_type": "markdown",
      "source": [
        "### Enrollment Numbers Over Time\n",
        "- Eliminating Observations with no Enrollment Data"
      ],
      "metadata": {
        "id": "Ewo-qvZj84p1"
      }
    },
    {
      "cell_type": "code",
      "source": [
        "# Eliminating Observations with no Enrollment Data\n",
        "clinical_df = clinical_df.loc[clinical_df.enrollment != 0, :]\n",
        "\n",
        "# Clinical enrollment data over time\n",
        "enrollment_over_time = clinical_df.groupby('start_year').enrollment.sum()\n",
        "t = np.arange(1, enrollment_over_time.shape[0]+1, 1)\n",
        "a, b = np.polyfit(t, enrollment_over_time.tolist(), 1)\n",
        "lbf = a*t + b # Line of best fit\n",
        "enrollment_over_time.plot(kind = 'line', figsize = (8, 6), color = '#0A2C08', label = \"Trend Line\")\n",
        "plt.plot(enrollment_over_time.index, lbf, label = \"Line of Best Fit\", color = \"#08CAF1\")\n",
        "plt.title(\"Clinical Trials Enrollment Figures Over Time\")\n",
        "plt.xlabel(\"Year\")\n",
        "plt.ylabel(\"Enrollment\")\n",
        "plt.legend()\n",
        "plt.grid()\n",
        "plt.show()\n"
      ],
      "metadata": {
        "id": "ZbxuRtoFpOub",
        "colab": {
          "base_uri": "https://localhost:8080/",
          "height": 564
        },
        "outputId": "831bcb1a-d73f-49ff-9d29-97c0bcd464f8"
      },
      "execution_count": 17,
      "outputs": [
        {
          "output_type": "display_data",
          "data": {
            "text/plain": [
              "<Figure size 800x600 with 1 Axes>"
            ],
            "image/png": "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\n"
          },
          "metadata": {}
        }
      ]
    },
    {
      "cell_type": "markdown",
      "source": [
        "## **Descriptive Statistics of the Numeric Data**"
      ],
      "metadata": {
        "id": "K7gGL2N59sNu"
      }
    },
    {
      "cell_type": "code",
      "source": [
        "clinical_df._get_numeric_data().drop(columns = ['start_year', 'has_collaborators']).describe()"
      ],
      "metadata": {
        "colab": {
          "base_uri": "https://localhost:8080/",
          "height": 300
        },
        "id": "v8wEYnNrpOxd",
        "outputId": "cb3e484a-7c00-4f07-ebaa-7d3d0f31738d"
      },
      "execution_count": 7,
      "outputs": [
        {
          "output_type": "execute_result",
          "data": {
            "text/plain": [
              "         enrollment  days_to_completion  interventions_count\n",
              "count  1.516770e+05       148856.000000        154117.000000\n",
              "mean   9.784273e+03         1406.555725             1.797180\n",
              "std    7.857562e+05         1378.653167             1.702755\n",
              "min    1.000000e+00            0.000000             0.000000\n",
              "25%    3.300000e+01          549.000000             1.000000\n",
              "50%    8.000000e+01         1078.000000             1.000000\n",
              "75%    2.480000e+02         1826.000000             2.000000\n",
              "max    1.888141e+08        40177.000000            57.000000"
            ],
            "text/html": [
              "\n",
              "  <div id=\"df-309d1e5e-5ac3-4786-9e63-1fb7b5c1ca90\" class=\"colab-df-container\">\n",
              "    <div>\n",
              "<style scoped>\n",
              "    .dataframe tbody tr th:only-of-type {\n",
              "        vertical-align: middle;\n",
              "    }\n",
              "\n",
              "    .dataframe tbody tr th {\n",
              "        vertical-align: top;\n",
              "    }\n",
              "\n",
              "    .dataframe thead th {\n",
              "        text-align: right;\n",
              "    }\n",
              "</style>\n",
              "<table border=\"1\" class=\"dataframe\">\n",
              "  <thead>\n",
              "    <tr style=\"text-align: right;\">\n",
              "      <th></th>\n",
              "      <th>enrollment</th>\n",
              "      <th>days_to_completion</th>\n",
              "      <th>interventions_count</th>\n",
              "    </tr>\n",
              "  </thead>\n",
              "  <tbody>\n",
              "    <tr>\n",
              "      <th>count</th>\n",
              "      <td>1.516770e+05</td>\n",
              "      <td>148856.000000</td>\n",
              "      <td>154117.000000</td>\n",
              "    </tr>\n",
              "    <tr>\n",
              "      <th>mean</th>\n",
              "      <td>9.784273e+03</td>\n",
              "      <td>1406.555725</td>\n",
              "      <td>1.797180</td>\n",
              "    </tr>\n",
              "    <tr>\n",
              "      <th>std</th>\n",
              "      <td>7.857562e+05</td>\n",
              "      <td>1378.653167</td>\n",
              "      <td>1.702755</td>\n",
              "    </tr>\n",
              "    <tr>\n",
              "      <th>min</th>\n",
              "      <td>1.000000e+00</td>\n",
              "      <td>0.000000</td>\n",
              "      <td>0.000000</td>\n",
              "    </tr>\n",
              "    <tr>\n",
              "      <th>25%</th>\n",
              "      <td>3.300000e+01</td>\n",
              "      <td>549.000000</td>\n",
              "      <td>1.000000</td>\n",
              "    </tr>\n",
              "    <tr>\n",
              "      <th>50%</th>\n",
              "      <td>8.000000e+01</td>\n",
              "      <td>1078.000000</td>\n",
              "      <td>1.000000</td>\n",
              "    </tr>\n",
              "    <tr>\n",
              "      <th>75%</th>\n",
              "      <td>2.480000e+02</td>\n",
              "      <td>1826.000000</td>\n",
              "      <td>2.000000</td>\n",
              "    </tr>\n",
              "    <tr>\n",
              "      <th>max</th>\n",
              "      <td>1.888141e+08</td>\n",
              "      <td>40177.000000</td>\n",
              "      <td>57.000000</td>\n",
              "    </tr>\n",
              "  </tbody>\n",
              "</table>\n",
              "</div>\n",
              "    <div class=\"colab-df-buttons\">\n",
              "\n",
              "  <div class=\"colab-df-container\">\n",
              "    <button class=\"colab-df-convert\" onclick=\"convertToInteractive('df-309d1e5e-5ac3-4786-9e63-1fb7b5c1ca90')\"\n",
              "            title=\"Convert this dataframe to an interactive table.\"\n",
              "            style=\"display:none;\">\n",
              "\n",
              "  <svg xmlns=\"http://www.w3.org/2000/svg\" height=\"24px\" viewBox=\"0 -960 960 960\">\n",
              "    <path d=\"M120-120v-720h720v720H120Zm60-500h600v-160H180v160Zm220 220h160v-160H400v160Zm0 220h160v-160H400v160ZM180-400h160v-160H180v160Zm440 0h160v-160H620v160ZM180-180h160v-160H180v160Zm440 0h160v-160H620v160Z\"/>\n",
              "  </svg>\n",
              "    </button>\n",
              "\n",
              "  <style>\n",
              "    .colab-df-container {\n",
              "      display:flex;\n",
              "      gap: 12px;\n",
              "    }\n",
              "\n",
              "    .colab-df-convert {\n",
              "      background-color: #E8F0FE;\n",
              "      border: none;\n",
              "      border-radius: 50%;\n",
              "      cursor: pointer;\n",
              "      display: none;\n",
              "      fill: #1967D2;\n",
              "      height: 32px;\n",
              "      padding: 0 0 0 0;\n",
              "      width: 32px;\n",
              "    }\n",
              "\n",
              "    .colab-df-convert:hover {\n",
              "      background-color: #E2EBFA;\n",
              "      box-shadow: 0px 1px 2px rgba(60, 64, 67, 0.3), 0px 1px 3px 1px rgba(60, 64, 67, 0.15);\n",
              "      fill: #174EA6;\n",
              "    }\n",
              "\n",
              "    .colab-df-buttons div {\n",
              "      margin-bottom: 4px;\n",
              "    }\n",
              "\n",
              "    [theme=dark] .colab-df-convert {\n",
              "      background-color: #3B4455;\n",
              "      fill: #D2E3FC;\n",
              "    }\n",
              "\n",
              "    [theme=dark] .colab-df-convert:hover {\n",
              "      background-color: #434B5C;\n",
              "      box-shadow: 0px 1px 3px 1px rgba(0, 0, 0, 0.15);\n",
              "      filter: drop-shadow(0px 1px 2px rgba(0, 0, 0, 0.3));\n",
              "      fill: #FFFFFF;\n",
              "    }\n",
              "  </style>\n",
              "\n",
              "    <script>\n",
              "      const buttonEl =\n",
              "        document.querySelector('#df-309d1e5e-5ac3-4786-9e63-1fb7b5c1ca90 button.colab-df-convert');\n",
              "      buttonEl.style.display =\n",
              "        google.colab.kernel.accessAllowed ? 'block' : 'none';\n",
              "\n",
              "      async function convertToInteractive(key) {\n",
              "        const element = document.querySelector('#df-309d1e5e-5ac3-4786-9e63-1fb7b5c1ca90');\n",
              "        const dataTable =\n",
              "          await google.colab.kernel.invokeFunction('convertToInteractive',\n",
              "                                                    [key], {});\n",
              "        if (!dataTable) return;\n",
              "\n",
              "        const docLinkHtml = 'Like what you see? Visit the ' +\n",
              "          '<a target=\"_blank\" href=https://colab.research.google.com/notebooks/data_table.ipynb>data table notebook</a>'\n",
              "          + ' to learn more about interactive tables.';\n",
              "        element.innerHTML = '';\n",
              "        dataTable['output_type'] = 'display_data';\n",
              "        await google.colab.output.renderOutput(dataTable, element);\n",
              "        const docLink = document.createElement('div');\n",
              "        docLink.innerHTML = docLinkHtml;\n",
              "        element.appendChild(docLink);\n",
              "      }\n",
              "    </script>\n",
              "  </div>\n",
              "\n",
              "\n",
              "<div id=\"df-cb5a99a3-a77c-46eb-9673-c997d413ac91\">\n",
              "  <button class=\"colab-df-quickchart\" onclick=\"quickchart('df-cb5a99a3-a77c-46eb-9673-c997d413ac91')\"\n",
              "            title=\"Suggest charts.\"\n",
              "            style=\"display:none;\">\n",
              "\n",
              "<svg xmlns=\"http://www.w3.org/2000/svg\" height=\"24px\"viewBox=\"0 0 24 24\"\n",
              "     width=\"24px\">\n",
              "    <g>\n",
              "        <path d=\"M19 3H5c-1.1 0-2 .9-2 2v14c0 1.1.9 2 2 2h14c1.1 0 2-.9 2-2V5c0-1.1-.9-2-2-2zM9 17H7v-7h2v7zm4 0h-2V7h2v10zm4 0h-2v-4h2v4z\"/>\n",
              "    </g>\n",
              "</svg>\n",
              "  </button>\n",
              "\n",
              "<style>\n",
              "  .colab-df-quickchart {\n",
              "      --bg-color: #E8F0FE;\n",
              "      --fill-color: #1967D2;\n",
              "      --hover-bg-color: #E2EBFA;\n",
              "      --hover-fill-color: #174EA6;\n",
              "      --disabled-fill-color: #AAA;\n",
              "      --disabled-bg-color: #DDD;\n",
              "  }\n",
              "\n",
              "  [theme=dark] .colab-df-quickchart {\n",
              "      --bg-color: #3B4455;\n",
              "      --fill-color: #D2E3FC;\n",
              "      --hover-bg-color: #434B5C;\n",
              "      --hover-fill-color: #FFFFFF;\n",
              "      --disabled-bg-color: #3B4455;\n",
              "      --disabled-fill-color: #666;\n",
              "  }\n",
              "\n",
              "  .colab-df-quickchart {\n",
              "    background-color: var(--bg-color);\n",
              "    border: none;\n",
              "    border-radius: 50%;\n",
              "    cursor: pointer;\n",
              "    display: none;\n",
              "    fill: var(--fill-color);\n",
              "    height: 32px;\n",
              "    padding: 0;\n",
              "    width: 32px;\n",
              "  }\n",
              "\n",
              "  .colab-df-quickchart:hover {\n",
              "    background-color: var(--hover-bg-color);\n",
              "    box-shadow: 0 1px 2px rgba(60, 64, 67, 0.3), 0 1px 3px 1px rgba(60, 64, 67, 0.15);\n",
              "    fill: var(--button-hover-fill-color);\n",
              "  }\n",
              "\n",
              "  .colab-df-quickchart-complete:disabled,\n",
              "  .colab-df-quickchart-complete:disabled:hover {\n",
              "    background-color: var(--disabled-bg-color);\n",
              "    fill: var(--disabled-fill-color);\n",
              "    box-shadow: none;\n",
              "  }\n",
              "\n",
              "  .colab-df-spinner {\n",
              "    border: 2px solid var(--fill-color);\n",
              "    border-color: transparent;\n",
              "    border-bottom-color: var(--fill-color);\n",
              "    animation:\n",
              "      spin 1s steps(1) infinite;\n",
              "  }\n",
              "\n",
              "  @keyframes spin {\n",
              "    0% {\n",
              "      border-color: transparent;\n",
              "      border-bottom-color: var(--fill-color);\n",
              "      border-left-color: var(--fill-color);\n",
              "    }\n",
              "    20% {\n",
              "      border-color: transparent;\n",
              "      border-left-color: var(--fill-color);\n",
              "      border-top-color: var(--fill-color);\n",
              "    }\n",
              "    30% {\n",
              "      border-color: transparent;\n",
              "      border-left-color: var(--fill-color);\n",
              "      border-top-color: var(--fill-color);\n",
              "      border-right-color: var(--fill-color);\n",
              "    }\n",
              "    40% {\n",
              "      border-color: transparent;\n",
              "      border-right-color: var(--fill-color);\n",
              "      border-top-color: var(--fill-color);\n",
              "    }\n",
              "    60% {\n",
              "      border-color: transparent;\n",
              "      border-right-color: var(--fill-color);\n",
              "    }\n",
              "    80% {\n",
              "      border-color: transparent;\n",
              "      border-right-color: var(--fill-color);\n",
              "      border-bottom-color: var(--fill-color);\n",
              "    }\n",
              "    90% {\n",
              "      border-color: transparent;\n",
              "      border-bottom-color: var(--fill-color);\n",
              "    }\n",
              "  }\n",
              "</style>\n",
              "\n",
              "  <script>\n",
              "    async function quickchart(key) {\n",
              "      const quickchartButtonEl =\n",
              "        document.querySelector('#' + key + ' button');\n",
              "      quickchartButtonEl.disabled = true;  // To prevent multiple clicks.\n",
              "      quickchartButtonEl.classList.add('colab-df-spinner');\n",
              "      try {\n",
              "        const charts = await google.colab.kernel.invokeFunction(\n",
              "            'suggestCharts', [key], {});\n",
              "      } catch (error) {\n",
              "        console.error('Error during call to suggestCharts:', error);\n",
              "      }\n",
              "      quickchartButtonEl.classList.remove('colab-df-spinner');\n",
              "      quickchartButtonEl.classList.add('colab-df-quickchart-complete');\n",
              "    }\n",
              "    (() => {\n",
              "      let quickchartButtonEl =\n",
              "        document.querySelector('#df-cb5a99a3-a77c-46eb-9673-c997d413ac91 button');\n",
              "      quickchartButtonEl.style.display =\n",
              "        google.colab.kernel.accessAllowed ? 'block' : 'none';\n",
              "    })();\n",
              "  </script>\n",
              "</div>\n",
              "    </div>\n",
              "  </div>\n"
            ]
          },
          "metadata": {},
          "execution_count": 7
        }
      ]
    },
    {
      "cell_type": "markdown",
      "source": [
        "### **Insights - Anomalies**\n",
        "\n",
        "- The mean enrollment is way greater than the 75th Percentile. The data is heavily right skewed.\n",
        "- Maximum days taken by clinical study is 40177days (roughly 110 years)\n",
        "- For any analysis, we will have to omit those outliers but before, ommision, let's find out what about them\n",
        "\n",
        "#### **Outlier Clinical Trials in Terms of Enrollment and Days to Completion**"
      ],
      "metadata": {
        "id": "pAYnOJqC-PUz"
      }
    },
    {
      "cell_type": "code",
      "source": [
        "# Investigate trials whose days to completion are beyond outlier range\n",
        "Q3_dtc, Q3_enrl = clinical_df.days_to_completion.quantile(0.75), clinical_df.enrollment.quantile(0.75)\n",
        "IQR_dtc = Q3_dtc - clinical_df.days_to_completion.quantile(0.25)\n",
        "IQR_enrl = Q3_enrl - clinical_df.enrollment.quantile(0.25)\n",
        "\n",
        "outlier_trials = clinical_df.loc[\n",
        "    (clinical_df.days_to_completion >= Q3_dtc + 1.5*IQR_dtc) & (clinical_df.enrollment >= Q3_enrl + 1.5*IQR_enrl ),\n",
        "    [\"sponsor\", \"funder_type\", \"study_area\", \"study_status\", \"enrollment\", \"start_date\", \"completion_date\", \"days_to_completion\"]\n",
        "]\n",
        "print(\"Number of Clinical Trials Taking longer than usual:\",outlier_trials.shape[0])\n",
        "\n",
        "funder_group = outlier_trials.groupby(\"funder_type\")\n",
        "study_area_group = outlier_trials.groupby(\"study_area\")\n",
        "study_status_group = outlier_trials.groupby(\"study_status\")\n",
        "\n",
        "# Visualize a few things to get the overall idea\n",
        "fig, ax = plt.subplots(nrows = 2, ncols = 3, constrained_layout = True, figsize = (15, 8), sharey = 'row')\n",
        "# Funder group\n",
        "funder_group[\"enrollment\"].mean().sort_values().plot(kind = \"bar\", ax =  ax[0,0], color = \"#71C26A\")\n",
        "funder_group[\"days_to_completion\"].mean().sort_values().plot(kind = \"bar\", ax =  ax[1,0], color = \"#71C26A\")\n",
        "# Study area\n",
        "study_area_group[\"enrollment\"].mean().sort_values().plot(kind = \"bar\", ax =  ax[0,1], color = \"#2FC3C6\")\n",
        "study_area_group[\"days_to_completion\"].mean().sort_values().plot(kind = \"bar\", ax =  ax[1,1], color = \"#2FC3C6\")\n",
        "# Study status\n",
        "study_status_group[\"enrollment\"].mean().sort_values().plot(kind = \"bar\", ax =  ax[0,2], color = \"#EC0D91\")\n",
        "study_status_group[\"days_to_completion\"].mean().sort_values().plot(kind = \"bar\", ax =  ax[1,2], color = \"#EC0D91\")\n",
        "ax[0,0].set_ylabel(\"Enrollment\")\n",
        "ax[0,0].set_yticks(range(0, 600001, 100000), range(0, 600001, 100000))\n",
        "ax[1,0].set_ylabel(\"Days to Completion\")\n",
        "ax[1,0].set_yticks(range(0, 8001, 1000), range(0, 8001, 1000))\n",
        "for a_x in ax.flat:\n",
        "    a_x.grid(True, axis = \"y\")\n",
        "fig.suptitle(\"Average Enrollment and Days to Completion Numbers for Outlier Clinical Trials\", fontweight = 20)\n",
        "plt.show()"
      ],
      "metadata": {
        "colab": {
          "base_uri": "https://localhost:8080/",
          "height": 845
        },
        "id": "WanEnqiN4_3s",
        "outputId": "6db4ec0c-f438-41bb-da1c-ba1e707fa24a"
      },
      "execution_count": 8,
      "outputs": [
        {
          "output_type": "stream",
          "name": "stdout",
          "text": [
            "Number of Clinical Trials Taking longer than usual: 2363\n"
          ]
        },
        {
          "output_type": "display_data",
          "data": {
            "text/plain": [
              "<Figure size 1500x800 with 6 Axes>"
            ],
            "image/png": "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\n"
          },
          "metadata": {}
        }
      ]
    },
    {
      "cell_type": "markdown",
      "source": [
        "#### **Normal Data - Clinical Trials Inside the Outlier Upper Threshold**"
      ],
      "metadata": {
        "id": "PJefntftTIux"
      }
    },
    {
      "cell_type": "code",
      "source": [
        "clinical_trials = clinical_df.loc[\n",
        "    ~((clinical_df.days_to_completion >= Q3_dtc + 1.5*IQR_dtc) & (clinical_df.enrollment >= Q3_enrl + 1.5*IQR_enrl )) # Negate the boolean filter used above\n",
        "]\n",
        "clinical_trials.shape"
      ],
      "metadata": {
        "colab": {
          "base_uri": "https://localhost:8080/"
        },
        "id": "oHTPQ5i58GPl",
        "outputId": "e96a99ff-5efd-4c17-cf93-e5ed624aa695"
      },
      "execution_count": 9,
      "outputs": [
        {
          "output_type": "execute_result",
          "data": {
            "text/plain": [
              "(151754, 28)"
            ]
          },
          "metadata": {},
          "execution_count": 9
        }
      ]
    },
    {
      "cell_type": "markdown",
      "source": [
        "#### Average Number of Days Taken by Each Study Area Clinical Trials"
      ],
      "metadata": {
        "id": "tZwN8PUphbki"
      }
    },
    {
      "cell_type": "code",
      "source": [
        "clinical_trials.groupby('study_area')['days_to_completion'].mean().sort_values().plot(\n",
        "    kind = 'bar', figsize = (8,6), color = [\"#28B463\", \"#BDCE2F\", \"#DB1D2F\", \"#3E3C45\", \"#CE2FC9\", \"steelblue\"])"
      ],
      "metadata": {
        "colab": {
          "base_uri": "https://localhost:8080/",
          "height": 623
        },
        "id": "QTWHQOZVhb74",
        "outputId": "50715773-218a-4675-ac57-8bbe74309d45"
      },
      "execution_count": 10,
      "outputs": [
        {
          "output_type": "execute_result",
          "data": {
            "text/plain": [
              "<Axes: xlabel='study_area'>"
            ]
          },
          "metadata": {},
          "execution_count": 10
        },
        {
          "output_type": "display_data",
          "data": {
            "text/plain": [
              "<Figure size 800x600 with 1 Axes>"
            ],
            "image/png": "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\n"
          },
          "metadata": {}
        }
      ]
    },
    {
      "cell_type": "code",
      "source": [
        "data_trials = clinical_trials.loc[clinical_trials.sex != 'ALL'].groupby('sex').days_to_completion.mean()\n",
        "def func(pct, data):\n",
        "    ab = int(np.round(pct/100.*np.sum(data)))\n",
        "    return f\"{pct:.1f}%\\n({ab:d} days)\"\n",
        "data_trials.plot(\n",
        "    kind = \"pie\", explode = [0.1, 0], figsize = (6,6), label = \"Average Days\", autopct = lambda x: func(x, data_trials)\n",
        ")\n",
        "plt.title(\"Days to Completion by Gender\")"
      ],
      "metadata": {
        "colab": {
          "base_uri": "https://localhost:8080/",
          "height": 538
        },
        "id": "DRNexLLPjH4g",
        "outputId": "3fba32b8-f276-4f73-bd90-e1721daa7746"
      },
      "execution_count": 11,
      "outputs": [
        {
          "output_type": "execute_result",
          "data": {
            "text/plain": [
              "Text(0.5, 1.0, 'Days to Completion by Gender')"
            ]
          },
          "metadata": {},
          "execution_count": 11
        },
        {
          "output_type": "display_data",
          "data": {
            "text/plain": [
              "<Figure size 600x600 with 1 Axes>"
            ],
            "image/png": "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\n"
          },
          "metadata": {}
        }
      ]
    },
    {
      "cell_type": "code",
      "source": [
        "clinical_trials.columns"
      ],
      "metadata": {
        "colab": {
          "base_uri": "https://localhost:8080/"
        },
        "id": "txMP715cW0YE",
        "outputId": "283f758e-489f-4c84-9f21-69f38722e6e5"
      },
      "execution_count": 13,
      "outputs": [
        {
          "output_type": "execute_result",
          "data": {
            "text/plain": [
              "Index(['study_status', 'study_results', 'conditions', 'interventions',\n",
              "       'sponsor', 'collaborators', 'sex', 'age', 'phases', 'enrollment',\n",
              "       'funder_type', 'study_type', 'study_design', 'start_date',\n",
              "       'primary_completion_date', 'completion_date', 'first_posted',\n",
              "       'results_first_posted', 'last_update_posted', 'locations', 'study_area',\n",
              "       'start_year', 'days_to_completion', 'intervention_model', 'masking',\n",
              "       'has_collaborators', 'interventions_count', 'all_outcome_measures'],\n",
              "      dtype='object')"
            ]
          },
          "metadata": {},
          "execution_count": 13
        }
      ]
    },
    {
      "cell_type": "markdown",
      "source": [
        "### Features of Interest\n",
        "1. study status\n",
        "2. study results\n",
        "3. sex\n",
        "4. age\n",
        "5. phases\n",
        "6. enrollment\n",
        "7. study area (disease)\n",
        "8. start year\n",
        "9. days to completion\n",
        "10. intervention model\n",
        "11. Masking\n",
        "12. has collaborator\n",
        "13. Inteventions count\n",
        "\n",
        "### Questions\n",
        "1. Are their differences in the number of collaborators different study areas get?\n",
        "2. Does the number of interventions differ in different study areas?\n",
        "3. Does availability of collaborators affect study status in completed and terminated, and suspended studies?\n",
        "4. Does the Funder type affect the study status"
      ],
      "metadata": {
        "id": "L51zbnQ5W4t_"
      }
    },
    {
      "cell_type": "code",
      "source": [
        "# Frequency of masking types under different study areas\n",
        "masking_study_area = clinical_trials.loc[clinical_trials.masking != ''].groupby(\n",
        "    ['masking', 'study_area']\n",
        "    )['masking'].count().to_frame().rename(\n",
        "        columns = {'masking' : 'frequency'}\n",
        "        ).reset_index().pivot(\n",
        "            index = 'study_area', columns = 'masking', values = 'frequency')\n",
        "fig, ax = plt.subplots(figsize = (10,7))\n",
        "sns.heatmap(masking_study_area, annot = True, ax = ax, cmap = \"RdPu\", fmt = \"g\")\n",
        "plt.title(\"Frequency of Different Masking Types per Study Area\")\n",
        "plt.xlabel(\"Masking Type\"), plt.ylabel(\"Study Area (Disease)\")\n",
        "plt.show()"
      ],
      "metadata": {
        "colab": {
          "base_uri": "https://localhost:8080/",
          "height": 641
        },
        "id": "IkuyRgtvW4Bc",
        "outputId": "2601049b-41d0-4d90-d754-5ca26def8b21"
      },
      "execution_count": 35,
      "outputs": [
        {
          "output_type": "display_data",
          "data": {
            "text/plain": [
              "<Figure size 1000x700 with 2 Axes>"
            ],
            "image/png": "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\n"
          },
          "metadata": {}
        }
      ]
    },
    {
      "cell_type": "code",
      "source": [
        "clinical_trials.head(6)"
      ],
      "metadata": {
        "id": "Mk0GiUV3URgb",
        "outputId": "2db5f770-9430-4e4a-8004-c2403d621507",
        "colab": {
          "base_uri": "https://localhost:8080/",
          "height": 510
        }
      },
      "execution_count": 12,
      "outputs": [
        {
          "output_type": "execute_result",
          "data": {
            "text/plain": [
              "         study_status study_results  \\\n",
              "0           COMPLETED           YES   \n",
              "1  NOT_YET_RECRUITING            NO   \n",
              "2  NOT_YET_RECRUITING            NO   \n",
              "3           COMPLETED            NO   \n",
              "4             UNKNOWN            NO   \n",
              "5           COMPLETED           YES   \n",
              "\n",
              "                                    conditions  \\\n",
              "0                         Urothelial Carcinoma   \n",
              "1                           Prostate Carcinoma   \n",
              "2  Breast Neoplasm Female|Lymphatic Metastasis   \n",
              "3                                 Pioglitazone   \n",
              "4                      First Line WT KRAS mCRC   \n",
              "5       Bladder Cancer|Low Testosterone Levels   \n",
              "\n",
              "                                       interventions  \\\n",
              "0    DRUG: Ramucirumab|DRUG: Docetaxel|DRUG: Placebo   \n",
              "1  DRUG: Fluorine F 18 DCFPyL|DRUG: Gadobenate Di...   \n",
              "2                            PROCEDURE: Radiotherapy   \n",
              "3  DRUG: Pioglitazone|DRUG: Metformin|DRUG: Clomi...   \n",
              "4                                                NaN   \n",
              "5                                                NaN   \n",
              "\n",
              "                                          sponsor  \\\n",
              "0                           Eli Lilly and Company   \n",
              "1                         Northwestern University   \n",
              "2  Kyungpook National University Chilgok Hospital   \n",
              "3                            Ain Shams University   \n",
              "4                               Dr.Laurent Mineur   \n",
              "5             University of Kansas Medical Center   \n",
              "\n",
              "                                       collaborators     sex  \\\n",
              "0                                                NaN     ALL   \n",
              "1                    National Cancer Institute (NCI)    MALE   \n",
              "2                   Korean Breast Cancer Study Group  FEMALE   \n",
              "3                                                NaN  FEMALE   \n",
              "4  Merck Serono International SA|BESPIM, CHU NÃ®me...     ALL   \n",
              "5                                                NaN    MALE   \n",
              "\n",
              "                  age        phases  enrollment  ... last_update_posted  \\\n",
              "0  ADULT, OLDER_ADULT        PHASE3       530.0  ...         2023-08-21   \n",
              "1  ADULT, OLDER_ADULT        PHASE2       106.0  ...         2022-08-03   \n",
              "2  ADULT, OLDER_ADULT           NaN      1380.0  ...         2019-10-04   \n",
              "3               ADULT  EARLY_PHASE1       400.0  ...         2021-06-02   \n",
              "4  ADULT, OLDER_ADULT           NaN       500.0  ...         2012-12-27   \n",
              "5  ADULT, OLDER_ADULT           NaN        25.0  ...         2021-08-03   \n",
              "\n",
              "                                           locations study_area start_year  \\\n",
              "0  Highlands Oncology Group, Fayetteville, Arkans...     cancer       2015   \n",
              "1  Northwestern University, Chicago, Illinois, 60...     cancer       2023   \n",
              "2                                                NaN     cancer       2020   \n",
              "3                Ain Shams Univerisity, Cairo, Egypt     cancer       2018   \n",
              "4  Institut Sainte-Catherine, Avignon, Vaucluse, ...     cancer       2010   \n",
              "5  University of Kansas Medical Center, Kansas Ci...     cancer       2017   \n",
              "\n",
              "  days_to_completion intervention_model masking has_collaborators  \\\n",
              "0             2570.0           PARALLEL  DOUBLE                 0   \n",
              "1             1841.0       SINGLE_GROUP    NONE                 1   \n",
              "2             1825.0       SINGLE_GROUP    NONE                 1   \n",
              "3             1155.0       SINGLE_GROUP  SINGLE                 0   \n",
              "4             1247.0                NaN     NaN                 1   \n",
              "5              385.0                NaN     NaN                 0   \n",
              "\n",
              "  interventions_count                               all_outcome_measures  \n",
              "0                   3  Progression Free Survival (PFS), PFS defined a...  \n",
              "1                   7  18-F-DCFPyL positron emission tomography (PET)...  \n",
              "2                   1  Disease-free survival, Disease free survival i...  \n",
              "3                   3  Clinical pregnancy rate, Pregnancy rate diagno...  \n",
              "4                   0  To compare PFS rate at 1 year with PFS in clin...  \n",
              "5                   0  Number of Hypogonadism in Participants Based o...  \n",
              "\n",
              "[6 rows x 28 columns]"
            ],
            "text/html": [
              "\n",
              "  <div id=\"df-fc6bca4d-5017-4c0e-8246-ef086203a5eb\" class=\"colab-df-container\">\n",
              "    <div>\n",
              "<style scoped>\n",
              "    .dataframe tbody tr th:only-of-type {\n",
              "        vertical-align: middle;\n",
              "    }\n",
              "\n",
              "    .dataframe tbody tr th {\n",
              "        vertical-align: top;\n",
              "    }\n",
              "\n",
              "    .dataframe thead th {\n",
              "        text-align: right;\n",
              "    }\n",
              "</style>\n",
              "<table border=\"1\" class=\"dataframe\">\n",
              "  <thead>\n",
              "    <tr style=\"text-align: right;\">\n",
              "      <th></th>\n",
              "      <th>study_status</th>\n",
              "      <th>study_results</th>\n",
              "      <th>conditions</th>\n",
              "      <th>interventions</th>\n",
              "      <th>sponsor</th>\n",
              "      <th>collaborators</th>\n",
              "      <th>sex</th>\n",
              "      <th>age</th>\n",
              "      <th>phases</th>\n",
              "      <th>enrollment</th>\n",
              "      <th>...</th>\n",
              "      <th>last_update_posted</th>\n",
              "      <th>locations</th>\n",
              "      <th>study_area</th>\n",
              "      <th>start_year</th>\n",
              "      <th>days_to_completion</th>\n",
              "      <th>intervention_model</th>\n",
              "      <th>masking</th>\n",
              "      <th>has_collaborators</th>\n",
              "      <th>interventions_count</th>\n",
              "      <th>all_outcome_measures</th>\n",
              "    </tr>\n",
              "  </thead>\n",
              "  <tbody>\n",
              "    <tr>\n",
              "      <th>0</th>\n",
              "      <td>COMPLETED</td>\n",
              "      <td>YES</td>\n",
              "      <td>Urothelial Carcinoma</td>\n",
              "      <td>DRUG: Ramucirumab|DRUG: Docetaxel|DRUG: Placebo</td>\n",
              "      <td>Eli Lilly and Company</td>\n",
              "      <td>NaN</td>\n",
              "      <td>ALL</td>\n",
              "      <td>ADULT, OLDER_ADULT</td>\n",
              "      <td>PHASE3</td>\n",
              "      <td>530.0</td>\n",
              "      <td>...</td>\n",
              "      <td>2023-08-21</td>\n",
              "      <td>Highlands Oncology Group, Fayetteville, Arkans...</td>\n",
              "      <td>cancer</td>\n",
              "      <td>2015</td>\n",
              "      <td>2570.0</td>\n",
              "      <td>PARALLEL</td>\n",
              "      <td>DOUBLE</td>\n",
              "      <td>0</td>\n",
              "      <td>3</td>\n",
              "      <td>Progression Free Survival (PFS), PFS defined a...</td>\n",
              "    </tr>\n",
              "    <tr>\n",
              "      <th>1</th>\n",
              "      <td>NOT_YET_RECRUITING</td>\n",
              "      <td>NO</td>\n",
              "      <td>Prostate Carcinoma</td>\n",
              "      <td>DRUG: Fluorine F 18 DCFPyL|DRUG: Gadobenate Di...</td>\n",
              "      <td>Northwestern University</td>\n",
              "      <td>National Cancer Institute (NCI)</td>\n",
              "      <td>MALE</td>\n",
              "      <td>ADULT, OLDER_ADULT</td>\n",
              "      <td>PHASE2</td>\n",
              "      <td>106.0</td>\n",
              "      <td>...</td>\n",
              "      <td>2022-08-03</td>\n",
              "      <td>Northwestern University, Chicago, Illinois, 60...</td>\n",
              "      <td>cancer</td>\n",
              "      <td>2023</td>\n",
              "      <td>1841.0</td>\n",
              "      <td>SINGLE_GROUP</td>\n",
              "      <td>NONE</td>\n",
              "      <td>1</td>\n",
              "      <td>7</td>\n",
              "      <td>18-F-DCFPyL positron emission tomography (PET)...</td>\n",
              "    </tr>\n",
              "    <tr>\n",
              "      <th>2</th>\n",
              "      <td>NOT_YET_RECRUITING</td>\n",
              "      <td>NO</td>\n",
              "      <td>Breast Neoplasm Female|Lymphatic Metastasis</td>\n",
              "      <td>PROCEDURE: Radiotherapy</td>\n",
              "      <td>Kyungpook National University Chilgok Hospital</td>\n",
              "      <td>Korean Breast Cancer Study Group</td>\n",
              "      <td>FEMALE</td>\n",
              "      <td>ADULT, OLDER_ADULT</td>\n",
              "      <td>NaN</td>\n",
              "      <td>1380.0</td>\n",
              "      <td>...</td>\n",
              "      <td>2019-10-04</td>\n",
              "      <td>NaN</td>\n",
              "      <td>cancer</td>\n",
              "      <td>2020</td>\n",
              "      <td>1825.0</td>\n",
              "      <td>SINGLE_GROUP</td>\n",
              "      <td>NONE</td>\n",
              "      <td>1</td>\n",
              "      <td>1</td>\n",
              "      <td>Disease-free survival, Disease free survival i...</td>\n",
              "    </tr>\n",
              "    <tr>\n",
              "      <th>3</th>\n",
              "      <td>COMPLETED</td>\n",
              "      <td>NO</td>\n",
              "      <td>Pioglitazone</td>\n",
              "      <td>DRUG: Pioglitazone|DRUG: Metformin|DRUG: Clomi...</td>\n",
              "      <td>Ain Shams University</td>\n",
              "      <td>NaN</td>\n",
              "      <td>FEMALE</td>\n",
              "      <td>ADULT</td>\n",
              "      <td>EARLY_PHASE1</td>\n",
              "      <td>400.0</td>\n",
              "      <td>...</td>\n",
              "      <td>2021-06-02</td>\n",
              "      <td>Ain Shams Univerisity, Cairo, Egypt</td>\n",
              "      <td>cancer</td>\n",
              "      <td>2018</td>\n",
              "      <td>1155.0</td>\n",
              "      <td>SINGLE_GROUP</td>\n",
              "      <td>SINGLE</td>\n",
              "      <td>0</td>\n",
              "      <td>3</td>\n",
              "      <td>Clinical pregnancy rate, Pregnancy rate diagno...</td>\n",
              "    </tr>\n",
              "    <tr>\n",
              "      <th>4</th>\n",
              "      <td>UNKNOWN</td>\n",
              "      <td>NO</td>\n",
              "      <td>First Line WT KRAS mCRC</td>\n",
              "      <td>NaN</td>\n",
              "      <td>Dr.Laurent Mineur</td>\n",
              "      <td>Merck Serono International SA|BESPIM, CHU NÃ®me...</td>\n",
              "      <td>ALL</td>\n",
              "      <td>ADULT, OLDER_ADULT</td>\n",
              "      <td>NaN</td>\n",
              "      <td>500.0</td>\n",
              "      <td>...</td>\n",
              "      <td>2012-12-27</td>\n",
              "      <td>Institut Sainte-Catherine, Avignon, Vaucluse, ...</td>\n",
              "      <td>cancer</td>\n",
              "      <td>2010</td>\n",
              "      <td>1247.0</td>\n",
              "      <td>NaN</td>\n",
              "      <td>NaN</td>\n",
              "      <td>1</td>\n",
              "      <td>0</td>\n",
              "      <td>To compare PFS rate at 1 year with PFS in clin...</td>\n",
              "    </tr>\n",
              "    <tr>\n",
              "      <th>5</th>\n",
              "      <td>COMPLETED</td>\n",
              "      <td>YES</td>\n",
              "      <td>Bladder Cancer|Low Testosterone Levels</td>\n",
              "      <td>NaN</td>\n",
              "      <td>University of Kansas Medical Center</td>\n",
              "      <td>NaN</td>\n",
              "      <td>MALE</td>\n",
              "      <td>ADULT, OLDER_ADULT</td>\n",
              "      <td>NaN</td>\n",
              "      <td>25.0</td>\n",
              "      <td>...</td>\n",
              "      <td>2021-08-03</td>\n",
              "      <td>University of Kansas Medical Center, Kansas Ci...</td>\n",
              "      <td>cancer</td>\n",
              "      <td>2017</td>\n",
              "      <td>385.0</td>\n",
              "      <td>NaN</td>\n",
              "      <td>NaN</td>\n",
              "      <td>0</td>\n",
              "      <td>0</td>\n",
              "      <td>Number of Hypogonadism in Participants Based o...</td>\n",
              "    </tr>\n",
              "  </tbody>\n",
              "</table>\n",
              "<p>6 rows Ã— 28 columns</p>\n",
              "</div>\n",
              "    <div class=\"colab-df-buttons\">\n",
              "\n",
              "  <div class=\"colab-df-container\">\n",
              "    <button class=\"colab-df-convert\" onclick=\"convertToInteractive('df-fc6bca4d-5017-4c0e-8246-ef086203a5eb')\"\n",
              "            title=\"Convert this dataframe to an interactive table.\"\n",
              "            style=\"display:none;\">\n",
              "\n",
              "  <svg xmlns=\"http://www.w3.org/2000/svg\" height=\"24px\" viewBox=\"0 -960 960 960\">\n",
              "    <path d=\"M120-120v-720h720v720H120Zm60-500h600v-160H180v160Zm220 220h160v-160H400v160Zm0 220h160v-160H400v160ZM180-400h160v-160H180v160Zm440 0h160v-160H620v160ZM180-180h160v-160H180v160Zm440 0h160v-160H620v160Z\"/>\n",
              "  </svg>\n",
              "    </button>\n",
              "\n",
              "  <style>\n",
              "    .colab-df-container {\n",
              "      display:flex;\n",
              "      gap: 12px;\n",
              "    }\n",
              "\n",
              "    .colab-df-convert {\n",
              "      background-color: #E8F0FE;\n",
              "      border: none;\n",
              "      border-radius: 50%;\n",
              "      cursor: pointer;\n",
              "      display: none;\n",
              "      fill: #1967D2;\n",
              "      height: 32px;\n",
              "      padding: 0 0 0 0;\n",
              "      width: 32px;\n",
              "    }\n",
              "\n",
              "    .colab-df-convert:hover {\n",
              "      background-color: #E2EBFA;\n",
              "      box-shadow: 0px 1px 2px rgba(60, 64, 67, 0.3), 0px 1px 3px 1px rgba(60, 64, 67, 0.15);\n",
              "      fill: #174EA6;\n",
              "    }\n",
              "\n",
              "    .colab-df-buttons div {\n",
              "      margin-bottom: 4px;\n",
              "    }\n",
              "\n",
              "    [theme=dark] .colab-df-convert {\n",
              "      background-color: #3B4455;\n",
              "      fill: #D2E3FC;\n",
              "    }\n",
              "\n",
              "    [theme=dark] .colab-df-convert:hover {\n",
              "      background-color: #434B5C;\n",
              "      box-shadow: 0px 1px 3px 1px rgba(0, 0, 0, 0.15);\n",
              "      filter: drop-shadow(0px 1px 2px rgba(0, 0, 0, 0.3));\n",
              "      fill: #FFFFFF;\n",
              "    }\n",
              "  </style>\n",
              "\n",
              "    <script>\n",
              "      const buttonEl =\n",
              "        document.querySelector('#df-fc6bca4d-5017-4c0e-8246-ef086203a5eb button.colab-df-convert');\n",
              "      buttonEl.style.display =\n",
              "        google.colab.kernel.accessAllowed ? 'block' : 'none';\n",
              "\n",
              "      async function convertToInteractive(key) {\n",
              "        const element = document.querySelector('#df-fc6bca4d-5017-4c0e-8246-ef086203a5eb');\n",
              "        const dataTable =\n",
              "          await google.colab.kernel.invokeFunction('convertToInteractive',\n",
              "                                                    [key], {});\n",
              "        if (!dataTable) return;\n",
              "\n",
              "        const docLinkHtml = 'Like what you see? Visit the ' +\n",
              "          '<a target=\"_blank\" href=https://colab.research.google.com/notebooks/data_table.ipynb>data table notebook</a>'\n",
              "          + ' to learn more about interactive tables.';\n",
              "        element.innerHTML = '';\n",
              "        dataTable['output_type'] = 'display_data';\n",
              "        await google.colab.output.renderOutput(dataTable, element);\n",
              "        const docLink = document.createElement('div');\n",
              "        docLink.innerHTML = docLinkHtml;\n",
              "        element.appendChild(docLink);\n",
              "      }\n",
              "    </script>\n",
              "  </div>\n",
              "\n",
              "\n",
              "<div id=\"df-8ea1b728-321f-4b18-b344-928937ffecb7\">\n",
              "  <button class=\"colab-df-quickchart\" onclick=\"quickchart('df-8ea1b728-321f-4b18-b344-928937ffecb7')\"\n",
              "            title=\"Suggest charts.\"\n",
              "            style=\"display:none;\">\n",
              "\n",
              "<svg xmlns=\"http://www.w3.org/2000/svg\" height=\"24px\"viewBox=\"0 0 24 24\"\n",
              "     width=\"24px\">\n",
              "    <g>\n",
              "        <path d=\"M19 3H5c-1.1 0-2 .9-2 2v14c0 1.1.9 2 2 2h14c1.1 0 2-.9 2-2V5c0-1.1-.9-2-2-2zM9 17H7v-7h2v7zm4 0h-2V7h2v10zm4 0h-2v-4h2v4z\"/>\n",
              "    </g>\n",
              "</svg>\n",
              "  </button>\n",
              "\n",
              "<style>\n",
              "  .colab-df-quickchart {\n",
              "      --bg-color: #E8F0FE;\n",
              "      --fill-color: #1967D2;\n",
              "      --hover-bg-color: #E2EBFA;\n",
              "      --hover-fill-color: #174EA6;\n",
              "      --disabled-fill-color: #AAA;\n",
              "      --disabled-bg-color: #DDD;\n",
              "  }\n",
              "\n",
              "  [theme=dark] .colab-df-quickchart {\n",
              "      --bg-color: #3B4455;\n",
              "      --fill-color: #D2E3FC;\n",
              "      --hover-bg-color: #434B5C;\n",
              "      --hover-fill-color: #FFFFFF;\n",
              "      --disabled-bg-color: #3B4455;\n",
              "      --disabled-fill-color: #666;\n",
              "  }\n",
              "\n",
              "  .colab-df-quickchart {\n",
              "    background-color: var(--bg-color);\n",
              "    border: none;\n",
              "    border-radius: 50%;\n",
              "    cursor: pointer;\n",
              "    display: none;\n",
              "    fill: var(--fill-color);\n",
              "    height: 32px;\n",
              "    padding: 0;\n",
              "    width: 32px;\n",
              "  }\n",
              "\n",
              "  .colab-df-quickchart:hover {\n",
              "    background-color: var(--hover-bg-color);\n",
              "    box-shadow: 0 1px 2px rgba(60, 64, 67, 0.3), 0 1px 3px 1px rgba(60, 64, 67, 0.15);\n",
              "    fill: var(--button-hover-fill-color);\n",
              "  }\n",
              "\n",
              "  .colab-df-quickchart-complete:disabled,\n",
              "  .colab-df-quickchart-complete:disabled:hover {\n",
              "    background-color: var(--disabled-bg-color);\n",
              "    fill: var(--disabled-fill-color);\n",
              "    box-shadow: none;\n",
              "  }\n",
              "\n",
              "  .colab-df-spinner {\n",
              "    border: 2px solid var(--fill-color);\n",
              "    border-color: transparent;\n",
              "    border-bottom-color: var(--fill-color);\n",
              "    animation:\n",
              "      spin 1s steps(1) infinite;\n",
              "  }\n",
              "\n",
              "  @keyframes spin {\n",
              "    0% {\n",
              "      border-color: transparent;\n",
              "      border-bottom-color: var(--fill-color);\n",
              "      border-left-color: var(--fill-color);\n",
              "    }\n",
              "    20% {\n",
              "      border-color: transparent;\n",
              "      border-left-color: var(--fill-color);\n",
              "      border-top-color: var(--fill-color);\n",
              "    }\n",
              "    30% {\n",
              "      border-color: transparent;\n",
              "      border-left-color: var(--fill-color);\n",
              "      border-top-color: var(--fill-color);\n",
              "      border-right-color: var(--fill-color);\n",
              "    }\n",
              "    40% {\n",
              "      border-color: transparent;\n",
              "      border-right-color: var(--fill-color);\n",
              "      border-top-color: var(--fill-color);\n",
              "    }\n",
              "    60% {\n",
              "      border-color: transparent;\n",
              "      border-right-color: var(--fill-color);\n",
              "    }\n",
              "    80% {\n",
              "      border-color: transparent;\n",
              "      border-right-color: var(--fill-color);\n",
              "      border-bottom-color: var(--fill-color);\n",
              "    }\n",
              "    90% {\n",
              "      border-color: transparent;\n",
              "      border-bottom-color: var(--fill-color);\n",
              "    }\n",
              "  }\n",
              "</style>\n",
              "\n",
              "  <script>\n",
              "    async function quickchart(key) {\n",
              "      const quickchartButtonEl =\n",
              "        document.querySelector('#' + key + ' button');\n",
              "      quickchartButtonEl.disabled = true;  // To prevent multiple clicks.\n",
              "      quickchartButtonEl.classList.add('colab-df-spinner');\n",
              "      try {\n",
              "        const charts = await google.colab.kernel.invokeFunction(\n",
              "            'suggestCharts', [key], {});\n",
              "      } catch (error) {\n",
              "        console.error('Error during call to suggestCharts:', error);\n",
              "      }\n",
              "      quickchartButtonEl.classList.remove('colab-df-spinner');\n",
              "      quickchartButtonEl.classList.add('colab-df-quickchart-complete');\n",
              "    }\n",
              "    (() => {\n",
              "      let quickchartButtonEl =\n",
              "        document.querySelector('#df-8ea1b728-321f-4b18-b344-928937ffecb7 button');\n",
              "      quickchartButtonEl.style.display =\n",
              "        google.colab.kernel.accessAllowed ? 'block' : 'none';\n",
              "    })();\n",
              "  </script>\n",
              "</div>\n",
              "    </div>\n",
              "  </div>\n"
            ]
          },
          "metadata": {},
          "execution_count": 12
        }
      ]
    },
    {
      "cell_type": "code",
      "source": [
        "# Topic Modelling\n",
        "clinical_complete = clinical_df.loc[(clinical_df.study_status == \"COMPLETED\") & (clinical_df.study_results == \"YES\")]\n",
        "clinical_complete.sample(5)\n",
        "\n",
        "train, test = train_test_split(clinical_complete, test_size = 0.3, random_state = 107)\n",
        "\n",
        "def tokenizer(text):\n",
        "    tokens = [word for word in nltk.word_tokenize(text) if len(word) > 3]\n",
        "    return tokens\n",
        "\n",
        "vectorizer = TfidfVectorizer(tokenizer = tokenizer,\n",
        "                             stop_words = \"english\",\n",
        "                             max_df = 0.8,\n",
        "                             max_features = 10000,\n",
        "                             use_idf = True,\n",
        "                             norm = None)\n",
        "train_vectors = vectorizer.fit_transform(train.all_outcome_measures)"
      ],
      "metadata": {
        "colab": {
          "base_uri": "https://localhost:8080/"
        },
        "id": "nvAdaAN2zlsL",
        "outputId": "ea125229-b1fd-44bb-cecd-e6e06a93943a"
      },
      "execution_count": 11,
      "outputs": [
        {
          "output_type": "stream",
          "name": "stderr",
          "text": [
            "/usr/local/lib/python3.10/dist-packages/sklearn/feature_extraction/text.py:528: UserWarning: The parameter 'token_pattern' will not be used since 'tokenizer' is not None'\n",
            "  warnings.warn(\n"
          ]
        }
      ]
    },
    {
      "cell_type": "code",
      "source": [
        "lda = LatentDirichletAllocation(n_components = 2,\n",
        "                                max_iter = 3,\n",
        "                                learning_method = \"online\",\n",
        "                                learning_offset = 50,\n",
        "                                n_jobs = -1,\n",
        "                                random_state = 107)\n",
        "weights = lda.fit_transform(train_vectors)\n",
        "H = lda.components_"
      ],
      "metadata": {
        "id": "JAiJyzGNhU7y"
      },
      "execution_count": 12,
      "outputs": []
    },
    {
      "cell_type": "code",
      "source": [
        "np.set_printoptions(suppress = True)\n",
        "weights"
      ],
      "metadata": {
        "id": "jwL46KVmkC5w",
        "colab": {
          "base_uri": "https://localhost:8080/"
        },
        "outputId": "a84f4530-4603-4fb5-95e9-551f711faf4f"
      },
      "execution_count": 13,
      "outputs": [
        {
          "output_type": "execute_result",
          "data": {
            "text/plain": [
              "array([[0.31817381, 0.68182619],\n",
              "       [0.82190548, 0.17809452],\n",
              "       [0.95225027, 0.04774973],\n",
              "       ...,\n",
              "       [0.36473117, 0.63526883],\n",
              "       [0.01939525, 0.98060475],\n",
              "       [0.44369335, 0.55630665]])"
            ]
          },
          "metadata": {},
          "execution_count": 13
        }
      ]
    },
    {
      "cell_type": "code",
      "source": [
        "np.argmax(weights, axis = 1)"
      ],
      "metadata": {
        "colab": {
          "base_uri": "https://localhost:8080/"
        },
        "id": "YBMmvrVg3jwz",
        "outputId": "e56ddc6f-569b-40ba-8456-53f23286bb5e"
      },
      "execution_count": 14,
      "outputs": [
        {
          "output_type": "execute_result",
          "data": {
            "text/plain": [
              "array([1, 0, 0, ..., 1, 1, 1])"
            ]
          },
          "metadata": {},
          "execution_count": 14
        }
      ]
    },
    {
      "cell_type": "code",
      "source": [
        "weights[:20]"
      ],
      "metadata": {
        "colab": {
          "base_uri": "https://localhost:8080/"
        },
        "id": "Jo2tc5iPGlIw",
        "outputId": "3eec0dbf-6796-4a03-914e-1f03ddc35436"
      },
      "execution_count": 15,
      "outputs": [
        {
          "output_type": "execute_result",
          "data": {
            "text/plain": [
              "array([[0.31817381, 0.68182619],\n",
              "       [0.82190548, 0.17809452],\n",
              "       [0.95225027, 0.04774973],\n",
              "       [0.02303901, 0.97696099],\n",
              "       [0.99442964, 0.00557036],\n",
              "       [0.00526826, 0.99473174],\n",
              "       [0.74328942, 0.25671058],\n",
              "       [0.21848674, 0.78151326],\n",
              "       [0.00127262, 0.99872738],\n",
              "       [0.99973958, 0.00026042],\n",
              "       [0.00045051, 0.99954949],\n",
              "       [0.10824625, 0.89175375],\n",
              "       [0.15915452, 0.84084548],\n",
              "       [0.77332634, 0.22667366],\n",
              "       [0.89463673, 0.10536327],\n",
              "       [0.91540893, 0.08459107],\n",
              "       [0.99690931, 0.00309069],\n",
              "       [0.83005221, 0.16994779],\n",
              "       [0.06404194, 0.93595806],\n",
              "       [0.47660675, 0.52339325]])"
            ]
          },
          "metadata": {},
          "execution_count": 15
        }
      ]
    },
    {
      "cell_type": "code",
      "source": [
        "print(*train.all_outcome_measures[:20].tolist(), sep = \"\\n---=>\")"
      ],
      "metadata": {
        "colab": {
          "base_uri": "https://localhost:8080/"
        },
        "id": "lOv2xE5aG474",
        "outputId": "0cd9c903-dc5d-4200-c485-7330337cb77f"
      },
      "execution_count": 16,
      "outputs": [
        {
          "output_type": "stream",
          "name": "stdout",
          "text": [
            "Overall Response Rate (ORR), ORR was defined as the percentage of participants with a confirmed Complete Response (CR) or Partial Response (PR) by investigator assessment as per RECIST v1 .1 criteria. Specifically, ORR = (number of subjects with a confirmed best overall response of CR or PR) divided by the total number of subjects in the corresponding analysis population., From study treatment start date until first documented complete response or partial response, assessed up to approximately 50 months Progression Free Survival (PFS) Based on Local Investigator Assessment, Progression Free Survival (PFS) was defined as the time from study treatment start date to the date of first radiologically documented progression or death due to any cause. If a patient did not progress or die at the time of the analysis data cut-off or start of new antineoplastic therapy, PFS was censored at the date of the last adequate tumor assessment before the earliest of the cut-off date or the start date of additional anti-neoplastic therapy. Progression was defined using Response Evaluation Criteria In Solid Tumors Criteria RECIST v1.1, as 20% increase in the sum of diameter of all measured target lesions, taking as reference the smallest sum of diameter of all target lesions recorded at or after baseline and/or unequivocal progression of the non-target lesions and/or appearance of a new lesion. In addition to the relative increase of 20%, the sum must demonstrate an absolute increase of at least 5 mm., From study treatment start date until date of radiographic progression or date of death from any cause, whichever comes first, assessed up to approximately 113 months|Duration of Response (DoR) Based on Local Investigator Assessment, Duration of Response (DoR) was defined as the time from the first documented occurrence of response (PR or CR) until the date of the first documented progression based on RECIST v1.1 or death., From first documented evidence of CR or PR (the response prior to confirmation) until time of documented disease progression or death due to any cause, whichever comes first, assessed up to approximately 113 months|Overall Survival (OS), Overall Survival (OS) was defined as the time from first dose until death due to any cause. If a patient was not known to have died at the time of analysis cut-off, OS was censored at the date of last contact., From study treatment start date until date of of death from any cause, assessed up to approximately 113 months|Number of Participants With Treatment Emergent Adverse Events, The distribution of adverse events (AE) was done via the analysis of frequencies for treatment emergent Adverse Event (TEAEs), Serious Adverse Event (TESAEs) and Deaths due to AEs, through the monitoring of relevant clinical and laboratory safety parameters., From study treatment start date till 30 days safety follow-up, assessed up to approximately 81 months|Apparent Clearance (CL/F) of Dabrafenib, Blood samples from participants were collected for population pharmacokinetic analysis including the apparent base clearance (CL/F) following oral dosing of dabrafenib. Concentrations of dabrafenib was determined in plasma samples using the currently approved analytical methodology., Week 3, Week 6, Week 12 and Week 18|Oral Volume of Distribution (V/F) of Dabrafenib, Blood samples from participants were collected for population pharmacokinetic analysis including the oral volume of distribution (V/F) following oral dosing of dabrafenib. Blood samples from participants were collected for population pharmacokinetic analysis including the apparent base clearance (CL/F) following oral dosing of dabrafenib. Concentrations of dabrafenib was determined in plasma samples using the currently approved analytical methodology., Week 3, Week 6, Week 12 and Week 18|Apparent Clearance (CL/F) of Trametinib, Blood samples from participants were collected for population pharmacokinetic analysis including the apparent base clearance (CL/F) following oral dosing of trametinib. Blood samples from participants were collected for population pharmacokinetic analysis including the apparent base clearance (CL/F) following oral dosing of dabrafenib. Concentrations of trametinib was determined in plasma samples using the currently approved analytical methodology., Week 3, Week 6, Week 12 and Week 18|Oral Volume of Distribution (V/F) of Trametinib, Blood samples from participants were collected for population pharmacokinetic analysis including the oral volume of distribution (V/F) following oral dosing of trametinib. Concentrations of trametinib was determined in plasma samples using the currently approved analytical methodology., Week 3, Week 6, Week 12 and Week 18 \n",
            "---=>Percent Change From Baseline in Fasting Triglycerides (TG) at the Primary Analysis Time Point, An analysis of covariance (ANCOVA) model was performed on the log ratio of TG value at the Primary Analysis Time Point to TG value at Baseline. The estimate of the log ratio was converted back to the original scale and percent change was calculated using formula: (ratio of TG value at the Primary Analysis Time Point to TG value at Baseline - 1) Ã— 100., Baseline and Month 6 (Week 25 for Cohorts A and B and Week 27 for Cohorts C and D)|Number of Participants With Treatment-Emergent Adverse Events (TEAEs), An adverse event (AE) was defined as any unfavorable and unintended sign (including a clinically-significant abnormal laboratory finding, for example), symptom, or disease temporally associated with the study or use of investigational drug product, whether or not the AE was considered to be related to the investigational drug product. A TEAE was defined as any AE starting on or after the first dose of the study drug., Up to the 13-week post-treatment follow-up period (Up to approximately 15 months) Percent Change From Baseline in ApoC-III, TC, LDL-C, HDL-C, Non-HDL-C, VLDL-C, ApoB, and ApoA-I at the Primary Analysis Time Point, An ANCOVA model was performed on the log ratio of Primary Analysis Time Point value to Baseline value for ApoC-III, TC, LDL-C, HDL-C, Non-HDL-C, VLDL-C, ApoB, and ApoA-I. The estimate of the log ratio was converted back to the original scale and percent change for each lipid parameter was calculated using formula: (ratio of Primary Analysis Time Point value to Baseline value - 1) Ã— 100., Baseline and Month 6 (Week 25 for Cohorts A and B and Week 27 for Cohorts C and D)|Percentage of Participants Who Achieved Fasting Triglycerides (TG) <= 150 mg/dL (<= 1.7 Millimoles Per Liter [mmol/L]), The percentage of participants who achieved \\<= 150 mg/dL or \\<= 1.7 mmol/L of fasting TG levels at the primary analysis time point were compared between each ISIS 678354 treatment group and pooled placebo group using a logistic regression model with log-transformed baseline TG value as a covariate., Baseline and Month 6 (Week 25 for Cohorts A and B and Week 27 for Cohorts C and D)|Percentage of Participants Who Achieved Fasting Triglycerides (TG) <= 100 mg/dL (<= 1.13 mmol/L), The percentage of participants who achieved \\<= 100 mg/dL or \\<= 1.13 mmol/L of fasting TG levels at the primary analysis time point were compared between each ISIS 678354 treatment group and pooled placebo group using a logistic regression model with log-transformed baseline TG value as a covariate., Baseline and Month 6 (Week 25 for Cohorts A and B and Week 27 for Cohorts C and D)|Maximum Plasma Concentration (Cmax) of ISIS 678354, Predose, 1, 2, 4, 8, 24 hours post the first dose (Day 1), Week 21 (for Cohorts A and B) and Week 25 (for Cohorts C and D)|Time to Reach Maximum Plasma Concentration (Tmax) of ISIS 678354, Predose, 1, 2, 4, 8, 24 hours post the first dose (Day 1), Week 21 (for Cohorts A and B) and Week 25 (for Cohorts C and D)|Area Under the Plasma Concentration Versus Time Curve From Time Zero to 24 Hours (AUC0-24) of ISIS 678354, Predose, 1, 2, 4, 8, 24 hours post the first dose (Day 1), Week 21 (for Cohorts A and B) and Week 25 (for Cohorts C and D) \n",
            "---=>Change of a Spectral Biomarker for Colonic Carcinogenesis (Called Spectral Slope or SPEC) From Baseline to 3 Months., Spectral marker assessment was performed via LEBS analysis (low-coherence enhanced backscattering spectroscopy) on the uninvolved mucosal biopsies of subjects taken at baseline and after 3 months of treatment with either aspirin or placebo. SPEC characterizes the size distribution of macromolecular complexes and other intracellular structures, with a decrease of the spectral slope implying a shift of the size distribution of intracellular structures toward smaller sizes.\n",
            "\n",
            "Spectral markers SPEC and FRAC provide a measure of the fundamental characteristics of the tissue nanoscale architecture., 3 months from baseline colonoscopy to end of intervention.|Change of a Spectral Biomarker for Colonic Carcinogenesis (Called Fractal Dimension or FRAC) From Baseline to 3 Months., Spectral marker assessment was performed via LEBS analysis (low-coherence enhanced backscattering spectroscopy) on the uninvolved mucosal biopsies of subjects taken at baseline and after 3 months of treatment with either aspirin or placebo. FRAC characterizes the spatial autocorrelation function of mass density distribution in tissue.\n",
            "\n",
            "SPEC and FRAC provide a measure of the fundamental characteristics of the tissue nanoscale architecture, 3 months from baseline colonoscopy to end of intervention. Colonic Epithelial Apoptosis as Measured by Immunohistochemical Detection of Cleaved Caspase 3, Evaluate the effect of aspirin on colonic epithelial apoptosis and cell proliferation as assessed by immunohistochemical detection of cleaved caspase 3 .These were performed on samples that had been previously analyzed for 4D-ELF., 3 months from baseline colonoscopy to end of intervention.|Changes in Colonic Cell Proliferation as Measured by Immunohistochemical Detection of Ki67, Evaluate the effect of aspirin on colonic epithelial apoptosis and cell proliferation as assessed by immunohistochemical detection of Ki-67. These were performed on samples that had been previously analyzed for 4D-ELF., 3 months from baseline colonoscopy to end of intervention.|Rectal Prostaglandin Levels as Measured by ELISA, Evaluate the effect of aspirin on rectal prostaglandin levels., 3 months from baseline colonoscopy to end of intervention. Platelet Cyclooxygenase (COX) Activity as Measured by a Peroxidase-based COX Enzyme Activity Assay, Evaluate the effect of aspirin on platelet COX activity as measured by a peroxidase-based Cox enzyme activity assay., 3 months from baseline colonoscopy to end of intervention.\n",
            "---=>Complete Response Rate at 3 Months, Complete response rate at 3 months in patients with CIS with or without resected papillary disease following initiation of Vicinium therapy. This is the percentage of patients who were free of high-grade disease at the post-induction (3 month) assessment timepoint. A patient was considered to have a complete response if the urine cytology was reported as negative or atypical AND the cystoscopy was reported as normal or any suspicious areas were deemed negative for high-grade disease upon biopsy assessment., 3 months from start of treatment|Duration of Complete Response, Duration of complete response in participants with CIS with or without resected papillary disease who achieved a complete response at the post-induction (3 month) assessment. This is the number of days from the date of first occurrence of complete response to the date of documented treatment failure or death, whichever occurs first, Up to 24 months Event-free Survival, Interval from the date of first dose of study treatment to the first event (persistent high-grade disease or low grade T1 if that was the baseline disease, high-grade disease tumor recurrence, tumor progression to muscle invasive bladder cancer, cystectomy due to treatment failure, or death) prior to treatment discontinuation, Up to 24 months|Complete Response Rate at 6, 9, 12, 15, 18, 21, 24 Months, Complete response rate in subjects with CIS with or without resected papillary disease after 6, 9, 12, 15, 18, 21, and 24 months of Vicinium therapy. This is measured as a proportion of the total number of participants in this group that are free of high-grade disease at the respective 3-month intervals, Participants on treatment were assessed at months 6, 9, 12, 15,18, 21, and 24|Time to Cystectomy, Time from the date of first dose of study treatment to physical removal of the bladder, Up to 48 months|Time to Disease Recurrence, Time from the first dose of study treatment to the first occurrence of treatment failure or death on or prior to treatment discontinuation for participants with papillary disease only, Up to 24 months|Progression-free Survival, Time from the date of first dose of study treatment to the date of disease progression (e.g., T2 or more advanced disease) or death on or prior to treatment discontinuation, Up to 24 months|Overall Survival, All participants were followed for survival during the period of consent (up to 24 months of study treatment and up to 24 months after last dose of study treatment). Any participants who were alive at last follow-up were censored., Up to 48 months (up to 24 months while on study treatment and up to 24 months in the post-treatment follow-up period from the date of last dose of study drug)|Number of Participants Who Experienced an Adverse Event (AE), An AE was defined as any untoward medical occurrence in a subject administered a pharmaceutical product and which did not necessarily have to have a causal relationship with this treatment. An AE could, therefore, be any unfavorable and unintended sign (that may include an abnormal laboratory finding), symptom, or disease temporally associated with the use of a medicinal product, whether or not related to the medicinal product. Any worsening of the participant's pre-existing medical conditions was also considered an AE, unless it was within the normal range of disease fluctuation for that participant., Up to 25 months (up to 24 months of study treatment + 30 days after the last dose of study drug)|Number of Participants That Discontinued Study Treatment Due to an AE, An AE was defined as any untoward medical occurrence in a participant administered a pharmaceutical product and which did not necessarily have to have a causal relationship with this treatment. An AE could, therefore, be any unfavourable and unintended sign, symptom, or disease temporally associated with the use of a medicinal product or protocol-specified procedure, whether or not considered related to the medicinal product or protocol-specified procedure. Any worsening of a pre-existing condition that was temporally associated with the use of the Sponsor's product, was also an adverse event. The number of participants that discontinued study treatment due to an AE was reported., Up to 24 months \n",
            "---=>BLOOD PRESSURE LIPIDS, Amongst patients with cardiovascular disease or type 2 diabetes, the study aims to test the safety and efficacy of giving double dose of polycap versus a single dose of polycap for 8 weeks; efficacy to lower blood pressure and elevated lipids and safety assessed as difference with tolerance to double dose of polycap compared to a single dose., 8 weeks|Tolerability of a Double Dose of Half Strength Polycap, 8 weeks Blood Pressure Reduction and Lipid Lowering in Type 2 Diabetics, 8 weeks \n",
            "---=>Complete Remission (CR), The peripheral blood neutrophil count is \\>= 1.5 x 10\\^9 / L and platelets more than 100 x 10\\^9 / L. Leukemia blast cells are not present in the peripheral blood. The cellularity of the bone marrow is more than 20% with maturation of all cell lines. The bone marrow contains less than 5% blast cells, and Auer rods is not detectable., 7 days post completion of induction chemotherapy Bone Marrow at Day 7 Post-Induction Chemotherapy, Bone marrow positive, negative cells at day 7 post-induction chemotherapy for leukemia (%), 7 days post completion of induction chemotherapy \n",
            "---=>Transcranial Doppler(TCD) Microembolic Signals During Surgical Aortic Valve Replacement Surgery, Transcranial Doppler measurement of microembolic signals will be measured during the surgical procedure.Microembolic signals are detected by offline analysis of the Dopplerspectral analysis of the blood flow in the medial cerebral artery. Different intensities (dB),flow direction and time frame appearances in the Doppler spectral envelope is distinguishable for a neurosonolgist according to predefined criteria for an embolic signal-defined in previous litterature.The total amount of signals during one surgical procedure is counted. The appearance of microembolic signals related to specific procedures performed during cardiac surgery with cardiopulmonary bypass is noted. The exact time range is not possible to estimate in advance,due to the fact that each surgical procedure varies in time.The range of values for each individual patient, based on pilos, will vary from 50 to approximately 1500 embolic counts for one surgical procedure. A high value is negative for the patient., (day 1) TCD will be performed from start of surgery till end of surgery-exact time cannot be stated in advance Cerebrospinal Fluid(CSF) Levels of S-100B(Microgram/Liter), Differences in preoperative vs postoperative CSF levels of S-100B in microgram/Liter\n",
            "\n",
            "The assumption is that a cardiac open heart surgical procedure with cardiopulmonary bypass will influence the postoperative level of marker of neuronal cell damage in the central nerve system. An increase in the levels, compared to the preoperative values, indicates neuronal cell damage detectable in the CSF, namely the brains own extracellular fluid., 24 Hours after Surgery \n",
            "---=>Number of Participants Who Experienced a Solicited Adverse Event (AE) Occurring on the Day of Vaccination and the Following 7 Days After Dose 1 and Dose 2, Solicited local AEs (injection site pain, redness, swelling, and itching) and solicited systemic AEs (fever, headache, fatigue, chills, myalgia, arthralgia, nausea/vomiting, and diarrhea) were recorded on the day of vaccination and the following 7 days using a diary (electronic or paper). By definition, all solicited local AEs occurring from the time of first vaccination were considered related to trial vaccination. For solicited systemic AEs, the Investigator assessed the relationship between trial vaccine and each occurrence of each AE., Up to 7 days after Dose 1 (Days 1 to 8) and Dose 2 (Days 29 to 36)|Intensity of Solicited AEs Per US Food and Drug Administration (FDA) Toxicity Grading Scale Occurring on the Day of Vaccination and the Following 7 Days After Dose 1 and Dose 2, Solicited local AEs (injection site pain, redness, swelling, and itching) and solicited systemic AEs (fever, headache, fatigue, chills, myalgia, arthralgia, nausea/vomiting, and diarrhea) were recorded on the day of vaccination and the following 7 days using a diary (electronic or paper). Intensity of solicited local AEs and solicited systemic AEs were graded per the FDA Toxicity Grading Scale at Grades 1-3, where higher grades indicate a worse outcome., Up to 7 days after Dose 1 (Days 1 to 8) and Dose 2 (Days 29 to 36)|Duration of Solicited AEs Occurring on the Day of Vaccination and the Following 7 Days After After Dose 1 and Dose 2, Solicited local AEs (injection site pain, redness, swelling, and itching) and solicited systemic AEs (fever, headache, fatigue, chills, myalgia, arthralgia, nausea/vomiting, and diarrhea) were recorded on the day of vaccination and the following 7 days using a diary (electronic or paper). Duration is calculated as consecutive days with a respective solicited AE regardless of the grade of the AE. AEs ongoing after day 8 are included., Up to 7 days after Dose 1 (Days 1 to 8) and Dose 2 (Days 29 to 36)|Number of Participants Who Experienced an Unsolicited AE Occurring on the Day of Vaccination and the Following 28 Days After Dose 1 and Dose 2, Diaries were used for collection of unsolicited AEs on each vaccination day and the following 28 days. In addition, participants received a prompt (by e.g., a phone call or text message) to verify whether the participants had any health concerns since the last visit. The Investigator assessed the relationship between trial vaccine and each occurrence of each AE., Up to 28 days after Dose 1 (Days 1 to 29) and Dose 2 (Days 29 to 57)|Intensity of Unsolicited AEs Per the Investigator's Assessment Occurring on the Day of Vaccination and the Following 28 Days After Dose 1 and Dose 2, Diaries were used for collection of unsolicited AEs on each vaccination day and the following 28 days. In addition, participants received a prompt (by e.g., a phone call or text message) to verify whether the participants had any health concerns since the last visit. The Investigator made an assessment of intensity for each AE reported during the trial and assigned it to one of the following categories:\n",
            "\n",
            "* Mild: an event that was easily tolerated by the participant, causing minimal discomfort and not interfering with everyday activities.\n",
            "* Moderate: an event that caused sufficient discomfort to interfere with normal everyday activities.\n",
            "* Severe: an event that prevented normal everyday activities., Up to 28 days after Dose 1 (Days 1 to 29) and Dose 2 (Days 29 to 57)|Number of Participants Who Experienced a Serious Adverse Event (SAE) During the Trial, An SAE was defined as any untoward medical occurrence that, at any dose:\n",
            "\n",
            "* Resulted in death.\n",
            "* Was life-threatening.\n",
            "* Required inpatient hospitalization or prolongation of existing hospitalization.\n",
            "* Resulted in persistent disability/incapacity.\n",
            "* Was a congenital anomaly/birth defect in the offspring of the participant.\n",
            "* Was an important medical event.\n",
            "\n",
            "The Investigator assessed the relationship between trial vaccine and each occurrence of each AE., Up to Day 393|Number of Participants Who Experienced an Adverse Event of Special Interest (AESI) During the Trial, AESIs included:\n",
            "\n",
            "* AEs with a suspected immune-medicated etiology.\n",
            "* COVID-19 disease.\n",
            "* Other AEs relevant to SARS-CoV-2 vaccine development or the target disease.\n",
            "\n",
            "Participants who became unblinded and/or received a licensed/authorized vaccine were censored at the day after unblinding or at the day after receiving the licensed/authorized vaccine, whichever was earlier. The Investigator assessed the relationship between trial vaccine and each occurrence of each AE., Up to Day 393|Percentage of Participants Seroconverting for SARS-CoV-2 Spike Protein Receptor-Binding Domain (RBD) Antibodies on Day 29 and Day 43, As measured by enzyme-linked immunosorbent assay (ELISA). In participants not exposed to SARS-CoV-2 before the trial seroconversion was defined as any increase in titer in antibodies against SARS-CoV-2 RBD versus baseline. Participants who received a licensed/authorized vaccine were censored at the day after receiving the licensed/authorized vaccine., Baseline, Day 29 and Day 43|Geometric Mean Titers (GMTs) of SARS-CoV-2 Spike Protein RBD Antibodies on Day 29 and Day 43, As measured by ELISA. The SARS-CoV-2 spike RBD protein-specific antibodies are expressed as GMT (geometric mean of reciprocal duplicate dilutions). Concentration/titers marked as below the lower limit of quantification (LLOQ) were arbitrary replaced by half of the LLOQ for GMT computations purpose. Participants who received a licensed/authorized vaccine were censored at the day after receiving the licensed/authorized vaccine., Day 29 and Day 43|Percentage of Participants Seroconverting for SARS-CoV-2 Neutralizing Antibodies on Day 29 and Day 43, As measured by an activity assay. In participants not exposed to SARS-CoV-2 before the trial, seroconversion was defined as any increase in titer in SARS-CoV-2 neutralizing antibodies versus baseline. Participants who received a licensed/authorized vaccine were censored at the day after receiving the licensed/ authorized vaccine., Baseline, Day 29 and Day 43|GMTs of SARS-CoV-2 Neutralizing Antibodies on Day 29 and Day 43, The SARS-CoV-2 neutralizing antibodies are expressed as GMT (geometric mean of reciprocal duplicate dilutions). Concentration/titers marked as below the lower limit of quantification (LLOQ) were arbitrary replaced by half of the LLOQ for GMT computations purpose. Participants who received a licensed/authorized vaccine were censored at the day after receiving the licensed/authorized vaccine., Day 29 and Day 43 Number of Participants Who Experienced a Solicited Adverse Event (AE) Occurring on the Day of Booster Vaccination and the Following 7 Days, Solicited local AEs (injection site pain, redness, swelling, and itching) and solicited systemic AEs (fever, headache, fatigue, chills, myalgia, arthralgia, nausea/vomiting, and diarrhea) were recorded on the day of vaccination and the following 7 days using a diary (electronic or paper). By definition, all solicited local AEs occurring from the time of first vaccination were considered related to trial vaccination. For solicited systemic AEs, the Investigator assessed the relationship between trial vaccine and each occurrence of each AE., Up to 7 days after booster vaccination (Days 57 to 64 and Days 180 to 187)|Intensity of Solicited AEs Per FDA Toxicity Grading Scale Occurring on the Day of Booster Vaccination and the Following 7 Days, Solicited local AEs (injection site pain, redness, swelling, and itching) and solicited systemic AEs (fever, headache, fatigue, chills, myalgia, arthralgia, nausea/vomiting, and diarrhea) were recorded on the day of vaccination and the following 7 days using a diary (electronic or paper). Intensity of solicited local AEs and solicited systemic AEs were graded per the FDA Toxicity Grading Scale at Grades 1-3, where higher grades indicate a worse outcome., Up to 7 days after booster vaccination (Days 57 to 64 and Days 180 to 187)|Duration of Solicited AEs Occurring on the Day of Booster Vaccination and the Following 7 Days, Solicited local AEs (injection site pain, redness, swelling, and itching) and solicited systemic AEs (fever, headache, fatigue, chills, myalgia, arthralgia, nausea/vomiting, and diarrhea) were recorded on the day of vaccination and the following 7 days using a diary (electronic or paper). Duration is calculated as consecutive days with a respective solicited AE regardless of the grade of the adverse event., Up to 7 days after booster vaccination (Days 57 to 64 and Days 180 to 187)|Number of Participants Who Experienced an Unsolicited AE Occurring on the Day of Booster Vaccination and the Following 28 Days, Diaries were used for collection of unsolicited AEs on each vaccination day and the following 28 days. In addition, participants received a prompt (by e.g., a phone call or text message) to verify whether the participants had any health concerns since the last visit. The Investigator assessed the relationship between trial vaccine and each occurrence of each AE., Up to 28 days after booster vaccination (Days 57 to 85 and Days 180 to 208)|Intensity of Unsolicited AEs Per the Investigator's Assessment Occurring on the Day of Booster Vaccination and the Following 28 Days, Diaries were used for collection of unsolicited AEs on each vaccination day and the following 28 days. In addition, participants received a prompt (by e.g., a phone call or text message) to verify whether the participants had any health concerns since the last visit. The Investigator made an assessment of intensity for each AE reported during the trial and assigned it to one of the following categories:\n",
            "\n",
            "* Mild: an event that was easily tolerated by the participant, causing minimal discomfort and not interfering with everyday activities.\n",
            "* Moderate: an event that caused sufficient discomfort to interfere with normal everyday activities.\n",
            "* Severe: an event that prevented normal everyday activities., Up to 28 days after booster vaccination (Days 57 to 85 and Days 180 to 208)|Percentage of Participants Seroconverting for SARS-CoV-2 Spike Protein RBD Antibodies on Day 57, Day 85, Day 180, Day 208 and Day 393, As measured by ELISA. In participants not exposed to SARS-CoV-2 before the trial seroconversion was defined as any increase in titer in antibodies against SARS-CoV-2 RBD versus baseline. Participants who received a licensed/authorized vaccine were censored at the day after receiving the licensed/ authorized vaccine., For participants who received the booster vaccination on Day 57: Baseline, Day 57, Day 85 and Day 180. For participants who received the booster vaccination on Day 180: Baseline, Day 180, Day 208 and Day 393|GMTs of SARS-CoV-2 Spike Protein RBD Antibodies on Day 57, Day 85, Day 180, Day 208 and Day 393, As measured by ELISA. The SARS-CoV-2 spike RBD protein-specific antibodies are expressed as GMT (geometric mean of reciprocal duplicate dilutions). Concentration/titers marked as below the lower limit of quantification (LLOQ) were arbitrary replaced by half of the LLOQ for GMT computations purpose. Participants who received a licensed/authorized vaccine were censored at the day after receiving the licensed/ authorized vaccine., For participants who received the booster vaccination on Day 57: Day 57, Day 85 and Day 180. For participants who received the booster vaccination on Day 180: Day 180, Day 208 and Day 393|Percentage of Participants Seroconverting for SARS-CoV-2 Neutralizing Antibodies on Day 57, Day 85, Day 180, Day 208 and Day 393, As measured by an activity assay. In participants not exposed to SARS-CoV-2 before the trial, seroconversion was defined as any increase in titer in SARS-CoV-2 neutralizing antibodies versus baseline. Participants who received a licensed/authorized vaccine were censored at the day after receiving the licensed/authorized vaccine., For participants who received the booster vaccination on Day 57: Baseline, Day 57, Day 85 and Day 180. For participants who received the booster vaccination on Day 180: Baseline, Day 180, Day 208 and Day 393|GMTs of SARS-CoV-2 Neutralizing Antibodies on Day 57, Day 85, Day 180, Day 208 and Day 393, As measured by an activity assay. The SARS-CoV-2 neutralizing antibodies are expressed as GMT (geometric mean of reciprocal duplicate dilutions). Concentration/titers marked as below the lower limit of quantification (LLOQ) were arbitrary replaced by half of the LLOQ for GMT computations purpose. Participants who received a licensed/authorized vaccine were censored at the day after receiving the licensed/ authorized vaccine., For participants who received the booster vaccination on Day 57: Day 57, Day 85 and Day 180. For participants who received the booster vaccination on Day 180: Day 180, Day 208 and Day 393 \n",
            "---=>Progression-free Survival at 6 Months, The primary endpoint is the 6 month post registration Progression-free survival (PFS) rate. Progression-free survival time is defined as the time from registration to documentation of disease progression using the RECIST criteria. Patients who died without documentation of disease progression will be considered to have progressed at death unless there is sufficient documented evidence to conclude no progression occurred prior to death. All patients, who meet the eligibility criteria, sign a consent form, and start treatment will be included in the evaluation of the 6 month PFS rate., at 6 months Tumor Response Rate, Calculated as a Percentage Along With it's 95% Confidence Interval, A confirmed tumor response is defined to be a Complete Response or Partial Response noted\n",
            "\n",
            "\\> as the objective status on 2 consecutive evaluations at least 8\n",
            "\n",
            "\\> weeks apart. The proportion of tumor responses will be\n",
            "\n",
            "\\> estimated by the number of confirmed tumor responses divided\n",
            "\n",
            "\\> by the total number of evaluable patients.\n",
            "\n",
            "\\> Complete Response (CR): Disappearance of all target lesions\n",
            "\n",
            "\\> Partial Response (PR): At least a 30% decrease in the sum of the LD of target lesions taking as reference the baseline sum LD.\n",
            "\n",
            "\\> Progression (PD): At least a 20% increase in the sum of target lesions taking as reference the smallest sum LD recorded since the treatment started or the appearance of one or more new lesions.\n",
            "\n",
            "\\> Stable Disease (SD): Neither sufficient shrinkage to Qualify for PR nor sufficient increase to Qualify for PD taking as reference the smallest sum LD. responses will be calculated assuming that the number of\n",
            "\n",
            "\\> confirmed tumor responses follows a binomial distribution., Up to 5 years|Overall Survival, Overall survival time is defined as the time from registration to death due to any cause. The distribution of survival time will be estimated using the method of Kaplan-Meier., Up to 5 years \n",
            "---=>Percent Change From Baseline in Low-density Lipoprotein Cholesterol (LDL-C) at the Primary Efficacy Time Point, LDL cholesterol was measured in mg/dL. Samples were taken following an overnight fast. LDL-C was obtained using Friedewald's calculation for patients with triglycerides â‰¤400 mg/dL and was directly measured by the central laboratory using ultracentrifugation for patients with triglycerides \\>400 mg/dL. The primary efficacy time point was the post-baseline visit closest to 14 days after the last dose of study treatment., Baseline (the average of the screening and Day 1 pre-treatment assessments) and the Primary Efficacy Time point (PET; Week 28 or the post-baseline visit closest to 14 days after the last dose).|Low-density Lipoprotein Cholesterol (LDL-C) at Baseline and at the Primary Efficacy Time Point, The primary efficacy time point (PET) was the post-baseline visit closest to 14 days after the last dose of study treatment., Baseline (the average of the screening and Day 1 pre-treatment assessments) and the Primary Efficacy Time point (PET; Week 28 or the post-baseline visit closest to 14 days after the last dose). Percent Change From Baseline in Apolipoprotein B at the Primary Efficacy Time Point, Apolipoprotein B was measured in mg/dL. Samples were taken following an overnight fast. The primary efficacy time point was the post-baseline visit closest to 14 days after the last dose of study treatment., Baseline (the average of the screening and Day 1 pre-treatment assessments) and the Primary Efficacy Time point (PET; Week 28 or the post-baseline visit closest to 14 days after the last dose).|Apolipoprotein B at Baseline and at the Primary Efficacy Time Point, The primary efficacy time point (PET) was the post-baseline visit closest to 14 days after the last dose of study treatment., Baseline (the average of the screening and Day 1 pre-treatment assessments) and the Primary Efficacy Time point (PET; Week 28 or the post-baseline visit closest to 14 days after the last dose).|Percent Change From Baseline in Total Cholesterol at the Primary Efficacy Time Point, Total cholesterol was measured in mg/dL. Samples were taken following an overnight fast. The primary efficacy time point was the post-baseline visit closest to 14 days after the last dose of study treatment., Baseline (the average of the screening and Day 1 pre-treatment assessments) and the Primary Efficacy Time point (PET; Week 28 or the post-baseline visit closest to 14 days after the last dose).|Total Cholesterol at Baseline and at the Primary Efficacy Time Point, The primary efficacy time point (PET) was the post-baseline visit closest to 14 days after the last dose of study treatment., Baseline (the average of the screening and Day 1 pre-treatment assessments) and the Primary Efficacy Time point (PET; Week 28 or the post-baseline visit closest to 14 days after the last dose).|Percent Change From Baseline in Non-High-Density Lipoprotein Cholesterol at the Primary Efficacy Time Point, Non-high-density lipoprotein cholesterol was measured in mg/dL. Samples were taken following an overnight fast. The primary efficacy time point was the post-baseline visit closest to 14 days after the last dose of study treatment., Baseline (the average of the screening and Day 1 pre-treatment assessments) and the Primary Efficacy Time point (PET; Week 28 or the post-baseline visit closest to 14 days after the last dose).|Non-High-Density Lipoprotein Cholesterol at Baseline and at the Primary Efficacy Time Point, The primary efficacy time point (PET) was the post-baseline visit closest to 14 days after the last dose of study treatment., Baseline (the average of the screening and Day 1 pre-treatment assessments) and the Primary Efficacy Time point (PET; Week 28 or the post-baseline visit closest to 14 days after the last dose). Percent Change From Baseline in Triglycerides at the Primary Efficacy Time Point, Triglycerides were measured in mg/dL. Samples were taken following an overnight fast. The primary efficacy time point was the post-baseline visit closest to 14 days after the last dose of study treatment., Baseline (the average of the screening and Day 1 pre-treatment assessments) and the Primary Efficacy Time point (PET; Week 28 or the post-baseline visit closest to 14 days after the last dose).|Triglycerides at Baseline and at the Primary Efficacy Time Point, The primary efficacy time point (PET) was the post-baseline visit closest to 14 days after the last dose of study treatment., Baseline (the average of the screening and Day 1 pre-treatment assessments) and the Primary Efficacy Time point (PET; Week 28 or the post-baseline visit closest to 14 days after the last dose).|Percent Change From Baseline in High Density Lipoprotein Cholesterol (HDL-C) at the Primary Efficacy Time Point, High-density lipoprotein cholesterol (HDL-C) was measured in mg/dL. Samples were taken following an overnight fast. The primary efficacy time point was the post-baseline visit closest to 14 days after the last dose of study treatment., Baseline (the average of the screening and Day 1 pre-treatment assessments) and the Primary Efficacy Time point (PET; Week 28 or the post-baseline visit closest to 14 days after the last dose).|High-Density Lipoprotein Cholesterol at Baseline and at the Primary Efficacy Time Point, The primary efficacy time point (PET) was the post-baseline visit closest to 14 days after the last dose of study treatment., Baseline (the average of the screening and Day 1 pre-treatment assessments) and the Primary Efficacy Time point (PET; Week 28 or the post-baseline visit closest to 14 days after the last dose).|Percent Change From Baseline in Lipoprotein (a) at the Primary Efficacy Time Point, Lipoprotein (a) was measured in mg/dL. Samples were taken following an overnight fast. The primary efficacy time point was the post-baseline visit closest to 14 days after the last dose of study treatment., Baseline (the average of the screening and Day 1 pre-treatment assessments) and the Primary Efficacy Time point (PET; Week 28 or the post-baseline visit closest to 14 days after the last dose).|Lipoprotein (a) at Baseline and at the Primary Efficacy Time Point, The primary efficacy time point (PET) was the post-baseline visit closest to 14 days after the last dose of study treatment., Baseline (the average of the screening and Day 1 pre-treatment assessments) and the Primary Efficacy Time point (PET; Week 28 or the post-baseline visit closest to 14 days after the last dose).|Percent Change From Baseline in Very Low Density Lipoprotein Cholesterol at the Primary Efficacy Time Point, Very low density lipoprotein (VLDL) cholesterol was measured in mg/dL. Samples were taken following an overnight fast. The primary efficacy time point was the post-baseline visit closest to 14 days after the last dose of study treatment., Baseline (the average of the screening and Day 1 pre-treatment assessments) and the Primary Efficacy Time point (PET; Week 28 or the post-baseline visit closest to 14 days after the last dose).|Very Low Density Lipoprotein Cholesterol at Baseline and at the Primary Efficacy Time Point, The primary efficacy time point (PET) was the post-baseline visit closest to 14 days after the last dose of study treatment., Baseline (the average of the screening and Day 1 pre-treatment assessments) and the Primary Efficacy Time point (PET; Week 28 or the post-baseline visit closest to 14 days after the last dose).|Percent Change From Baseline in the Ratio of LDL Cholesterol to HDL Cholesterol at the Primary Efficacy Time Point, The ratio of low-density lipoprotein (LDL) cholesterol to high-density lipoprotein (HDL) cholesterol was measured at Baseline and the post-baseline visit closest to 14 days after the last dose of study treatment., Baseline (the average of the screening and Day 1 pre-treatment assessments) and the Primary Efficacy Time point (PET; Week 28 or the post-baseline visit closest to 14 days after the last dose).|Ratio of LDL Cholesterol to HDL Cholesterol at Baseline and at the Primary Efficacy Time Point, The primary efficacy time point (PET) was the post-baseline visit closest to 14 days after the last dose of study treatment., Baseline (the average of the screening and Day 1 pre-treatment assessments) and the Primary Efficacy Time point (PET; Week 28 or the post-baseline visit closest to 14 days after the last dose).|Percent Change From Baseline in Apolipoprotein A1 at the Primary Efficacy Time Point, Apolipoprotein A1 was measured in mg/dL. Samples were taken following an overnight fast. The primary efficacy time point was the post-baseline visit closest to 14 days after the last dose of study treatment., Baseline (the average of the screening and Day 1 pre-treatment assessments) and the Primary Efficacy Time point (PET; Week 28 or the post-baseline visit closest to 14 days after the last dose).|Apolipoprotein A1 at Baseline and at the Primary Efficacy Time Point, The primary efficacy time point (PET) was the post-baseline visit closest to 14 days after the last dose of study treatment., Baseline (the average of the screening and Day 1 pre-treatment assessments) and the Primary Efficacy Time point (PET; Week 28 or the post-baseline visit closest to 14 days after the last dose).\n",
            "---=>Number of Patients With All-cause Mortality, Cardiogenic Shock, Congestive Heart Failure and Recurrent Myocardial Infarction Within 30 Days for FAS., The number of observed patients with all-cause mortality, cardiogenic shock, congestive heart failure (CHF) and recurrent myocardial infarction within 30 days was reported for full analysis set (FAS)., 30 days Number of Patients With All Cause Mortality, This is a key secondary endpoint. The number of observed patients with all cause mortality within 30 days was reported., 30 days|Number of Patients With Cardiac Mortality, This is a key secondary endpoint. The number of observed patients with cardiac mortality within 30 days was reported., 30 days|Number of Patients With Cardiogenic Shock, This is a key secondary endpoint. The number of observed patients with cardiogenic shock within 30 days was reported., 30 days|Number of Patients With Congestive Heart Failure (CHF), This is a key secondary endpoint. The number of observed patients with congestive heart failure (CHF) within 30 days was reported., 30 days|Number of Patients With Recurrent Myocardial Infarction (Reinfarction), This is a key secondary endpoint. The number of observed patients with recurrent myocardial infarction (reinfarction) within 30 days was reported, 30 days|Number of Patients With Rehospitalisation for Cardiac Reasons, This is a key secondary endpoint. The number of observed patients with rehospitalisation for cardiac reasons within 30 days was reported, 30 days|Number of Patients With Rehospitalisation for Non-cardiac Reasons, This is a key secondary endpoint. The number of observed patients with rehospitalisation for non-cardiac reasons within 30 days was reported, 30 days|Number of Patients With Serious Repeat Target Vessel Revascularization, This is a key secondary endpoint. The number of observed patients with serious repeat target vessel revascularization within 30 days was reported, 30 days|Number of Patients With All Cause Death and Shock, This is a key secondary endpoint. The number of observed patients with all cause death and shock within 30 days was reported, 30 days|Number of Patients With All Cause Death and Shock and CHF, This is a key secondary endpoint. The number of observed patients with all cause death and shock and CHF within 30 days was reported., 30 days|Number of Patients With All Cause Death and Shock and Reinfarction, This is a key secondary endpoint. The number of observed patients with all cause death and shock and reinfarction within 30 days was reported, 30 days|Number of Patients With Total Fatal Stroke, This is a key secondary endpoint. The number of observed patients with total fatal stroke within 30 days was reported, 30 days|Number of Patients With Total Disabling Stroke, This is a key secondary endpoint. The number of observed patients with total disabling stroke within 30 days was reported, 30 days|Number of Patients With Total Non-disabling Stroke, This is a key secondary endpoint. The number of observed patients with total non-disabling stroke within 30 days was reported, 30 days|Number of Patients With Intracranial Haemorrhage, This is a key secondary endpoint. The number of observed patients with intracranial haemorrhage within 30 days was reported, 30 days|Number of Patients With Ischaemic Stroke, This is a key secondary endpoint. The number of observed patients with ischaemic stroke within 30 days was reported, 30 days|Number of Patients With Total Stroke (All Types), This is a key secondary endpoint. The number of observed patients with total stroke (all types) within 30 days was reported, 30 days|Number of Patients With Major Non-intracranial Bleeds Including Blood Transfusions, This is a key secondary endpoint. The number of observed patients with major non-intracranial bleeds including blood transfusions within 30 days was reported, 30 days|Number of Patients With Minor Non-intracranial Bleeds, This is a key secondary endpoint. The number of observed patients with minor non-intracranial bleeds within 30 days was reported, 30 days|Number of Patients With Total Non-intracranial Bleeds, This is a key secondary endpoint. The number of observed patients with total non-intracranial bleeds within 30 days was reported, 30 days|Number of Patients With Serious Resuscitated Ventricular Fibrillation, This is a key secondary endpoint. The number of observed patients with serious resuscitated ventricular fibrillation within 30 days was reported, 30 days|Number of Patients With Serious Resuscitated Ventricular Fibrillation in Association With Invasive Procedures, This is a key secondary endpoint. The number of observed patients with serious resuscitated ventricular fibrillation in association with invasive procedures (occurring at any time during catheterisation or urgent/elective PCI) within 30 days was reported, 30 days|Number of Patients With All Cause Death and Non-fatal Stroke, This is a key secondary endpoint. The number of observed patients with all cause death and non-fatal stroke within 30 days was reported, 30 days|Number of Patients With All Cause Death and Shock and CHF and Reinfarction and Disabling Stroke, This is a key secondary endpoint. The number of observed patients with all cause death and shock and CHF and reinfarction and disabling stroke within 30 days was reported, 30 days \n",
            "---=>Maximum Observed Everolimus Blood Concentration (Cmax), Venous blood draw up to 24 hours prior to implantation of the first study stent (predose time point) and at 30 minutes, 1, 2, 4, 6, 12, 24, 48, and 72 hours after completion of implantation of the last study stent, Predose <24 hours; post dose at 30 minutes, 1, 2, 4, 6, 12, 24, 48, and 72 hours Area Under the Concentration Versus Time Curve (AUC 0-t) Everolimus, Venous blood draw up to 24 hours prior to implantation of the first study stent (predose time point) and at 30 minutes, 1, 2, 4, 6, 12, 24, 48, and 72 hours after completion of implantation of the last study stent; t is the last time at which concentration can be quantified, Predose <24 hours; post dose at 30 minutes, 1, 2, 4, 6, 12, 24, 48, and 72 hours|Area Under the Concentration Versus Time Curve (AUC 0-24), Everolimus, Venous blood draw up to 24 hours prior to implantation of the first study stent (predose time point) and at 30 minutes, 1, 2, 4, 6, 12, 24, 48, and 72 hours after completion of implantation of the last study stent, Predose <24 hours; post dose at 30 minutes, 1, 2, 4, 6, 12, 24, 48, and 72 hours|Area Under the Concentration Versus Time Curve (AUC 0-infinity) Everolimus, Venous blood draw up to 24 hours prior to implantation of the first study stent (predose time point), 30 minutes, 1, 2, 4, 6, 12, 24, 48, and 72 hours after implantation of the last study stent., Predose <24 hours; post dose at 30 minutes, 1, 2, 4, 6, 12, 24, 48, and 72 hours|Time of Occurrence of Maximum Everolimus Concentration (Tmax), Venous blood draw up to 24 hours prior to implantation of the first study stent (predose time point) and at 30 minutes, 1, 2, 4, 6, 12, 24, 48, and 72 hours after completion of implantation of the last study stent, Predose <24 hours; post dose at 30 minutes, 1, 2, 4, 6, 12, 24, 48, and 72 hours|Terminal Phase Half-life (t1/2) Everolimus, Venous blood draw up to 24 hours prior to implantation of the first study stent (predose time point), at 30 minutes, 1, 2, 4, 6, 12, 24, 48, and 72 hours after completion of implantation of the last study stent., Predose <24 hours; post dose at 30 minutes, 1, 2, 4, 6, 12, 24, 48, and 72 hours|Total Blood Clearance - Everolimus (CL), Venous blood draw up to 24 hours prior to implantation of the first study stent (predose time point), 30 minutes, 1, 2, 4, 6, 12, 24, 48, and 72 hours after completion of implantation of the last study stent., Predose <24 hours; post dose at 30 minutes, 1, 2, 4, 6, 12, 24, 48, and 72 hours|All Death, Number of participants no longer alive, 6 months|Myocardial Infarction (MI) Related to the Target Vessel, New Q-waves in â‰¥2 leads lasting â‰¥0.04 sec with creatine kinase (CK) MB or troponin \\>normal; if no new Q-waves total CK levels \\>3Ã— normal (peri-percutaneous coronary intervention \\[PCI\\]) or \\>2Ã— normal (spontaneous) with elevated CK-MB or troponin \\>3Ã— normal (peri-PCI) or \\>2Ã— normal (spontaneous) plus at least one of the following: ECG changes indicating new ischemia (new ST-T changes, left bundle branch block), imaging evidence of new loss of viable myocardium, or new regional wall motion abnormality. Similar for MI diagnosis post coronary artery bypass graft with CK-MB or troponin \\>5Ã— normal, 6 months|Target Vessel Revascularization (TVR), TVR is any ischemia-driven repeat percutaneous intervention to improve blood flow, or bypass surgery of not previously existing lesions with diameter stenosis â‰¥50% by quantitative coronary angiography in the target vessel, including the target lesion., 6 months|Target Lesion Revascularization (TLR), TLR is any ischemia-driven repeat percutaneous intervention to improve blood flow of the successfully treated target lesion or bypass surgery of the target vessel with a graft distally to the successfully treated target lesion., 6 months|Definite + Probable Stent Thrombosis (ST) Rate Based on Academic Research Consortium (ARC) Definition, DEFINITE ST: acute coronary syndrome and angiographic or pathologic evidence of stent thrombosis; PROBABLE ST: unexplained death within 30 days or target-vessel infarction without angiographic information ARC ST is reported as a cumulative value at different time points and within the different separate time points. Time 0 is the time point after the guide catheter has been removed. Acute ST: 0-24 hours after stent implantation; Subacute ST: \\>24 hours to 30 days post; late ST: \\>30 days to 1 year post; Very late ST: \\>1 year post; NOTE: Acute/subacute can be replaced by early ST (0-30 days)., 24 hours|Definite + Probable Stent Thrombosis Rate Based on Academic Research Consortium (ARC) Definition, DEFINITE ST: acute coronary syndrome and angiographic or pathologic evidence of stent thrombosis; PROBABLE ST: unexplained death within 30 days or target-vessel infarction without angiographic information ARC ST is reported as a cumulative value at different time points and within the different separate time points. Time 0 is the time point after the guide catheter has been removed. Acute ST: 0-24 hours after stent implantation; Subacute ST: \\>24 hours to 30 days post; late ST: \\>30 days to 1 year post; Very late ST: \\>1 year post; NOTE: Acute/subacute can be replaced by early ST (0-30 days)., >24 hours-30 days|Definite + Probable Stent Thrombosis Rate Based on Academic Research Consortium (ARC) Definition, DEFINITE ST: acute coronary syndrome and angiographic or pathologic evidence of stent thrombosis; PROBABLE ST: unexplained death within 30 days or target-vessel infarction without angiographic information ARC ST is reported as a cumulative value at different time points and within the different separate time points. Time 0 is the time point after the guide catheter has been removed. Acute ST: 0-24 hours after stent implantation; Subacute ST: \\>24 hours to 30 days post; late ST: \\>30 days to 1 year post; Very late ST: \\>1 year post; NOTE: Acute/subacute can be replaced by early ST (0-30 days)., >30 days-1 year \n",
            "---=>Angiomyolipoma Response Rate as Per Central Radiology Review, Angiomyolipoma response defined as the combination of the following criteria: reduction in angiomyolipoma volume of â‰¥ 50% relative to baseline, where angiomyolipoma volume was sum of volumes of all target lesions identified at baseline, and with a confirmatory scan performed approximately 12 weeks later (no sooner than 8 weeks later); no new angiomyolipoma lesions â‰¥ 1.0 cm in longest diameter were identified; there were no kidney increases in volume \\> 20% from nadir. The patient did not have any angiomyolipoma-related bleeding of â‰¥ grade 2.\n",
            "\n",
            "For the everolimus (core/extension periods) treatment group, the baseline means the latest value on or before starting everolimus., From date of randomization until the earliest date of first documented AML progression, date of further anti-AML medication (including open-label Everolimus)/surgery or up to 5.7 years Time to Angiomyolipoma Progression as Per Central Radiology Review, Time to angiomyolipoma progression (TTAP) is defined as time from date of randomization to date of first documented angiomyolipoma progression. Angiomyolipoma progression was defined as one or more of the following: Increase from nadir of â‰¥ 25% in angiomyolipoma volume to value greater than baseline; the appearance of a new angiomyolipoma â‰¥ 1.0 cm in longest diameter; an increase from nadir of 20% or more in the volume of either kidney to a value greater than baseline; angiomyolipoma-related bleeding grade â‰¥ 2.\n",
            "\n",
            "For the everolimus (core/extension periods) treatment group, the time to angiomyolipoma progression is defined starting from the start of everolimus. The baseline means the latest value on or before starting everolimus., From date of randomization until the earliest date of first documented AML progression, date of further anti-AML medication (including open-label Everolimus)/surgery or up to about 5.7 years|Skin Lesion Response Rate as Per Investigator (Only Patients With at Least One Skin Lesion at Baseline), Skin lesion response rate in the double-blind period was determined only among patients with at least one skin lesion at baseline, and is the percentage of this group of patients with a best overall skin lesion response on the Physician's Global Assessment of Clinical Condition (PGA) of either complete clinical response (CCR) or partial response (PR). A complete clinical response (CCR) requires a grading of 0 indicating the absence of disease (histological confirmation is not required). Grades 1, 2, and 3 constitute partial response, indicating improvement of at least 50 percent, but less than 100 percent improvement. For the everolimus (core/extension periods) treatment group, the baseline means the latest value on or before starting everolimus., From date of randomization until the earliest date of first documented AML progression, date of further anti-AML medication (including open-label Everolimus)/surgery or up to 5.7 years|Percentage of Participants With Renal Impairment, Renal Impairment was measured by glomerular filtration rate which was calculated using the Modification of Diet in Renal Disease formula. Percentage of participants with renal impairment was reported. Severe renal impairment was defined as a GFR of \\<30ml/min/1.73m2., Day 1 up to 28 days after end of treatment|Change From Baseline in Plasma Angiogenic Molecules - Vascular Endothelial Growth Factor (VEGF) Marker, Blood samples for biomarker assessment were collected immediately prior to study administration. On-treatment samples was compared to baseline samples with the change from baseline., 4 weeks, 12 weeks, 24 weeks, 36 weeks 48 weeks, 60 weeks, 72 weeks|Everolimus Trough Concentrations (Cmin), Cmin values collected prior to dose administration on the same study day and at 20-28 hours after previous dose, at steady state, and patient did not vomit within 4 hours of previous dose. Samples collected during the first 4 days of dosing were excluded from all analyses., Prior to dosing at weeks 2, 4, 12, 24, 48|Everolimus Blood Concentrations (C2h) at 2 Hours Post-dose, C2h values collected 1-3 hours after dose administration on the same study day, at steady state, and patient did not vomit between taking previous dose and blood collection. Samples collected during the first 4 days of dosing will be excluded from all analyses., 2 hours post-dose administration at Weeks 2, 4, 12, 24, 48|Time to Angiomyolipoma Response - Only Everolimus Patients With Angiomyolipoma Response, Time to angiomyolipoma response was defined as the time from the date of randomization until the date of the first documented angiomyolipoma response. Angiomyolipoma response defined as the combination of the following criteria: reduction in angiomyolipoma volume of â‰¥ 50% relative to baseline, where angiomyolipoma volume was sum of volumes of all target lesions identified at baseline, and with a confirmatory scan performed approximately 12 weeks later (no sooner than 8 weeks later); no new angiomyolipoma lesions â‰¥ 1.0 cm in longest diameter were identified; no kidney increases in volume \\> 20% from nadir; no angiomyolipoma-related bleeding of â‰¥ grade 2.\n",
            "\n",
            "For the everolimus (core/extension periods) treatment group, the time to angiomyolipoma response is from the start of everolimus. The baseline in the response definition means the latest value on or before starting everolimus., From date of randomization until the earliest date of first documented AML progression, date of further anti-AML medication (including open-label Everolimus)/surgery or up to 5.7 years|Duration of Angiomyolipoma Response - Only Everolimus Patients With Angiomyolipoma Response, Duration of angiomyolipoma response was defined as the time from the date of the first documented angiomyolipoma response until the date of the first documented angiomyolipoma progression . Angiomyolipoma response was defined as the combination of the following criteria: reduction in angiomyolipoma volume of â‰¥ 50% relative to baseline, where angiomyolipoma volume was sum of volumes of all target lesions identified at baseline, and with a confirmatory scan performed approximately 12 weeks later (no sooner than 8 weeks later); no new angiomyolipoma lesions â‰¥ 1.0 cm in longest diameter were identified; there were no kidney increases in volume \\> 20% from nadir. The patient did not have any angiomyolipoma-related bleeding of â‰¥ grade 2., From date of randomization until the earliest date of first documented AML progression, date of further anti-AML medication (including open-label Everolimus)/surgery or up to about 5.7 years|Duration of Skin Lesion Response - Only Everolimus Patients With Best Overall Skin Lesion Response of Complete Clinical Response (CCR) or Partial Response (PR), Duration of skin lesion response is defined as the time from the date of the first skin lesion response until the date of the first skin lesion progression, according to the PGA (physician's global assessment of clinical condition). A progression is when the disease is worse than at baseline evaluation by \\>=25% or more., From date of randomization until the earliest date of first documented AML progression, date of further anti-AML medication (including open-label Everolimus)/surgery or up to about 5.7 years \n",
            "---=>Related Adverse Events, Adverse event : Device relationship - Definite, Probable, Possible, Within 12 months post RFA Subject Tolerability: Post -Ablation Anal Pain, Median post-ablation anal pain from 10 patients' survey after RFA treatment. Anal pain scale range: 0-10 (minimum pain=0, maximum pain=10), within 4 weeks post RFA|Quality of Life Assessment: Subject Score for Worry About Anal Canal Condition, Median from subject scores for worry about anal canal condition at 0-2 weeks prior to RFA treatment and after 9-12 months post RFA. Median scale range: 0-10 (minimum concern=0, maximum concern=10), 0-2 weeks Prior RFA and after 9-12 months post RFA \n",
            "---=>Incidence of Grade 3 or Higher Hypotension, Acute Kidney Injury, Allergic Reaction, or Anaphylaxis, as Measured Using the National Cancer Institute Common Terminology Criteria for Adverse Events (NCI CTCAE) Version 4.0, Incidence of grade 3 or higher hypotension, acute kidney injury, allergic reaction, or anaphylaxis, as measured using the National Cancer Institute Common Terminology Criteria for Adverse Events (NCI CTCAE) version 4.0. Descriptive statistics of frequency (percentage) will be used to summarize adverse event (AE) incidence and severity in the lisinopril and placebo arms separately., Up to 3 months post-radiation therapy Acute Respiratory Distress (Dyspnea), Measured Using of the Maximum Score, at Any Time, of the Shortness of Breath Question (Item #4) on the LCSS (Worst Dyspnea Score), Acute respiratory distress (dyspnea), measured using of the maximum score, at any time, of the shortness of breath question (Item #4 \"How much shortness of breath do you have?\") on the Lung Cancer Symptom Scale (LCSS) (Worst Dyspnea Score). The LCSS tool contains 6 major symptoms associated with lung malignancies and their effect on overall symptomatic distress, functional activities, and global quality of life (QOL). The item scale ranges from 0-10 (0 = None; 10 = As much as it could be) where the LCSS scoring algorithm is applied to convert to a 0-100 point scale where 100 is best quality of life (QOL), for comparability. Patient scores range from 0 to 100, where 100 was best QOL (i.e. less pulmonary distress)., Up to 3 months post-radiation therapy|Experience Shortness of Breath During Exercise as Measured Using Item #3 on the Symptom Experience Questionnaire (SEQ) at Week 4, Experience shortness of breath during exercise as measured using Item #3 (\"Over the past week, did you experience shortness of breath when you exercise or exert yourself?\") on the Symptom Experience Questionnaire (SEQ) at Baseline. The item scale ranges from 0-10 (0 = Not at all; 10 = As bad as it can be) where the SEQ scoring algorithm is applied to convert to a 0-100 point scale where 100 is best quality of life (QOL), for comparability., At Week 4|Quality of Life (Dyspnea When Climbing Stairs) Assessed Using Item #5 of the European Organization for Research on the Treatment of Cancer Lung Cancer Module Survey (EORTC-QLQ-LC13) at Week 4, Dyspnea when climbing as measured using item #5 (\"Were you short of breath when you climbed stairs?\") of the EORTC-QLQ-LC13 at Week 4. The item scale ranges from 1-4 (1 = Not at all; 4 = Very Much) where the EORTC-QLQ-LC13 scoring algorithm is applied to convert to a 0-100 point scale where 100 is best quality of life (QOL), for comparability., At Week 4|Total LCSS Score as Measure by the Lung Cancer Symptom Scale (LCSS) at Week 4, Total LCSS score as measured using the Lung Cancer Symptom Scale (LCSS) at Week 4. The item scale ranges from 0-10 (0 = None; 10 = As much as it could be) where the LCSS scoring algorithm is applied to convert to a 0-100 point scale where 100 is best quality of life (QOL), for comparability., At Week 4 \n",
            "---=>Number of Participants With Any Grade 2 or Higher Event in the Injection Phase, Clinical adverse event (AE) were graded using the Division of Acquired Immunodeficiency Syndrome (DAIDS) table for grading the severity of adult and pediatric AE Version 1.0, December 2004; Clarification August 2009. The grades were: 1 (mild)=Symptoms causing no or minimal interference with usual social and functional activities; 2 (moderate)= Symptoms causing greater than minimal interference with usual social and functional activities; 3 (severe)= Symptoms causing inability to perform usual social and functional activities; 4 (potentially life threatening): Symptoms causing inability to perform basic self-care functions or medical or operative intervention indicated to prevent permanent impairment, persistent disability, or death. Data has been presented for any Grade 2 or higher event in the injection phase for injection phase (Week 5- Week 41)., Up to Week 41|Number of Participants Who Recieved Injection Site Reaction (ISR) Related Concomitant Medication in the Injection Phase, The concurrent medications that were consumed by participants during the injection phase were of the class nervous system, musculo-skeletal system, genito urinary systems and sex hormones, various, respiratory system, dermatologicals, alimentary tract and metabolism, sensory organs, systemic hormonal preparations, excluding sex hormones, blood and blood forming organs, cardiovascular system. The participants who took medication from any of the above class of during the injection phase (Week 5-Week 41) have been presented., Up to Week 41|Number of Participants Who Experienced Grade 2 or Higher Laboratory Results in the Injection Phase, The severity of laboratory results was graded according to the DAIDS table for grading the severity of adult and pediatric AE Version 1.0, December 2004; Clarification August 2009. The DAIDS displays events as Grades 1-5 based on this general guideline: Grade 1, mild; Grade 2, moderate; Grade 3, severe; Grade 4, potentially life threatening. Data for Number of participants who experienced grade 2 or higher laboratory results in the injection phase (Week 5-Week 14) have been presented., Up to Week 41|Number of Participants Who Had Abnormal Electrocardiogram (ECG) Findings in the Injection Phase, Full 12-lead ECGs included heart rate, PR, QRS, QT and QTc intervals. Measurements were taken from the participant following 5 minutes of rest in a semi-supine position. ECGs were performed at Week 5, Week 17, Week 29 and Week 41 in the injection phase (Week 5-Week 41). ECG abnormalities characterized as abnormal-not clinically significant (A-NCS) and abnormal-clinically significant (A-CS) upto Week 41 have been presented. There were no A-CS findings for ECG in the injection phase., Up to Week 41|Change From Baseline in Vital Sign Assessment for Systolic Blood Pressure (SBP) and Diastolic Blood Pressure (DBP) in the Injection Phase, Vital signs measurements were performed for SBP and DBP following 5 minutes of rest. Baseline was defined as the first injection at Week 5 for the injection phase. Change from Baseline was calculated by subtracting the Baseline value from the individual post-Baseline value at Week 17, Week 29 and Week 41., Baseline (Week 5) to Week 41|Change From Baseline in Vital Sign Assessment for Heart Rate (HR) in the Injection Phase, Vital signs measurements were performed for HR following 5 minutes of rest. Baseline was defined as the first injection at Week 5 for the injection phase. Change from Baseline was calculated by subtracting the Baseline value from the individual post-Baseline value at Week 17, Week 29 and Week 41., Baseline (Week 5) to Week 41|Number of Participant With ISR for the Injection Phase Defined by Maximum Grades, Common ISR included pain, erythema, nodules and any other ISR with greater or equal to 5 participants. The number of participants who experienced pain events by needle length, swelling events by needle length, bump events by needle length for injection phase by maximum grades have been presented for the injection phase (Week 5-Week 41)., Up to Week 41 Plasma Pharmacokinetic Assessment for Area Under the Plasma Concentration-time Curve Over the Dosing Interval [AUC(0-tau)] in the Injection Phase, Blood samples for pharmacokinetic analysis were collected starting on the first day of the First Injection Phase prior to the injection. At each injection visit a blood sample was collected prior to the injection at Week 5, Week 17 and Week 29, 1 Week post-injection at Week 6, Week 18, and Week 30, and 12 Week post-injection at Week 17, Week 29, and Week 41. The sample collected 12 Week following each injection served as the pre-dose sample for the subsequent dosing interval. Two additional samples were collected 4 and 8 Week after the first injection (Week 9 and Week 13), and 1 additional sample was collected 6 Week following the second and third injections (Week 23 and Week 35). Assessment was carried out for AUC(0-tau) a measure of the amount of drug available at target tissue (in plasma) for a fixed dosing interval (i.e.12 hours)., Up to Week 41|Plasma Pharmacokinetic Assessment for Concentration at the End of the Dosing Interval (Ctau) and Maximum Observed Concentration (Cmax) in the Injection Phase, Blood samples for pharmacokinetic analysis were collected starting on the first day of the First Injection Phase prior to the injection. At each injection visit a blood sample was collected prior to the injection at Week 5, Week 17 and Week 29, 1 Week post-injection at Week 6, Week 18, and Week 30, and 12 Week post-injection at Week 17, Week 29, and Week 41. The sample collected 12 Week following each injection served as the pre-dose sample for the subsequent dosing interval. Two additional samples were collected 4 and 8 Week after the first injection (Week 9 and Week 13), and 1 additional sample was collected 6 Week following the second and third injections (Week 23 and Week 35). Assessment was carried out for Ctau defined as the concentration at the end of the dosing interval and Cmax defined as the maximum observed plasma concentration., Up to Week 41|Plasma Pharmacokinetic Assessment for Time to Maximum Observed Concentration (Tmax), Apparent Terminal Phase Half-life for (tÂ½) in the Injection Phase, Blood samples for pharmacokinetic analysis were collected starting on the first day of the First Injection Phase prior to the injection. At each injection visit a blood sample was collected prior to the injection at Week 5, Week 17 and Week 29, 1 Week post-injection at Week 6, Week 18, and Week 30, and 12 Week post-injection at Week 17, Week 29, and Week 41. The sample collected 12 Week following each injection served as the pre-dose sample for the subsequent dosing interval. Two additional samples were collected 4 and 8 Week after the first injection (Week 9 and Week 13), and 1 additional sample was collected 6 Week following the second and third injections (Week 23 and Week 35). Assessment was carried out for tmax defined as the time to the maximum observed plasma concentration and tÂ½ defined as the time taken for the concentration of drug in the blood to decrease by half of the original amount., Up to Week 41|Plasma Pharmacokinetic Assessment for AUC(0-tau) by Demographic Factor Body Mass Index (BMI) and Needle Length in the Injection Phase, The median BMI was 26 kilogram per meter square. Plasma pharmacokinetic assessments were performed for AUC (0-tau) by BMI, either above or below the median BMI (50 percent upper and lower, where upper summary included all participants with BMI greater than or equal to the median BMI of the population and lower summary included all participants with BMI below the median BMI). Assessments was also performed for AUC (0-tau) by needle length (1.5 inch and 2 inch). Needle length and BMI were correlated in that the longer needle was recommended for participants with BMI greater than 30 kilogram per meter square., Up to Week 41|Plasma Pharmacokinetic Assessment for Ctau and Cmax by Demographic Factor BMI and Needle Length in the Injection Phase, The median BMI was 26 kilogram per meter square. Plasma pharmacokinetic assessments were performed for Ctau and Cmax by BMI, either above or below the median BMI (50 percent upper and lower, where upper summary included all participants with BMI greater than or equal to the median BMI of the population and lower summary included all participants with BMI below the median BMI.\n",
            "\n",
            "). Assessments was also performed for Ctau and Cmax by needle length (1.5 inch and 2 inch). Needle length and BMI were correlated in that the longer needle was recommended for participants with BMI greater than 30 kilogram per meter square., Up to Week 41|Plasma Pharmacokinetic Assessment for Tmax and tÂ½ by Demographic Factor BMI and Needle Length in the Injection Phase, The median BMI was 26 kilogram per meter square. Plasma pharmacokinetic assessments were performed for tmax and tÂ½ by BMI, either above or below the median BMI (50 percent upper and lower, where upper summary included all participants with BMI greater than or equal to the median BMI of the population and lower summary included all participants with BMI below the median BMI). Assessments was also performed for tmax and tÂ½ by needle length (1.5 inch and 2 inch). Needle length and BMI were correlated in that the longer needle was recommended for participants with BMI greater than 30 kilogram per meter square., Up to Week 41|Number of Participants With Severity of ISRs and ISR Symptoms for Injection Phase Defined by Grades and Needle Length, Acceptability of cabetogravir injections was assessed number of participants who had severe ISRs and ISR symptom. ISR examination for severity included an assessment of pain, pruritis, warm to touch, bruising, discoloration, erythema, swelling, induration and bump events. Common ISR Symptoms for Injection Phase included pain, erythema, nodules and any other ISRs with greater or equal to five participants. Data has been presented for the injection phase (W5-W41) by grades and needle length., Up to Week 41|Number of Participants With AE, Grade 2-4 AE and Serious Adverse Events (SAE) in the Oral Phase, Clinical AE were graded using the DAIDS table for grading the severity of adult and pediatric AE Version 1.0, December 2004; Clarification August 2009. The grades were: 1 (mild)=Symptoms causing no or minimal interference with usual social and functional activities; 2 (moderate)= Symptoms causing greater than minimal interference with usual social and functional activities; 3 (severe)= Symptoms causing inability to perform usual social and functional activities; 4 (potentially life threatening): Symptoms causing inability to perform basic self-care functions or medical or operative intervention indicated to prevent permanent impairment, persistent disability, or death. Data has been presented for any Grade 2 or higher event in the injection phase for injection phase (Week 5- Week 41)., Up to Week 4|Number of Participants Who Received Concurrent Medication in Overall Study Duration, The concurrent medications that were consumed by participants during the injection phase were of the class nervous system, musculo-skeletal system, genito-urinary systems and sex hormones, various, respiratory system, dermatologicals, alimentary tract and metabolism, anti-infectives for systemic use, sensory organs, systemic hormonal preparations excluding sex hormones, blood and blood forming organs, cardiovascular system, anti-neoplastic and immunomodulating agents, anti-parasitic products, insecticides and repellents . The participants who took medication from any of the above class of during the during the overall study duration injection phase (Day 1 until Week 41) have been presented., Up to Week 41|Number of Participants Who Experienced Maximum Clinical Chemistry Including Liver Chemistry and Hematology Toxicities in the Oral Phase by Grades, The severity of clinical chemistry including liver chemistry and hematology toxicities was graded according to the DAIDS table for grading the severity of adult and pediatric AE Version 1.0, December 2004; Clarification August 2009. The DAIDS displays events as Grades 1-5 based on this general guideline: Grade 1, mild; Grade 2, moderate; Grade 3, severe; Grade 4, potentially life threatening. Data for maximum clinical chemistry and hematology toxicities for oral phase (Day 1 upto Week 4) by grades have been presented., Up to Week 4 \n",
            "---=>CIAS (Computerized Intervention Authoring Software) Satisfaction Measure Scores to Assess the Feasibility and Acceptability of the Computer and HCEM Software, CIAS Satisfaction Measure (adapted from Ondersma et al., 2005). Self-report instrument assessing the extent to which participants found the software acceptable. Mean ratings on items including Likeability and Ease of use; scores range from 1 (low) to 5 (high) in satisfaction.\n",
            "\n",
            "HCEM Satisfaction Measure. Self-report instrument assessing the extent to which participants found specific components of the HCEM intervention acceptable (e.g., videos, resources, information); scores range from 1 (low) to 7 (high) in satisfaction., 4 month follow up Percentage of Participants With Reduced HIV/STI Risk Behavior (Condomless Sex) From Baseline to Follow-Up., Participants completed the Timeline Followback interview and self-reported their daily sex risk behavior including condomless sex, 4 month follow up|Percentage of Participants Endorsing Alcohol/Drug Use at Baseline and 4-Month Follow-Up, The Timeline Followback approach was used to collect self-reported data regarding alcohol and/or drug use over a 4-month time period., Baseline and 4-Month Follow-Up \n",
            "---=>Complete Clearance of Disease at Week 14, Number of participants achieving complete clearance of genital warts at Week 14, Week 14|Number of Adverse Events (AE)/Serious Adverse Events (SAE) as a Measure of Safety and Tolerability up to 30 Weeks, Number of participants with at least one AE/SAE in the category up to 30 weeks, 30 weeks Number of Participants That Had Partial Clearance Rate of at Least 75 Percent Reduction in External Genital Wart (EGW)s Count at End of Treatment (EOT) Week 12 or 16, Number of Participants that had partial clearance rate of at least 75 percent reduction in External Genital Wart (EGW)s count at end of treatment (EOT) Week 12 or 16, End of Treatment (EOT) Week 12 or Week 16 \n",
            "---=>Progression Free Survival (PFS), The 2-year PFS was measured from the date of enrollment to the first occurrence of new metastatic lesions, objective tumor progression, or death. The combination of cisplatin and cetuximab concurrent with radiation therapy for head and neck cancer has shown to have a favorable PFS. Patients were followed until death or from 7.5 months to 63.6 months (median 25.6 months) in those alive at last evaluation., 2 year from the date of enrollment Number of Participants With Acute and Late Toxicities, Incidence rate of acute and late toxicities of grade 3 or higher was measured after each treatment cycle was over. The most common late toxicities defined as toxicity occurring more than 90 days after treatment included laryngeal edema and xerostomia., 6 months within the end of treatment \n",
            "---=>Progression-Free Survival (PFS): Independent Radiological Facility (IRF) Assessment, IRF assessed PFS was defined as time (in months) from randomization until the date of first documented radiologic progressive disease per response evaluation criteria in solid tumors (RECIST) version 1.1 or death from any cause, whichever occurs first. As per RECIST v1.1, progression defined as 1) for target lesions: at least a 20% increase in the sum of target lesion measurements, compared to the smallest sum on study (including baseline), the absolute increase in the sum has to be at least 5 millimeter (mm); 2) for non-target lesions: unequivocal progression of non-target lesions, evaluated as a whole, such that it is clear that treatment has failed and disease is progressing, regardless of the status of the target lesions; 3) and/or appearance of one or more new lesions. The analysis was performed by Kaplan-Meier method., Baseline until radiologic progressive disease or death due to any cause (up to maximum duration of 36.9 months) Percentage of Participants With Objective Response: Investigator Assessment, Investigator assessed objective response was defined as the percentage of participants with a partial response (PR) or complete response (CR) as defined by RECIST v1.1. For target lesions: 1) CR: disappearance of all non-nodal target lesions. Target lymph nodes must reduce to less than 10 mm in short axis. 2) PR: At least a 30% decrease in the sum of diameters of target lesions, compared to the sum at baseline. For non-target lesions, CR: disappearance of all non-target lesions. Percentage of participants with objective response reported are based upon unconfirmed CR/PR., Baseline until radiologic progressive disease or death due to any cause (up to a maximum duration of 36.9 months)|Overall Survival (OS), OS was defined as the time (in months) from randomization to death due to any cause. If death was not observed at the time of study cut-off date or permanently lost to follow-up, OS was censored at the date the participant was last known to be alive on or before the study cut-off date, whichever was earlier. The analysis was performed by Kaplan-Meier method., Baseline until death due to any cause or analysis cut-off, up to a maximum duration of 61.4 months|Trough Plasma Talazoparib Concentrations, A predose PK sample was considered dose-compliant based on the following criteria: A participant must have received 21 consecutive days of 1 mg talazoparib without dosing interruption prior to sample collection; and the predose PK sample must have been collected 24 hours +/- 10 percent (2 hours and 24 minutes) after the previous day's dose and no more than 5 minutes (0.083 hours) after the administration of the dose on the day of PK sample collection., Predose on Day 1 of Cycle 2, 3 and 4|Number of Participants With Treatment-emergent Adverse Events (TEAEs) and Serious Adverse Events (SAEs), An adverse events (AE) was any untoward medical occurrence (e.g., sign, symptom, illness, disease or injury) in a participant administered study drug or other protocol-imposed intervention, regardless of attribution. SAE was an AE resulting in any of the following outcomes or deemed significant for any other reason: death; initial or prolonged inpatient hospitalization; life-threatening experience (immediate risk of dying); persistent or significant disability/incapacity; congenital anomaly. Treatment-emergent are events between first dose of study drug or the day before initiation of a new antineoplastic therapy or 30 days after the date of the last dose date of study drug, whichever occurred first, that were absent before treatment or that worsened relative to pretreatment state. AEs included both SAEs and all non-SAEs., Talazoparib: Baseline up to a maximum duration of 71.3 months; Physician's Choice Treatment: Baseline up to maximum duration of 46.1 months|Number of Participants With Grade 3 or 4 Post-baseline Toxicities in Laboratory Parameters: Hematology, Toxicity grades were evaluated based on as National Cancer Institute Common Toxicity Criteria for Adverse Events Version 4.03 (NCI CTCAE v4.03). NCI CTCAE v4.03 defined the severity grade as: grade 1 (mild), grade 2 (moderate), grade 3 (severe), grade 4 (potentially life threatening) and grade 5 (death related to AE) for each parameter. Key hematology parameters included hemoglobin (gram per liter \\[g/L\\]), leukocytes (10\\^6 cells per liter), lymphocytes (10\\^6 cells per liter), neutrophils (10\\^6 cells per liter), and platelets (10\\^9 cells per liter). Low value indicated lower values than the baseline values and high value indicated higher values than the baseline values. Only those categories in which at least 1 participant had data were reported., Talazoparib: Baseline up to a maximum duration of 71.3 months; Physician's Choice Treatment: Baseline up to maximum duration of 46.1 months.|Number of Participants With Grade 3 or 4 Post-baseline Toxicities in Laboratory Parameters: Chemistry, Toxicity grades were evaluated based on as NCI CTCAE v4.03. NCI CTCAE v4.03 defined the severity grade as: grade 1 (mild), grade 2 (moderate), grade 3 (severe) and grade 4 (potentially life threatening) and grade 5 (death related to AE) for each parameter. Key chemistry parameters included alanine aminotransferase (units per liter), alkaline phosphatase (units per liter), aspartate aminotransferase (units per liter) and bilirubin (micromole per liter). High value indicated higher values than the baseline values and low value indicated lower values than the baseline values. Only those categories in which at least 1 participant had data were reported., Talazoparib: Baseline up to a maximum duration of 71.3 months; Physician's Choice Treatment: Baseline up to maximum duration of 46.1 months|Number of Participants With Potentially Clinically Significant Changes From Baseline in Vital Signs, Criteria for potentially clinically significant changes in vital signs included a) Systolic blood pressure: 1) absolute results (AB) greater than (\\>) 180 millimeter of mercury (mmHg) and increase from baseline (IFB) greater than or equal to (\\>=) 40 mmHg, 2) absolute results less than (\\<) 90 mmHg and decrease from baseline (DFB) \\>30 mmHg; b) Diastolic blood pressure: 1) absolute results \\>110 mmHg and \\>=30 mmHg increase from baseline, 2) absolute results \\<50 mmHg and \\>20 mmHg decrease from baseline 3) \\>=20 mmHg increase from baseline; c) Heart rate: 1) absolute results\\>120 beats per minute \\[bpm\\] and \\>30 bpm increase from baseline, 2) absolute results \\<50 bpm and \\>20 bpm decrease from baseline and d) Weight: \\>10 percent \\[%\\] decrease from baseline., Talazoparib: Baseline up to a maximum duration of 71.3 months; Physician's Choice Treatment: Baseline up to maximum duration of 46.1 months|Number of Participants Taking At-least One Concomitant Medication, Any medication (other than study drug) which was administered to participants during study after first dose of study drug were considered as concomitant medications., Talazoparib: Baseline up to a maximum duration of 71.3 months; Physician's Choice Treatment: Baseline up to maximum duration of 46.1 months Duration of Response (DOR): Investigator Assessment, DOR = time from first radiographic documentation of OR (PR or CR) till radiographic disease progression (PD) as per RECIST v1.1 by investigator assessment or to death due to any cause, whichever was first. RECIST 1.1, a) target lesion (TL): CR= disappearance of all non-nodal TL, target lymph nodes reduce to \\<10 mm in short axis, PR= at least 30% decrease in sum of diameters of TL, compared to the sum at baseline, PD= at least 20% increase in sum of TL measurements, compared to smallest sum on study including baseline, absolute increase in sum has to be at least 5 mm; b) for non-TL: CR= disappearance of all non-TL, PD= unequivocal progression of non-TL, such that treatment has failed, disease is progressing, regardless of status of TL; c) PD =and/or appearance of \\>=1 new lesions. DOR = (earliest date of progression, death, or censoring-date of first documented OR + 1)/30.4375. Analysis was performed by Kaplan-Meier method., From first documentation of CR or PR until disease progression or death due to any cause, whichever occurred first (up to 36.9 months)|Change From Baseline in Global Health Status/Quality of Life (QoL) Measured by European Organization for Research and Treatment of Cancer Quality of Life Questionnaire Core 30 (EORTC QLQ-C30) at Average Duration Over Week 4 up to Week 160, EORTC QLQ-C30: cancer-specific instrument with 30 questions to assess the participant QoL. First 28 questions used to evaluate 5 functional scales (physical, role, cognitive, emotional, social), 3 symptom scales (fatigue, nausea and vomiting, pain) and other single items (dyspnea, appetite loss, insomnia, constipation, diarrhea, financial difficulties). Each question assessed on 4-point scale (1= not at all, 2= a little, 3= quite a bit, 4= very much); functional scales: higher score = better level of functioning; symptom scale: higher score = more severe symptoms; for single items: higher score= more severe problem. Last 2 questions used to evaluate global health status (GHS)/QoL. Each question was assessed on 7-point scale (1= very poor to 7= excellent). Scores averaged, transformed to 0-100 scale; higher score=better quality of life/better level of functioning. Change from baseline was calculated by subtracting the baseline value from the average value of Week 4 to 160., Baseline, Week 4 up to Week 160|Time to Deterioration (TTD) in Global Health Status/Quality of Life (QOL), TTD in global health status (GHS)/QoL=time (in months) from randomization to the first observation with \\>=10 point decrease and no subsequent observations with\\<10 point decrease from baseline in GHS/QoL score based on EORTC-QLQ-C30. EORTC QLQ-C30 is a cancer-specific instrument with 30 questions to assess participant quality of life. Question 29 and 30 were used to evaluate GHS/QoL. Each question was assessed on a 7-point scale (1=very poor to 7=excellent). Scores averaged, transformed to 0-100 scale; higher score=better quality of life/better level of functioning., Baseline up to a maximum duration of 36.9 months|Time to Deterioration (TTD) in Breast Symptoms Scale as Assessed by the European Organization for the Research and Treatment of Cancer Quality of Life Questionnaire Breast Cancer Module (EORTC-QLQ-BR23), TTD was defined as the time (in months) from randomization to the first observation with a\\>=10 point increase and no subsequent observations with a \\<10 point increase from baseline in breast symptom score based on the EORTC-QLQ-BR23. EORTC-QLQ-BR23 is a disease-specific module for breast cancer developed as a supplement for the EORTC-QLQ-C30 to assess the quality of life of participants with breast cancer. EORTC-QLQ-BR23 symptoms subscale includes 4 items: systemic therapy side effects, breast symptoms, arm symptoms, upset by hair loss. Each item is rated by choosing 1 of 4 possible responses that record the level of intensity (1= not at all, 2= a little, 3= quite a bit, and 4= very much), higher scores=high level of symptom/problems., Baseline up to a maximum duration of 36.9 months\n"
          ]
        }
      ]
    },
    {
      "cell_type": "code",
      "source": [],
      "metadata": {
        "id": "wBRhEn-YHE4Q"
      },
      "execution_count": 16,
      "outputs": []
    }
  ]
}